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One of the present challenge in life sciences is the investigation of the roles of 
biomolecules in the molecular machines. Structural biology contributes to address this 
relevant biological puzzle by deciphering the unique tridimensional structure of biomolecules 
since it is directly linked with their function in the cell.  
However, a complete illustration of the activity of biomolecules requires a 
combination of the knowledge of the tridimensional structure at the atomic level with the 
understanding of the nature and role of the conformational dynamics
1
. Therefore, a 
description of the dynamics must be associated to the snapshots of biomolecules frozen in 
their static structures to solve the structure-function paradigm. 
The three-dimensional structure of a biomolecule only provides the lowest energy 
average atomic positions originated from motions of sizable amplitudes experienced by the 
atoms
2
. Such motions can occur on a small timescale (fast motions of the order of picosecond 
to nanosecond), involving atomic fluctuations around the average structure, or can involve 
large-scale reorganization (slow motions up to seconds), occurring in many biological 
processes, such as folding processes, enzyme catalysis, signal transduction and protein-protein 
interactions (Figure 1). 
 
 
 
 
 
 
 
 
Biomolecules must be able to move in order to function and also the fluctuations on 
small timescale observed at the equilibrium govern the biological function itself. In fact, the 
conformational sub-states, sampled at the equilibrium in the fast-timescale, disclose the 
functional conformational states covered by collective domain motions on the slow-timescale. 
Therefore, DNA replication, enzyme catalysis, protein–ligand interactions and signal 
transduction occur as a result of the binding of specific ligands to complementary pre-existing 
states of a biomolecule and the consequent shifts in the equilibria
3
.  
Figure 1. Timescale range for different biomolecules motions. 
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Since the last decades two different mechanisms have been invoked for the description 
and coupling of the processes of ligands binding and conformational changes occurring in 
macromolecules: induced fit and conformational selection. The induced fit mechanism 
concerns with the previous binding of the ligand to the biomolecule and the occurring of a 
subsequent conformational change. Instead, the conformational selection mechanism regards 
the pre-existence of conformational states in the biomolecule independently of the ligand 
presence and their selective stabilization by the ligand binding itself. The issue of distinction 
between the two mechanism has proven to be of fundamental importance in understanding the 
mechanism of biological processes, such as folding mechanism, action of enzymes, protein-
protein interactions and signal transduction
4
. However, when dealing with conformational 
ensembles, where multiple conformations are involved, the distinction between the two 
mechanisms is confusing and both conformational selection and induced fit should be recalled 
to have a more accurate description of the biological process.
5
 
Nuclear Magnetic Resonance (NMR) spectroscopy has emerged as the method of 
choice for studying both biomolecules structure and dynamics in solution.  
NMR-based structure determination relies on the collection of a set of experimental 
structural parameters, such as interatomic distances and dihedral angles, that are implemented 
as restraints in a molecular modeling algorithm to obtain a representation of the 
tridimensional structure of the biomolecule
6
.  
NMR can be exploited also to determine the rates of interconversion between different 
biomolecule states and have a detailed picture of the dynamics, meant as any time-dependent 
change in atomic coordinates. Various timescales (from picosecond up to seconds) can be 
investigated by NMR, with experiments measuring the nuclear relaxation rates. The values of 
longitudinal and transverse relaxation rates provide, indeed, indications about internal 
motions occurring on the fast timescale, shorter than the rotational correlation time (τc), while 
relaxation dispersion measures dynamics in the timescale between microseconds to 
milliseconds.  
The presence of a paramagnetic metal ion in a system affords the possibility to extract 
additional distance, orientational and dynamics information for a more accurate description of 
the biomolecule. Paramagnetism-based constraints, such as pseudo-contact shifts (PCS) and 
residual dipolar couplings (RDC), can be exploited as long-range distance restraints and as 
orientational restraints, respectively, for the structural refinement of proteins in solution
7
. 
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Moreover, the measurement of the modulation of the values of residual dipolar couplings 
(RDC)
8
 provides important indications about the dynamics in the timescale window between 
nanoseconds and microseconds (blind zone), otherwise hidden to NMR relaxation 
measurements
9
. 
The fundamental challenge of NMR remains to combine and reconcile all the available 
structural and dynamic information. In this way, a complete, more accurate and realistic 
representation of the conformational space sampled by biomolecular systems can be obtained, 
and the relationship between structure, dynamics, and function can be resolved
6
.  
Experimental data obtained by NMR represent average values over the entire 
ensemble of conformations that coexist and rapidly interconvert in dynamic equilibrium. 
Therefore, a system can be better described by ensembles of conformations with respect to a 
single static structure
10
. For this reason, solution structures obtained by NMR are provided as 
families of structures displaying higher heterogeneity and lower definition in the regions 
characterized by higher mobility. Moreover, the description of the activity of multidomain 
proteins can be provided only by ensembles of conformations with different reciprocal 
interdomain orientations and positions. The accurate identification of these ensembles 
represent an “ill-defined inverse problem” whose resolution requires the development of 
robust statistical approaches to determine the existence probability of any conformation
11
.  
Changes in global orientation of protein domains are more difficult to characterize 
using NMR alone, and can be determined more accurately by combining NMR with small-
angle X-ray scattering (SAXS)
12
. SAXS is particularly suitable for the study of less structured 
systems, such as intrinsically disordered proteins and multidomain proteins with flexible 
linkers. It provides information about the global shape of the systems, that is handled as a 
mixture of conformations in solution, and accounts for complementary information to NMR
12
. 
Conformational changes always requires hopping from one allowed state to another 
that involves the crossing of a barrier of high energy. A complete description of dynamics 
thus requires a multidimensional energy landscape that defines the relative probabilities of the 
conformational states and the energy barriers between them. As consequence, the timescale of 
the transition depends on the energy barriers themselves (Figure 2). 
Although NMR experiments can determine with atomic resolution the dynamics of 
biomolecules, only molecular-dynamics simulations can speculate about the rationale behind 
the biomolecule motions and provide a complete description of the dynamics. In molecular-
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dynamics simulations the precise position 
of each single atom at any instant in time 
with the associated energy can be 
followed, provided that one high-
resolution structure is known as starting 
point. 
An accurate energy description of 
the system can be, however, achieved only 
if the computational prediction are then 
experimentally validated.  
However, conventional molecular 
dynamics can access only the timescale of the motions of hundreds of nanoseconds and 
biomolecules dynamics on the microsecond-to-millisecond timescale, that mostly occur 
during biological processes, are out of reach for these simulations
3,13
. 
Nevertheless advances in the study of long timescale processes have been recently 
reported with the aid of enhanced sampling techniques, such as metadynamics
14
. 
Metadynamics allows the exploration of the free energy surface (FES) of the process of 
interest combining the idea of coarse-grained dynamics in a space defined by a few collective 
coordinates with the introduction of a history-dependent (adaptive) bias. The chosen 
collective variables (CVs) must describe in the best way all the slow modes relevant for the 
process under study. Metadynamics simulations can be applied for the investigation of ligand-
protein interaction process
13
, protein conformational rearrangement
15
 and folding/unfolding 
processes of nucleic acids.  
In the present research project, an extensive NMR analysis has been carried out on 
four different biomolecules to clarify the structure/dynamics-function paradigm. NMR data 
have been integrated with structural and dynamical information provided by other biophysical 
and computational techniques such as SAXS and metadynamics to better characterize the 
structural and dynamical features of the investigated biomolecules in solution. NMR has thus 
been used i) for the identification of a new DNA structural folding, ii) for the speculation of 
the mechanism of catalysis of an enzyme, highlighting the most probable conformations in 
solution, iii) to underline the functional states of proteins in solution, and iv) to shed light on 
the mechanism of signal transduction of the Receptor for Advanced Glycation Endproducts.  
Figure 2 Free-energy landscape describing the energy 
related to possible motions of biomolecules. 
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NMR is, indeed, the most suitable technique for the structural characterization of 
nucleic acids. A high percentage of DNA and RNA structures, present in structural databases 
(Protein Data Bank (PDB) and Nucleic Acid Database (NDB)), has, actually, been solved by 
NMR. In the present research project, NMR has been used for the experimental validation in 
solution of a new structural folding of DNA identified during metadynamics simulations on 
the folding/unfolding process of a particular DNA construct. The integration of NMR and 
metadynamics techniques has provided a complete description of the properties of this new 
motif and hints for the speculation about the folding/unfolding processes of DNA occurring 
during cell replication. 
The assessment of the conformational space sampled by multidomain enzymes, 
required for the explanation of their mechanism of catalysis, can also be accessed using NMR. 
The description of the ensemble of conformations spanned by a multidomain protein in 
solution can be achieved only with the implementation of sophisticated computational 
approaches. In the present research project, a new computational method (the maximum 
occurrence
16
 approach) has been exploited for the inspection of the conformational 
heterogeneity of the enzyme matrix metalloprotease-1. Using a combination of paramagnetic 
NMR constraints and SAXS experimental data the conformations that can exist for the 
maximum percent of time in solution have been identified; those conformations account for 
the description of the antecedent step of the mechanism of catalysis.  
Detailed knowledge of proteins structural characteristics is necessary for 
understanding their biological function. NMR can provide a high-resolution description of the 
structure acquired by a protein in solution and information about its dynamical properties. In 
this respect, in the present research, the structure, dynamics and metal-binding properties of 
one of the members of S100 proteins family (S100A14) have been solved using NMR 
techniques. The new conformation discovered for this member and its sizable dynamical 
properties account for its functional properties and assess the high heterogeneity of the EF-
hand protein superfamily. 
Membrane proteins and receptors can also be investigated by NMR. Speculation about 
the signal transduction mechanism can be provided by the dynamics analysis of the 
cytoplasmic domain of those proteins. In fact, the extracellular activation of a receptor 
triggers the interactions of its cytoplasmic tail with intracellular partners. In the present 
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research project, the cytoplasmic tail of the multiligand receptor RAGE has been investigated 
by NMR as part of the full-length protein in the presence of a membrane-mimicking 
environment and for comparison purpose as isolated domain. The highlighted versatile 
properties of this domain shed light on the mechanism of the signal transduction. 
Introduction 
8 
 
1.1 A New DNA Structural Motif: the G-Triplex 
 
Nucleic acids represent one of the main class of the biomolecules of interest for 
structural biology because they regulate functions at the basis of cell life.  
Despite DNA oligonucleotides exhibit lower conformational and chemical diversity 
than RNA oligonucleotides, since the discovery of DNA double helix conformation in 1953
17
, 
several folding have been revealed for DNA. Beside the canonical Watson-Crick hydrogen 
bonding scheme present in DNA double-stranded structures (A-DNA, B-DNA, C-DNA, Z-
DNA) a large number of base paring schemes that allow DNA molecules to form high-order 
structures have been identified. Hydrogen-bond complementarity is at the basis of the 
recognition and stabilization of the strands of DNA and among the nonstandard DNA base 
pairing the Hoogsteen pairings
18
 has been found in many tertiary structures. These complex 
tertiary structures of DNA, such as hairpins
19
, cruciforms
20
, parallel-stranded duplexes
21
, 
triplexes
22
, G-quadruplexes
23
 and the i-motif
24
 are involved in many important processes like 
DNA packaging, replication, transcription and recombination. Moreover a strict relationship 
between the sequence composition, the geometry and the function of these oligonucleotides 
has been highlighted. Among those peculiar organizations of DNA, G-quadruplex structures 
have been widely studied. 
 
1.1.1 G-quadruplex DNA structures 
 
During the last decades unusual four-stranded DNA arrangements, named G-
quadruplexes, has emerged as three-dimensional structures of large interest.  
Guanine-rich sequences exhibit G-quadruplex formation tendency and are widely 
distributed in the eukaryotic genome because of their fundamental role in protecting the cells 
from recombination and degradation. Prevalently, these motives can be found at the telomeric 
ends of chromosome
25
, as non-coding repeat sequences associated with the chromosomal 
maintenance, and in other regions with various roles, such as in the promoters of many 
important genes and oncogenes
26
, at the immunoglobulin-switch regions
27
 and in the 
regulation of insulin gene
28
. Telomeres, in particular, are composed of double-stranded 
(TTAGGG)n repeat sequences with protruding 3’ single-stranded overhang that can fold back 
into a G-quadruplex structure. The maintenance of telomeres length is ensured by telomerase 
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activity that adds repeats to their ends. In human somatic cells, telomerase activity is 
gradually lost at each mitotic cycle causing the shortening of telomeres with the associated 
genomic instability, growth arrest and eventual cell death
29
. Conversely, transformed cells, 
such as cancer cells, can bypass the progressive telomere loss and the limitations on 
proliferation by activating telomerase and thus becoming immortal cells. Many telomerase 
inhibitors have therefore been proposed as anticancer drugs. Furthermore, G-quadruplexes 
have been shown to inhibit telomerase activity and drugs that stabilize these tetraplex 
structures can interfere with telomere replication
30,31
. In this respect, the interest in the study 
of the structure and folding/unfolding process of this particular DNA folding has increased. 
G-quadruplexes are constituted by a core of squares of guanine tetrads or G-tetrads 
stacked one upon the other. A G-tetrad consists of a planar arrangement of four guanine bases 
associated through a cyclic array of Hoogsteen-like hydrogen-bonds in which each guanine 
accepts and donates two hydrogen-bonds (Figure 3).  
G-quadruplexes are characterized by extensive polimorfism depending on the strand 
stoichiometry and polarity, on the glycosidic torsion angle variation and on the conformation 
of the connecting loops
32
. In fact, G-quadruplexes can be formed by the association of one up 
to four strands and irrespective of the stoichiometry, the strands can come together in four 
different ways: all parallel, three parallel and one antiparallel, adjacent parallel, or alternating 
antiparallel. Moreover, unlike canonical B-DNA tertiary structures, that present exclusively a 
anti conformation for the glycosidic torsion angle, in G-quadruplexes organization both the 
syn and the anti conformation are observed (Figure 3). The glycosidic conformation 
Figure 3. G-tetrad representation. In this case, the strands are alternating antiparallel and 
the Guanines have opposite glycosidic torsion angle conformation. Two wide and two 
narrow grooves are produced. Representation of the syn and anti conformations.  
Introduction 
10 
 
influences indeed the relative orientation of bases in the G-tetrad and also affects the stacking 
energy. For example, if the guanines forming the G-tetrads are located in antiparallel strands 
they must have opposite torsion angles to be in the correct orientation to form Hoogsteen-like 
hydrogen-bonds. Furthermore the stacking of guanine tetrads produces four grooves that are 
not necessarily identical but can be wide, narrow and medium; i.e. in the case of alternating 
antiparallel strands exclusively two wide and two narrow grooves are produced (Figure 3).  
Those grooves are the sites of specific recognition of partners such as proteins and of 
therapeutic agents that acts through electrostatic interactions and intercalation with π-π 
stacking, exploiting the particular features of this structure.  
The sugar puckering usually adopted by bases in B-DNA is the C2’endo. In the case of 
G-quadruplexes the bases in the anti conformation usually adopt a C2’endo sugar puckering, 
instead the bases in the syn conformation can adopt also the C3’endo organization. 
The loops that connect the G-tetrads run on the outside of the guanines core and form 
either diagonal or edgewise tracts. Most of those loops are not loose or flexible but form 
stacking interactions with the guanine tetrads close to them. The conformation and 
composition of the loops can vary among the different G-quadruplexes and are also 
responsible of the specific interaction with partners
23
. 
In addition to the eight Hoogsteen hydrogen bonds the G-quadruplex tertiary 
structures are further stabilized by the presence of metal ions, such as sodium, potassium and 
strontium that can fit well in the cavities formed by the stacking of guanine tetrads. The cavity 
between two planes of guanine tetrads is lined by eight carbonyl oxygen atoms that can all 
participate in the precise coordination of cations, reducing the repulsions and further 
promoting the stacking itself of the G-quartets. Most of G-quadruplexes greatly prefer 
potassium as coordinating ion, whose concentration is also higher than other metal ions in live 
cells nuclei (around 150 mM). In this respect, in living cells the presence of other ions can 
hinder the G-quadruplexes formation. 
New G-quadruplex structures still continue to emerge and provide insight into their 
biological roles in the telomere function. NMR is a unique method to screen for the formation 
of nonstandard structural elements and establish local details and stability as well as dynamic 
behavior of noncanonical helical-type structures with single residue resolution. 
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1.1.2 The Thrombin-binding aptamer (TBA) 
 
The thrombin-binding aptamer (15-TBA) is an intriguing example of a DNA assuming 
a G-quadruplex structure and for this reason it has been widely characterized and studied. 
Aptamers are synthetic DNA or RNA oligonucleotides that specifically bind with high 
affinity a wide range of targets, from small molecules to whole cells.  
15-TBA was screened from a randomly generated population of sequences for its 
ability to bind a desired molecular target, such as the serine protease thrombin, which plays a 
key role in the blood coagulation cascade. This aptamer was, indeed, able to inhibit the 
thrombin-catalyzed fibrin-clot formation in vitro via thrombin binding. In addition to its 
intrinsic affinity for thrombin and potential medicinal value, 15-TBA also represents an 
important system to study the structure and the basic physical chemistry of G-quadruplex 
DNA folding. It contains the minimum number of G-quartets (just two) formed by 15 
nucleotides (15-mer), d(GGTTGGTGTGGTTGG). The oligonucleotide folds into a 
unimolecular quadruplex
33
 where the 
two G-quartets are linked by two TT 
loops at one end and a TGT loop at the 
other end. The nucleotides in the two G-
quartets are 5'-syn-anti-3' along each 
strand. Adjacent strands are anti-
parallel, resulting in G-quartets in which 
the bases are alternately syn and anti 
around the quartet and interact with 
head-to-tail faces; two wide and two 
narrow grooves are formed (as 
illustrated in the scheme above, figure 
3). The two TT loops span the narrow 
grooves at one end and the TGT loop 
spans one of the wide grooves at the 
other end of the quadruplex
34
 (Figure 
4).  
X-ray and NMR structures have 
Figure 4 Thrombin binding aptamer. In cyan the G-tedrads 
core, in orange the TT loops spanning from one side and in 
violet the TGT loop spanning on the other side of the G-
tetrad. 
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been deposited for the isolated 15-TBA
34,35
 and for 15-TBA in complex with thrombin
36
. The 
two models are mutually inconsistent differing both in chain direction and loop geometry. 
Molecular dynamics simulations performed using these models as starting structures, 
respectively, strongly support the NMR-based model of 15-TBA
34
. Moreover, those 
simulation highlight the importance of the loops in the stabilization of the G-stem, being the 
whole 15-TBA NMR-structure more stable than the G-quartet stem alone, and at least two 
nucleotides (G8 and T9) stacked with the upper G-quartet are needed for the molecule’s 
viability. Conversely, the X-ray structure resulted less stable than both the NMR structure and 
the G-quartet stem
37
. The TT loops have a destabilizing effect and are essential for the 
interaction with thrombin. A further stabilization for the structure is provided by potassium 
ion coordinated in the middle of the two G-quartets. 
 
1.1.3 Folding/unfolding process of G-quadruplex formation 
 
The understanding of quadruplex conformation and dynamics is crucial to elucidate its 
function. Although, the G-quadruplex conformation has been described in many studies, the 
details of the dynamics occurring during the folding/unfolding are not clearly understood.  
Single-molecule fluorescence resonance energy transfer (FRET) was previously used 
to investigate conformational heterogeneity and dynamics fluctuations in nucleic acids
38
. 
Other conditions and constructs were then exploited by another group to study the process of 
G-quadruplex formation
39
. Conformations different from G-quadruplex were highlighted in 
these studies as important intermediates for the folding process.  
Independent studies performed recently using molecular dynamics simulations
40
, have 
proposed that those intermediates could assume a hairpin and a triplex structure. These 
predicted G-triplex conformations diverge from the already known triplex
41
 structures 
because constituted by G:G:G triad planes stabilized by an array of Hoogsteen-like hydrogen-
bonds.  
The existence of a G-triplex structure has been evidenced by NMR in the (3+1) G-
quadruplex structure, where it has been proposed that constructs displaying only three tandem 
guanine repeats can form an asymmetric heterodimeric complex between the three-repeats 
and a single-repeat of the human telomeric sequence
42
. Nevertheless, stand-alone G-triplex 
structures were not directly observed in three tandem guanine repeats.  
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The only experimental evidence of an intramolecular folding in three tandem guanine 
repeats of human telomeric DNA has been recently proposed using optical-tweezers, MD 
simulation and circular dichroism
43
. A mechanically and thermodynamically stable species in 
this sequence has shown a structure consistent with a triplex conformation. The G-triplex was 
found to be less stable than the G-quadruplex due to the greater contribution from stronger 
base stacking and higher number of Hoogsteen hydrogen bonds in the latter. However, with 
this experimental evidence the existence of an intramolecular G-triplex folding can only be 
hypothesize.  
Currently, the G-triplex conformation has thus not been experimentally demonstrated 
yet with a model at atomic resolution.  
 
1.1.4 Aim of the project 
 
Only advanced state-of-the-art computations, such as metadynamics, can allow the 
identification of short-lived and less stable states of biomolecules and can thus be used for the 
description of the intermediates of a pathway. Therefore, in the present research project a 
combination of metadynamics simulations with NMR, circular dicronism (CD) and 
differential scanning calorimetry (DSC) experiments was carried out for the identification of 
an intramolecular G-triplex DNA structural motif. 
The folding/unfolding process of the DNA G-quadruplex, thrombin binding aptamer 
(15-TBA), has been described through well-tempered metadynamics simulations and the 
formation of a very stable intermediate, displaying G:G:G triad planes stabilized by an array 
of Hoogsteen-like hydrogen-bonds, has been highlighted.  
The present project aims at providing an experimental evidence to this new DNA 
structural motif. A truncation of 15-TBA, involving the last strand at the 3’ ends 
(d(GGTTGGTGTGG)), has been investigated and its intramolecular folding with G-triads 
planes has been confirmed using NMR distance constraints. 
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1.2 Towards the characterization of the mechanism of 
collagenolysis by matrix-metalloprotease-1 
 
a) The family of Matrix Metalloproteases  
 
Matrix metalloproteases (MMPs) are a family of extracellular hydrolytic enzymes in 
charge of the degradation of the components of the extracellular matrix (ECM).  
MMPs belong to the metzincin superfamily of metalloproteinases, characterized by the 
presence of a catalytic zinc atom in the active center and the HEXXHXXGXXH/D zinc-
binding consensus sequence, followed by a conserved methionine residue. The family of 
human matrix metalloproteinases includes 24 members, displaying different substrate 
specificity for the components of the extracellular matrix. The latter is a heterogeneous 
mixture of well-organized and well-structured proteins, such as collagens, elastines, laminins, 
fibronectins and proteoglycans, that provides the scaffold on which cells and tissues are 
anchored. However, extracellular matrix, is not a passive support for cells but acts also as 
reservoir for embedded cytokines and growth factors. Moreover, the ECM conceals “cryptic” 
information within the proteins that constitute itself
44
. 
An old classification of MMPs
45
 was performed on the basis of substrate preferences 
and MMPs were subgrouped as: i) stromelysins (MMP-3, MMP-10, MMP-11), ii) gelatinases 
(MMP-2, MMP-9), iii) collagenases (MMP-1, MMP-8, MMP-13), iv) elastases (MMP-12), v) 
matrylisins (MMP-7, MMP-26) and vi) membrane proteins (MMP-14, MMP-15, MMP-16, 
MMP-24). However, their selectivity towards these substrates is not high
46
 and most of them 
hydrolyze also other extracellular components
47
, such as extracellular domains of membrane 
receptors
48
, as well as other proteases.  
Recent classifications are based on bioinformatics and structural analysis, which 
through sequence and structural alignment allow to identify five main groups: i) non-furine 
regulated MMPs, ii) gelatinases, iii) transmembrane MMPs, iv) glycosylphosphatidylinositol 
(GPI)-anchored MMPs and v) others
49
.  
MMPs are involved in several physiological functions such as embryogenesis, tissues 
growth, development
50,51
, wound healing, and cell migration. However, MMPs function does 
not depend only on the direct effect of the hydrolysis of the extracellular matrix
52,53
 but is also 
related to the release and activation of cytokines and growth factors stored inside and to the 
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disclosure of the “cryptic” information by generating bioactive fragments. In this way, MMPs 
can modulate the activities of a wide range of extracellular but also intracellular proteins and 
regulate cell proliferation, adhesion, migration, growth factor bioavailability, chemotaxis, and 
cell-signaling
54
. Recently, an intracellular localization has been reported for some members 
and a role in the proteolysis of intracellular substrates proposed
55
.  
Because of their potential 
destructive effect, MMPs activity is 
strictly regulated in healthy tissues 
(Figure 5) by a tight control of 
expression, secretion and clearance and 
by the presence of endogenous 
inhibitors, tissue inhibitors of 
metalloproteinases (TIMPs)
56
. 
Moreover, MMPs are produced by the 
cell as inactive with a pro-domain 
preventing the enzymatic activity that is 
then removed by proteolytic cleavage. 
Some of the members of the MMPs 
family themselves participate in the 
activation of other members, for 
example the subgroup of stromelysins 
regulates collagenases function
57
 and the membrane-type metalloproteinases, such as MMP-
14, activate MMP-2
58
.  
When the balance among the inhibition and activation of MMPs is disrupted, 
pathological states occurs. In fact, the dysregulated activity of these enzymes is associated to 
some diseases, such as inflammatory and auto-immune disorders, rheumatoid arthritis, cancer 
and metastasis
59
. Some synthetic inhibitors of MMPs were thus designed as potential anti-
cancer drugs
60
. Unfortunately, these molecules failed the clinical trials due to side effects and 
a poor pharmacological activity. The main reasons of these unsuccessful results are related to 
the no proper MMPs subgroup selection by these inhibitors
61
 and to the different roles exerted 
by various MMPs in distinct stages of cancer
62
, to such extent that the inhibition of the 
activity of some MMPs can exacerbate the pathology. Therefore, the future development of 
MMPs inhibitors as anticancer drugs comprise the identification of more selective molecules 
Figure 5. Regulation of MMPs function at various levels.
49
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towards the mechanism of action of specific MMPs
63
 or the identification of particular 
exosites (see later).  
 
b) Structural and dynamic features 
 
MMPs are synthesized as zymogens with a signal peptide which leads them to the 
secretory pathway. Then, they can be secreted outside the cell or can be anchored to the 
plasma membrane, thereby confining their catalytic activity to the extracellular space or to the 
cell surface, respectively 
(Figure 5). However, 
several MMP family 
members
52,55,64
 can be 
found also as intracellular 
proteins, although their 
functions at this subcellular 
location are still unclear.  
Most of MMPs are 
constituted by a prodomain 
(from 66 to 80 amino 
acids), a catalytic 
metalloproteinase domain 
(of about 160 amino acids) 
and a hemopexin domain 
(of about 210 amino acids) 
connected to the catalytic 
domain by a linker peptide 
of variable length (Figure 
6).  
The prodomain maintains the active site inaccessible to substrates through a cysteine 
switch PRCXXPD consensus sequence, until the proteolytic activation occurs.  
The catalytic (CAT) domain is largely conserved in all MMPs and consists of three α-
helices, a twisted five-stranded β-sheet and eight intervening loops. In almost all MMPs the 
CAT domain contains two zinc(II) ions, one responsible for the catalytic activity, and the 
Figure 6. General structural representation of MMPs. The pro-domain, 
CAT and HPX domains are highlighted in the figure. The active site with 
the zinc(II) ligands and the loop L8 that flanks the S1’ pocket are colored 
in blue. 
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second with a structural function. Furthermore, in the CAT domain from one to four 
calcium(II) ions with structural role are present.  
The catalytic zinc(II) ion is coordinated by three conserved histidines and by one 
water molecule that is hydrogen bonded to the catalytically relevant glutamate and is, in this 
way, activated for a nucleophilic attack towards the peptide bond of the substrate, allowing its 
hydrolysis also at neutral pH
65
. The substrate binding groove is constituted by the catalytic 
zinc ion and several binding pockets. The hydrophobic S1’ pocket, delimited by the last loop 
(L8), represent together with the zinc(II) ion, the preferred site for synthetic inhibitors. In fact, 
this loop is a region of relatively large variability among MMPs and can be targeted in order 
to have selectivity
66
. The inhibitors bind the active site in a way that resembles the substrate in 
the transition state, fitting the deep S1’ pocket with a lipophilic moiety67. 
The hemopexin-like 
(HPX) domain has the same 
structural features in all the 
members of the family and it 
is constituted by four β-
sheets organized in a 
symmetric four-blade 
propeller, forming a deep 
tunnel closed by a calcium 
ion at the bottom. The 
folding of HPX domain is 
stabilized by a disulfide 
bridge that links the 
beginning of the first blade 
with the end of the fourth 
blade of the propeller.  
These two domains 
experience large amplitude 
motions in correspondence 
of the loops. Especially the loop flanking the S1’ pocket in the CAT domain, mainly involved 
in the substrate recognition, is characterized by high flexibility in all the members of the 
Figure 7 Schematic domain structure of MMPs with the corresponding 
linker length
68
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family, indicating the importance of conformational heterogeneity in these domains for the 
hydrolysis of the substrates
68
. 
The CAT and the HPX domain are connected together by a proline-rich linker whose 
length vary among the members of the family (Figure 7) ranging from 14 amino acids in 
collagenases (MMP-1, MMP-8 and MMP-13) to 68 AA in MMP-9. 
The linker allows large interdomain flexibility and binding to structurally unrelated 
substrates with a variety of molecular conformations. It, thus, permits interdomain 
reorientation during the explication of the mechanism of these enzymes. 
Interdomain flexibility of two of the members of the family with the shortest linkers 
(MMP-1 and MMP-12)
69,70
 has been recently investigated by a combination of solution NMR 
and SAXS measurements. NMR relaxation data indicated that the two domains are not rigidly 
held to each other but they can experience independent motions. Moreover, the analysis of 
SAXS data indicated that a good description of the behavior of these proteins in solution can 
be provided only when ensembles of heterogeneous conformations are taken into account. In 
fact, the crystallographic structures displaying a closed conformations, when taken alone, fail 
in the description of experimental data. Instead, when these structures are flanked by a 
significant amount of extended conformations in equilibrium with the closed ones, a good 
agreement with the experimental data is achieved. 
From these observations it was shown that the two domains can freely reorient among 
each other. This data can, however, hardly provide a quantitative and detailed description of 
the conformational heterogeneity of the protein and highlight the most probable 
conformations sampled in solution, that are necessary to afford hints for the mechanism of 
collagenolysis.  
 
c) MMP-1 and the collagenolytic mechanism 
 
Collagens are the major structural proteins of connective tissues and can be classified 
in three different types, I, II and III. Interstitial collagens have a unique molecular structure 
that consist of three α-chains staggered by one residue and constituted by repeating Gly–X–Y 
triplets, where X and Y are often proline and hydroxyproline, respectively
71
. Each α-chain, for 
the high content of proline and hydroxyproline in the sequence, forms a left-handed poly-Pro 
II-like helix. The three α-chains are coiled in overall right-handed superhelical 
conformation
72
, stabilized by hydrogen bonds among the backbones of three α-chains, that 
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make the structure resistant to many proteases. In vertebrates, the only enzymes that can 
cleave this very complex triple-helical structure are collagenases
56
 of the MMPs family and 
cathepsin K
73
 produced by osteoclasts.  
The preferential cleavage site of MMPs on the three α-chains of native triple-helical 
collagens is after a Gly residue. In particular, the sequence of choice is (Gln/Leu)–
Gly#(Ile/Leu)–(Ala/Leu) (# indicates the scissile bond), that is located approximately three 
quarters away from the N-terminus of the entire collagen molecule. Once collagens are 
cleaved into 3/4 and 1/4 length fragments
74
, they denature at physiological temperature and 
can be degraded by gelatinases
75
 or by other non-specific proteases. 
Among the collagenases, MMP-1 can cleave collagen type I, that is constituted by two 
α1 chains and one α2 and is 3000 Å in length and 15 Å in diameter. Although the CAT domain 
of MMP-1 by itself can cleave a number of non-collagenous proteins, its activity on native 
triple-helical collagen is negligible. In particular, it has been demonstrated that the presence of 
the HPX domain is required for the degradation of collagen type I by MMP-1
76,77,78,79,80,81,82
, 
although the molecular details of the collagenolysis have not been completely elucidated. 
HPX domain has been proven to locally unwind the triple-helix in correspondence of the 
cleavage site, that is also more susceptible to change in conformation at high temperature. In 
this way, the accommodation of a single 
filament of collagen, otherwise inaccessible, in 
the CAT domain cleft, is allowed. The CAT 
domain partially participate itself in the local 
perturbation of the triple helical structure of 
collagen and is responsible of the sequential 
cleavage of the chains one by one (Figure 8). 
The two domains, joint together by the linker, 
cooperate for the interaction with collagen and 
the global affinity of the full-length protein is 
increased because of the benefit in the entropic 
contribution
81
.  
The overall reinforcement of the 
interaction due to cooperativity in the full-
length protein with respect to the isolated 
Figure 8 MMP-1 binds to and locally unwinds 
collagenbefore it cleaves the triple-helical 
interstitial collagen. 
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domains has been recently demonstrated also by NMR
83
. The surface of HPX domain, 
comprising blades 1 and 2 of the four-bladed propeller, has been identified
83,84
 as responsible 
for the binding of collagen and for its destabilization and unwinding. Intriguingly, the HPX 
domain exosites are concealed in the interface between CAT and HPX domains in the crystal 
structure of full-length MMP-1
85
. This further suggests the presence of an equilibrium in 
solution among the closed conformation and more open/extended ones, that are also more 
poised for the interaction with collagen.  
Also the region on collagen, where the binding of HPX domain occurs, has been 
Figure 9. The initial steps of collagenolysis. (A) Equilibrium between the closed (left) and open/extended (right) 
forms of FL-MMP-1 in solution. (B) The extended protein domain binds the first two chains of THP with the HPX in 
a position downstream the cleavage site and with the CAT domain near the cleavage site. The THP is still in a 
compact conformation. (C) Closed FL-MMP-1 interacting with one of the released chain (in magenta). (D) After 
hydrolysis, both peptide fragments (C- and N-terminal) are initially bound to the active site. (E) The C-terminal region 
of the N-terminal peptide fragment is release84,65 
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highlighted using a collagen-like peptide and a plausible mechanism of collagenolysis has 
been proposed (Figure 9). The HPX domain drives the mechanism, interacting with the first 
two chains of THP in a position downstream to the cleavage site. Then the correct positioning 
of the CAT domain in front of the cleavage site is facilitated by interdomain flexibility and 
reorientation.  
The linker flexibility appears thus crucial for the mechanism of collagenolysis by 
allowing the proper reorientation of the two domains during the catalysis. In particular, the 
residue Gly-271 in the linker has been reported to be critical for this mechanism and its 
substitution with bulkier amino acids reduces the efficiency of catalysis because of alteration 
of the flexibility of the linker
86
. In fact, once bound to collagen, a back-rotation of the HPX 
and CAT domains, to achieve the energetically favored closed conformation of the 
crystallographic structure, needs to occur, to induce the conformational change in the 
collagen. In this way, the overall favorable energetics, associated with the mechanism of 
collagenolysis, can readily account for collagen catabolism without the necessity of external 
energy source (such as ATP)
83
. 
Recently the complex between the full-length MMP-1 and a collagen-like peptide has 
been crystalized and the extensive interactions between CAT and HPX domains and collagen 
highlighted
87
. MMP-1 binds collagen in an extended manner rather than surrounding it and 
involves for the interaction many recognition sites distant from the catalytic site itself 
(exosites). This findings also agrees with a proposed “inchworm” mechanism88 for the 
progressive movement and processing of collagen fibrils by matrix metalloproteases. 
Although all aspects of collagenolysis have not been clarified yet, most of the 
experimental evidences suggest that the interdomain flexibility and conformational 
reorganization is fundamental for this enzymatic mechanism. Therefore, a detailed inspection 
in the internal dynamics of this multidomain enzyme is a prerequisite to enlarge the 
knowledge about collagenolysis. 
 
d) Use of paramagnetic NMR for the study of dynamical properties 
 
Paramagnetic NMR has been widely exploited for the study of the structure and 
dynamics of globular and multidomain proteins and for protein-protein interactions.  
Biological systems can be naturally paramagnetic because of the presence of 
constitutive paramagnetic metal ion (such as Fe(III) or Cu(II)) or can be made artificially 
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paramagnetic by replacement of structural diamagnetic metal ions with paramagnetic ones 
89
. 
Moreover, the implementation of tags chelating lanthanides with different paramagnetic 
strength has been largely employed as alternative
90
, since this allows to select whatever 
position on the surface of any protein and monitor specific properties. For the use of 
paramagnetic experimental data as structural constraints, at least three different paramagnetic 
metal ions have to be exploited. In fact, only in this way it is possible to remove the 
symmetric, not real (or ghost) solution deriving from the degeneracy in the PCS and RDC 
equation (see Methodological Aspects). 
Important prerogatives for these tags are the absence of isomerization and the rigid 
functionalization to the protein with well-defined position of the metal ion with respect to the 
protein. In fact, only in these cases single signals can be detected for the protein and no 
averaging of paramagnetic constraints due to motions of the tag with respect to the protein 
occurs, respectively.  
Caged Lanthanide NMR Probe 5 (CLaNP-5)
91
 has been widely used to introduce 
paramagnetic centers in diamagnetic proteins because it does not give isomerization, for its 
symmetry, and it is rigidly attached
92
 to the protein via two disulphide bridge provided by two 
cysteins engineered on the protein surface. 
Pseudo-contact shift (PCS) and residual dipolar coupling (RDC) can be investigated as 
distance and orientation constraints. Their combined use allows to highlight many important 
characteristics of a system. First of all it is possible to derive with high accuracy the 
orientation and magnitude of the tensors of the paramagnetic metal ions from PCS since they 
are less sensitive to local structural disorder and mobility. Second, the simultaneous use of 
PCS and RDC provides indications about local and global flexibility and about 
conformational freedom. Moreover, it is possible to exploit these paramagnetic constraints to 
determine the relative position and orientation of secondary structure elements (α-helices or 
β-sheet) and of entire domains with respect to the metal ion frame and to refine 
crystallographic structures accordingly to their values. 
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1.2.1 The catalytic domain of MMP-1 studied through 
tagged lanthanides 
 
1.2.1.1. Structure refinement 
 
Detailed information about the structure in solution of soluble proteins is required to 
better understand their function. However, NMR solution structures are not very precise 
because of the relatively few and loose experimental restraints and the precision of an “atomic 
resolution” crystal structure can never be obtained by NMR. On the other hand, 
crystallographic structures are more reliable, and are often taken as models of solution 
structures, although they may be inaccurate for the representation of the structure in solution 
because affected by crystal packing forces and evaluated in static conditions.  
A possible strategy to obtain accurate and precise structures in solution is that of using 
a relatively good crystal structure as starting model and refining it by applying well-selected 
NMR restraints sensitive to local and/or global changes. An example of this strategy is 
provided by the use of PCS from a paramagnetic ion in a metalloprotein
93
. Also RDC 
measured with external orienting media have been proposed and used with high success
94
. 
More recently, a strategy for the refinement of protein structures or domains assumed to be 
rigid, based on the measurement of paramagnetism-based PCS and RDC deriving from a 
paramagnetic center, was proposed
7
. 
PCS and RDC, in fact, can act as reporters of structural information because they 
depend on the position of the observed nuclei (for PCS) or on the orientation of the vector 
connecting dipole–dipole coupled nuclei (for RDC) with respect to the paramagnetic 
susceptibility anisotropy tensor of the metal ion. PCS and RDC are, thus, differently sensitive 
to local and global motions.  
PCS are mostly sensitive to large global protein conformational changes, and are 
scarcely affected by local mobility and structural inaccuracies. A robust estimation of the 
tensor of magnetic susceptibility anisotropy and of the position of the metal ion with respect 
to the protein can thus be obtained using PCS, once a structural model of the protein is 
available. 
RDC, on the other hand, are sensitive also to small local reorientations and their 
agreement with crystal structures can be very poor. This can be caused both by local structural 
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inaccuracies and by global conformational differences and therefore RDC can be used for the 
adjustment of the orientation of protein regions.  
Hence both PCS and RDC can be used to refine the structure through the PCS tensor. 
Moreover, the independent availability of an accurate estimate of the orientation tensor from 
PCS, actually permits a more quantitative use of RDC themselves for both structural and 
dynamical considerations.  
 
1.2.1.2. Aim of the project 
 
Previous protocols for structural refinement concerned with the use of dihedral angles, 
resulting from a crystal structure to fix the model, and the implementation of paramagnetic 
constraints (PCS and RDC), to drive local adjustments. The drawback of such approach is that 
even small changes in the values of backbone dihedral angles may result in relatively large 
structural changes after propagation on a number of residues, so that the protein structure may 
result distorted if the experimental restraints are few. 
In the present research project, a new protocol has been proposed with the aim of 
obtaining structures with increased accuracy by anchoring the structure itself to the position of 
the atoms in the crystal model and adjusting only locally the orientation of the plane of bond 
vectors according to the solution paramagnetic constraints. With this protocol, PCS and RDC 
have been used to access the quality of X-ray structures and to refine them in solution 
performing only small variation. Two distinct cases have been considered and analyzed. In 
particular, if the solution and solid state structures are similar, a good agreement with 
paramagnetic experimental constraints can be achieved and the structure can be refined. 
Conversely, when the solution and solid state structures present different orientation for one 
or more secondary structural elements, the good agreement cannot be obtained.  
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1.2.2 Analysis of conformational heterogeneity in 
multidomain enzymes: the prologue of MMP-1 
collagenolysis 
 
1.2.2.1 Study of the conformational heterogeneity of multidomain proteins using 
paramagnetic NMR: the maximum occurrence approach. 
 
Flexible systems, such as intrinsically disordered proteins and multidomain proteins 
with flexible linkers, can only be described by ensembles of structures in equilibrium with 
each other that take into account all the possible orientations and conformations acquired by 
the system. Usually multidomain proteins and unfolded proteins are involved in relevant 
biological functions and understanding their conformational heterogeneity is crucial for the 
investigation of their mechanism of action. However, the identification of ensembles of 
conformations sampled by these proteins from the solution average data represents an “ill-
defined inverse problem”11, because it has not a unique solution and instead infinite number 
of ensembles, not necessarily endowed of physical significance, can reproduce the 
experimental data. Various approaches have thus been proposed to solve this paradigm.  
A combination of paramagnetic NMR with theoretical modeling through ensemble 
simulations is generally used to describe the conformational space covered by flexible 
systems in spite of NMR alone that can only provide a single, unique and averaged 
conformation. 
The general approach adopted for globular proteins of limited mobility has been that 
of generating heterogeneous ensembles of conformations including the dynamics features of 
the protein to better fit the experimental parameters
1,95,96,97
.  
The algorithm flexible meccano
98
 has been developed in the case of intrinsically 
disordered proteins to sample the conformational space on the basis of residue-specific 
propensity and side chains volume
99
. In this way, with the implementation of paramagnetic 
NMR restraints and SAXS data, it is possible to study the structural propensity of these 
proteins by selecting the best ensembles of conformers that better fits the experimental data 
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by averaging. Non-uniform weights can be given to the conformers with the inclusion of 
different numbers of conformers with similar shapes
12
.  
Towards the characterization of flexible systems, paramagnetic relaxation 
enhancement (PRE) has been widely used to detect transient sparsely populated states of 
multidomain proteins
100
 as well as transient intermediates of macromolecular dynamic 
complexes
101
, such as encounter ensembles
102,103
. With this approach, it is possible to 
determine the minimum degree of mobility of the system, necessary to recover an agreement 
with the experimental data and to define a probability distribution map for the lower 
populated states using ensemble simulated annealing refinement against paramagnetic 
relaxation enhancement data
101,102
.  
In the laboratory where I have performed my doctorate, for the structural and 
dynamics characterization of systems displaying conformational heterogeneity the idea of the 
maximum allowed probability (MAP)
104,105,106
, then extended to the maximum occurrence 
(MO)
16,107,108,109,110
 of a conformation, has been proposed. With the MAP approach, the 
conformations, defined by orientation plus translation, with the maximum probability to be 
sampled in solution by a protein with two rigid domains relatively free to move with respect 
to each other, could be searched and highlighted. The combined use of three set of PCS and 
RDC allowed to discriminate between real and symmetric ghost solutions.  
With the evolution of the concept of the maximum occurrence, moreover, it is possible 
to assess the entire conformational space experienced by a multidomain protein and provide 
for each sterically allowed conformation a MO value, combining together paramagnetic NMR 
and SAXS constraints as averaged experimental data. The MO of any given conformation can 
be thus calculated and the regions with largest MO, as well as the regions which cannot be 
significantly sampled by the system, are identified. The maximum occurrence is defined as the 
maximum weight that a conformation can have, when taken together with any ensemble of 
conformations with variable weights, and still be in agreement with the experimental data. 
Since many different ensembles can equally well describe the experimentally averaged data, 
without necessarily be really represented in solution, no reliability can be given to the 
structures of the ensemble surrounding the selected conformation. Therefore, unlike ensemble 
averaging approaches, which can recover the conformational variability but give only 
plausible ensembles of conformations, with the maximum occurrence approach specific 
conformations sampled by the systems with their upper limit probability can be identified. In 
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this way, a more rigorous description of the conformational space of multidomain proteins 
can be given
111
.  
Moreover, the maximum occurrence method, scoring the conformations according to 
the maximum percent of time they can exist in solution, provides a distinct, even if not fully 
complementary, information to that obtained with the other described approaches
100
. Those 
approaches, in fact, search for the minimum lifetime of lower populated conformational states 
of multidomain proteins and complexes using paramagnetic relaxation enhancement alone.  
The possibility of using together independent constraints, that are averaged in different 
ways in solution, such as paramagnetic constraints and SAXS data, allows to obtain MO 
values closer to the actual probability of the conformations in solution. In fact, increasing the 
number of variables used in the simulated annealing calculation, the MO values of less 
probable conformations decrease more than those of more probable conformations allowing 
an accurate mapping of the conformational space
108,110
. Moreover, with a higher number of 
independent constraints some possible ghost solutions due to degeneracy of both PCS and 
RDC can be better removed. 
 
1.2.2.2 Aim of the project 
 
 The mechanism of collagenolysis by matrix metalloprotease-1 is at the basis of many 
physiological and pathological processes. Many speculations about this mechanism based on 
experimental data have been carried out since many years. The identification of the 
interaction areas of the two domains of MMP-1 and of a collagen-like peptide by NMR 
allowed to hypothesized a plausible mechanism for the collagenolysis in this laboratory
83
.  
 Interdomain flexibility has been also largely invoked for the occurrence of the 
hydrolysis of structurally well-organized components of ECM, such as collagens. 
 In the present research project, the most probable conformations to be sample in 
solution by this multidomain enzyme have been highlighted using a recently developed 
computational method, the maximum occurrence approach. Moreover, with this method it is 
possible to obtain a complete characterization of the conformational space of the active MMP-
1 in the absence of the substrate. The maximum occurrence value, defined as the maximum 
percent of time a conformer can exist in solution together with any ensemble of 
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conformations and be in agreement with experimental data, has been evaluated for more than 
1000 random conformations covering all the possible conformational space. In this way, both 
the regions with high occupancy and those with low probability to be sampled have been 
identified.  
The conformations with the highest maximum occurrence value are more extended 
and a have different interdomain orientation with respect to crystallographic structures. 
Moreover, the HPX binding region in these high MO conformations is solvent exposed.  
This analysis sheds light on the elusive step preceding the collagenolysis and better 
elucidate the mechanism itself.  
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1.3. Solution structure and dynamics of human 
S100A14 
 
1.3.1. The S100 proteins family 
 
The family of the S100 proteins includes more than twenty calcium(II)-binding 
proteins, that belong to the EF-hand superfamily
112
. The members of the EF-hand superfamily 
are involved in the regulation of the intracellular calcium(II) homeostasis and/or in the 
transduction of the intracellular calcium(II)-mediated signals. These proteins are thus 
important for the regulation of numerous cellular functions, including the cell cycle, muscle 
contraction and apoptosis. Moreover, they have been implicated in various disease states, 
including cancer, Alzheimer’s disease, and rheumatoid arthritis.  
S100 proteins are calcium(II) sensor proteins and constitute one of the main protein 
families implicated in the aforementioned activities. They are expressed in a cell and tissue 
specific manner and have a variety of intracellular biological roles, such as the regulation of 
cytoskeletal protein assembly
113
, 
protein phosphorylation
114
, the 
activities of enzymes
115
, the cycle 
of contraction–relaxation, 
calcium(II) homeostasis, cell 
proliferation and differentiation
116
. 
Among the intracellular partners of 
S100 proteins, over than 90 
potential protein targets have been 
identified, including annexins (A1, 
A2, A5, A6, A11)
117,118
, the 
ubiquitination protein CacyBP
119
, 
p53
120
, and tau
121
.  
S100 proteins can be also released or secreted into the extracellular space and exert 
their function in a cytokine-like manner through the Receptor for Advanced Glycation End-
products (RAGE) (Figure 10) and participate in tissue organization during development, in 
Figure 10 Scheme of the biological activity of S100 proteins in 
the intracellular and extracellular spaces
113
. 
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the inflammatory response, and/or in tissue remodeling in specific pathological states
122
. S100 
family members can also perform their extracellular functions by interacting with other 
receptors besides RAGE. 
The altered expression of several S100 proteins is associated with tumor development 
and progression to metastatic phenotype. By the way, while S100A4, S100A6, S100A7, and 
S100B are up-regulated in human tumors
123
, S100A1, S100A2
124
 and S100A11
125
 are down-
regulated in neoplastic tissues and have been postulated to have a tumor suppressor function. 
Overexpression of specific S100 proteins is also associated with other diseases, such as 
neurodegenerative diseases (S100B), cardiomyopathies (S100A1), and several inflammatory 
disorders, such as rheumatoid arthritis, chronic bronchitis, cystic fibrosis, psoriasis and 
allergy (S100A8, S100A9, S100A12, S100A7, S100A15). 
 
1.3.2 Structural features 
 
All EF-hand proteins contain 
two paired EF-hand motifs (helix-
loop-helix), connected by an hinge 
region or linker (Figure 11), which 
constitute the so-called EF-hand 
domain (EFhD).  
S100 proteins are small acidic 
10-12 kDa proteins, displaying high 
sequence homology (aminoacid 
identity ranging from 25% to 65%) 
and a typical structural architecture for 
the members of the family. The 
highest sequence identity is found in 
the loop of each EF-hand motif where 
are present the ligands for the 
calcium(II) binding. Conversely, the 
Figure 11. The S100 subunits (EF-hand domains) are shown 
in blue and red, respectively. Each subunit is composed of 
two EF-hands motives, shown in light and dark colors, 
connected by a hinge region or linker. The nomenclature of 
helices (H) and loops (L) is indicated. Calcium(II) ions are 
displayed as green spheres. 
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hinge region and the C-terminal extension, usually present in these proteins, exhibit high 
sequence diversification, suggesting that these two regions might have a role in their 
individual and specific biological activity. 
S100 proteins usually exist as homo- and hetero-dimers in which the two monomers 
are related by a two-fold axis of rotation and held together by Van der Waals interactions 
between strictly conserved hydrophobic residues placed at the interface of the two monomers. 
In each monomer, the two EF-hand motifs, a modified S100-specific EF-hand, located at the 
N-terminus, and a canonical calcium(II)-binding EF-hand, interplay in a cooperative manner 
to bind calcium(II) ions with the N-terminal EF-hand displaying a reduced binding affinity 
(up to 100 times lower) with respect to the C-terminal one. The N-terminal EF-hand consists 
of 14 amino acids consensus sequence motif and the carbonyl oxygen of the residues placed 
in position 1, 4, 6, 9 and the side chain of the residue in position 14 represent the ligands. In 
this metal binding site only the residue in position 14 is highly conserved and can be a 
glutamate or an aspartate. The canonical calcium(II)-binding loop, instead consists of 12 
amino acids, that form the well characterized binding motif D-x-N-x-D-x-(E/K/R/Q/A)-x-x-x-
x-E, where the calcium(II) ion is bound to Asp(1), Asn(3), Asp(5) and Glu(12) side-chains 
and to the carbonyl oxygen of the less conserved amino acid in position 7. The replacement of 
one or more amino acids at positions 1, 3, and 12 affects dramatically the metal binding 
affinity of the C-terminal EF-hand motif and can disrupt the global affinity of the protein 
towards calcium(II). 
In the apo state these proteins can adopt a wide range of conformations especially in 
the second EF-hand binding loop related to the positioning of helix III, that is the most 
loosely packed helix and undergoes the most dramatic conformational change after the 
binding of calcium(II). In fact, the presence of this metal ion causes a structural 
reorganization that places helix III from antiparallel, in the apo-form, to almost perpendicular, 
in the calcium(II)-bound form, with respect to helix IV. This “opens” the structure of the 
protein and determines the exposure of a hydrophobic cleft delimited by helix III and IV and 
the hinge region that regulates most of the S100 proteins function and is responsible for the 
binding of substrates. In this way, the conformational heterogeneity experienced in the apo 
form is directly correlated to the function of S100 proteins because it discloses the protein 
active states and the calcium(II)-induced conformational change results in this way 
facilitated
126
.  
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S100 proteins, therefore, usually exhibit a so-called “closed” conformation in their apo 
state and an “open” conformation in the calcium(II) bound state. However, some exceptions 
have also been described, such as S100A10
127
, that is already in the “open” conformation in 
the apo state, does not undergo calcium(II)-dependent conformational changes and it is in a 
permanently activated state. Conversely, S100A16
128
 assumes a “closed” conformation in 
both the apo and calcium(II)-bound forms.  
The structural features of S100 proteins have been widely analyzed in this laboratory 
using the Principal Component Analysis (PCA) performed on the six interhelical angles of the 
EFhD
129
. In this way, it is possible to obtain a complete description of the conformational 
space spanned by the EFhDs in the S100 protein family in comparison with in the other 
members of the EF-hand superfamily. The PCA analysis provides a quantitative parameter to 
classify in a reliable way the “open” and “closed” conformations and to highlight eventual 
outliers to this partition. Distinct packing of the helices in the EFhD with respect to the 
“open” and “closed” conformations have been identified for other members of the EF-hand 
superfamily. For example, a “semi-open” conformation has been described for the C-terminal 
domain of myosin light chains
130
, while it has not been reported for the S100 proteins family. 
In addition to the well characterized affinity for calcium(II) ion, many S100 proteins 
display high affinities towards zinc(II) and copper(II) ions
131-132
, which are suggested to 
influence the biological activity of these proteins in the extracellular space where these metals 
are more abundant. Moreover, the binding of these metal ions can impair or enhance the 
relative affinity towards calcium(II). 
 
1.3.3 S100A14: a novel member of the S100 family. 
 
S100A14 is one of the latest characterized members of the S100 proteins family, 
whose biological function is largely unknown, and presents many peculiar and unique 
features.  
The expression of S100A14 gene has been reported only in mammals and represent a 
phylogenetically young protein among the S100 proteins and, more in general, the EF-hand 
proteins. This protein shares the highest sequence homology with S100A13
133
 (38% of 
sequence identity) and has the S100-specific N-terminal EF-hand formed by only 13 amino 
acids, in contrast with the 14-amino-acid loop of the other family members, that, however, 
preserves the critical residue (Glu) in the last position of the consensus motif (see above). The 
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C-terminal canonical EF-hand instead has only two out of the six conserved ligands of 
calcium(II) and thus appears not fully functional. In this way, the activity of S100A14 seems 
not to be regulated by the calcium(II) level as it occurs also for other members, such as 
S100A10. These mutations in the C-terminal EF-hand loop are reported for all the species 
expressing S100A14 except for of the evolutionary predecessor Meleagris gallopavo, where 
one of the four calcium binding residues is still in place as in S100A13.  
S100A14 presents in its sequence some cysteins and histidines that could have a role 
in the binding of zinc(II) and copper(II). Moreover, two of the residues responsible of the 
binding of cooper(II) in S100A13 are conserved in S100A14.  
S100A14 contains with respect to the other S100 family members an extended 
hydrophilic loop at the N-terminus, including the N-myristoylation site, that suggests the 
possibility of an interaction with a membrane receptor or the lipid bilayer itself. This long N-
terminal loop probably accounts for the specific function of this protein
134
. 
S100A14 present a heterogenic expression in tumors. In fact, it is preferentially over-
expressed in ovary, breast, and uterus, and mainly under-expressed in kidney, rectum, and 
colon tumors, unlike the other S100 proteins that usually present a homogeneous expression 
and are either under- or over-expressed in tumor cells
134
. In addition to the role in the 
regulation of cell proliferation S100A14 has been recently proven to have a function in the 
regulation of the invasiveness in the oral squamous cell carcinomas by influencing the 
expression of MMP-1 and MMP-9. In particular, in these cancer cells it has been found that 
the under-expression of S100A14 is associated with the over-expression of these matrix 
hydrolytic enzymes
135
. The metastatic potential of S100A14 has been demonstrated also in 
colorectal cancer as correlated with high-expression of S100A4
136
.  
Furthermore, it has been demonstrated that S100A14 promotes cell proliferation and 
survival at relatively low doses and induces apoptosis at high doses in a RAGE-dependent 
manner on esophageal squamous cell carcinoma
137
. S100A14 thus triggers the RAGE 
intracellular cascade, activating ERK1/2 and NF-kB signaling. 
 
1.3.4 Aim of the project. 
 
A detailed description of the structure, dynamics and metal binding properties of 
S100A14 is required to shed light on its largely unknown biological function. NMR is the 
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most suitable technique to provide simultaneously those information at the atomic level and to 
highlight the unique features of this member of S100 proteins family.  
In the present project, classical NMR experiments for structure determination together 
with programs for structure calculation, refinements and validation have been exploited to 
solve the structure of S100A14 protein.  
Longitudinal and transverse relaxation measurements have allowed to elucidate the 
dimeric state and the large flexibility occurring at the N- and C-terminal regions of this 
protein. 
NMR allowed to prove that this protein is in the apo state and is in a permanently 
activated conformation at physiological temperature. 
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1.4. NMR characterization of the C-terminal tail of full-
length RAGE in a membrane mimicking environment  
 
1.4.1 The RAGE receptor 
 
RAGE is a multiligand receptor of the immunoglobulin superfamily present both in 
normal tissues and in vascular cells. It is constitutively expressed during embryonic 
development and is under-regulated in adult life in physiological states, whereas in 
inflammatory states it becomes up-regulated in the sites where its ligands accumulate. 
RAGE is able to recognize tertiary structures rather than amino acid sequences, thus it 
engages multiple families of molecules instead of individual ligands and is considered a 
pattern recognition receptor (PRR)
138
. In particular it can bind β-sheet fibrillar structures, such 
as amyloid components characteristic of Alzheimer’s disease, the members of the S100 
protein family, already described above, the advanced glycation end products (AGEs), that 
derive from nonenzymatic glycoxidation reaction of extracellular proteins and accumulate 
especially in diabetic states and neurodegenerative diseases, and amphoterin. Therefore, the 
RAGE receptor plays a key role in many inflammation-related pathological states such as 
diabetes, vascular diseases, neurodegenerative diseases, autoimmune diseases and in 
cancer
139
.  
Ligations to RAGE determine a sustained period of cellular activation mediated by 
receptor-dependent signaling. RAGE activation, indeed, triggers multiple signaling pathways 
such as ERK1/2 MAP kinases, SAPK/JNK MAP kinases, phosphoinositol-3 kinase and the 
JAK/STAT pathway and regulates important cellular functions through the transcription 
factors AP-1, NF-κB, etc.  
 
1.4.2 Structural features 
 
RAGE is a 45 kDa receptor constituted by three immunoglobulin-like extracellular 
domain, a variable portion, “V type” domain (23-116), and two constant portions, “C type” 
domains (“C1” (124-221) and “C2” (227-317)), by a transmembrane helix (343-363), and by 
a short cytoplasmic tail (364-404). The “V” and “C1” domains form an integrated structural 
unit connected with a flexible linker to “C2”140, which is fully independent and the angle 
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between the long axes of “VC1” and “C2” units is around 80°141. Free rotation around the C1-
C2 linker allows the “VC1” domains to utilize different surfaces to interact with different 
ligands. The “V” domain has a positively charged surface142 and is responsible for most of the 
extracellular ligand recognitions. It is characterized by large ms-μs fluctuations in both the 
secondary structures and loops that ensure high plasticity. Nevertheless, in the case of S100 
proteins, all the three domains can be involved in the interaction and the differences in RAGE 
binding sites may account for 
the diverse cellular responses 
caused by these proteins
143
. 
RAGE is expressed as 
both full-length, membrane-
bound form, and as various 
soluble forms, lacking both the 
transmembrane domain and the 
cytosolic domain, which 
appears to be essential for the 
intracellular signaling. The 
soluble forms can derive from 
alternative mRNA splicing and 
from the proteolytic cleavage of 
the RAGE full-length receptor 
by the membrane 
metalloprotease ADAM-1
144
. 
Soluble RAGE acts both as 
extracellular (decoy) sink for 
the ligands, antagonizing their 
binding to the active receptor 
and has also a pro-inflammatory 
effect. 
Recently, it was shown that RAGE forms homodimers and also oligomers on the 
plasma membrane and that this is an important step in receptor signaling. Constitutive 
oligomerization of RAGE that brings together several “V” domains, increases the number of 
sites available for binding and thus enhances the affinity of the receptor towards structurally 
Figure 12. (A) RAGE preassembles in the plasma membrane and 
ligand binding to RAGE stabilizes oligomers, which then can bind a 
signaling adaptor protein to the cytoplasmic region of RAGE. 
(B) Action of soluble RAGE. The interaction with intact RAGE form 
a hetero-oligomer that limits the binding of intracellular adaptors and 
blocks signal transduction
148
. 
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heterogeneous ligands
145
. Moreover, oligomers of S100 proteins, such as S100B tetramers, 
that binds RAGE with higher affinity than the dimeric protein, can induce RAGE 
oligomerizzation at the “V” domain146.  
The effect of oligomerization might potentiate RAGE signaling not only by increasing 
the affinity of the receptor towards its ligands but also triggering signal transduction through 
the association of RAGE cytosolic tail to its interacting proteins
147
, e.g.Dia-1 (Figure 12).  
In this way, the soluble forms of RAGE, since they lack the cytoplasmic domain, can 
prevent RAGE signaling not only through competitive ligand binding but also through 
blockade of intrinsic RAGE homodimerization on the cell surface (Figure 12). 
 
1.4.3 The cytosolic domain of RAGE receptor and its adaptor proteins. 
 
The cytosolic domain of the RAGE receptor is essential for the intracellular signal 
transduction consequent to the receptor activation. In fact, many evidences have revealed that 
the deletion of the cytoplasmic tail exerts a “dominant-negative” effect and blunts the signal 
transduction downstream to the ectodomains interaction with ligands
148,149
. 
It has been highlighted that proteins and domains involved in cell-signaling in 
eukaryotic systems are usually characterized by an increased propensity in intrinsic disorder 
due to the functional advantages deriving from molecular recognition involving disordered 
structures. In fact, intrinsic disorder enables binding with high specificity and low affinity and 
promotes the interaction with multiple different partners
150
. 
The cytosolic domain of RAGE receptor is characterized by low sequence complexity 
with low content of bulky hydrophobic aminoacids and high portions of polar and charged 
aminoacids. These features are familiar to intrinsically unstructured proteins
151
 and suggest 
the presence of a heterogeneous and not well-defined structure also for this domain, that is 
essential for the execution of its function. In the case of intrinsically disordered proteins the 
resonance assignment through NMR allows site-specific characterization of average 
properties over the ensemble of conformers. 
The unique primary sequence of this domain is conserved in various species and can 
be divided into three distinct regions, one proximal to the cell membrane, rich of basic amino 
acids, a central fragment rich of acidic amino acids, especially glutamic acid, and a low-
conserved C-terminal region
152
. Moreover, this sequence lacks any known motifs involved in 
receptor signaling and any enzymatic activity such as the endogenous tyrosine kinase activity. 
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Thus it necessarily has to interact with endogenous multiple partners or adaptor to trigger the 
recruitment of various downstream effector pathways.  
Among the endogenous signaling molecules associated with the cytosolic domain the 
extracellular signal-regulated protein kinase-1 and -2 (ERK-1/2) have been identified. It has 
been proposed that the cytosolic RAGE stabilizes ERK under the proximal region of the 
plasma membrane and favors the interaction between ERK and its substrates
152
. 
Moreover, it has been reported that the cytosolic domain of the RAGE receptor is able 
to bind, after phosphorylation by PKCζ, TIRAP and MyD88, two adaptor proteins for the 
Toll-like receptor-4 (TLR-4), and to transduce signal to downstream molecules. In this way, a 
possible coordinated regulation of inflammation and immune response has been postulated for 
the two receptors
153
. 
Another adaptor protein for RAGE receptor is the diaphanous-1 (Dia1). Recently, it 
has been demonstrated that the cytosolic domain stimulate fundamental signaling networks, in 
particular the activation of Rac-1 and Cdc42, and the cellular migration through the 
interaction with the formin homology (FH1) domain of diaphanous-1 (Dia1) 
154
, that induces 
actin and microtubule polimerization.  
The solution structure of cytosolic domain has been recently solved and reveals the 
presence of a α-turn structure located nearby the membrane and a long flexible C-terminal 
tail. The interaction area of the cytosolic domain with the FH1 of Dia-1 has also been 
identify
155
. A novel mechanism of action has been proposed for this receptor and implicate a 
constitutive presence of FH1 bound to the cytosolic domain in an inactive state and its 
consequent activation in the presence of ligands for the ectodomain that cause RAGE 
oligomerization. 
 
1.4.4 Aim of the project 
 
Investigation of the signaling pathway occurring through the RAGE receptor is 
critically important in understanding its function and its role in the pathologies correlated to 
it. High resolution structure of the RAGE receptor and knowledge of the way of interaction 
with its ligands is necessary for the elucidation of the molecular basis for RAGE function. 
Although, several extracellular and intracellular partners of the RAGE receptor have been 
identified and possible mechanism of signal transduction have been proposed, the molecular 
details of the signal transduction are still unknown.  
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Since the binding capability of cytosolic domain are related to its dynamics and 
accessibility to the intracellular partner, the present research project aims at investigating the 
structural and dynamics features of the cytosolic domain when it is linked to the full length 
receptor.  
The cytosolic RAGE has been thus investigated as isolated domain and as tethered to 
the full-length receptor in a membrane-mimicking environment and the dynamics have been 
compared in the two different conditions. 
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2.1 NMR and solution structure calculation 
 
2.1.1 NMR experiments for assignment and structure calculation 
 
Two different strategies can be followed for the assignment of NMR spectral 
resonances and for the solution structure determination of biomolecules. In the case of 
biomolecules with low molecular weight (up to 7 kDa) the NMR analysis is based on the use 
of two-dimensional 
1
H–1H NMR experiments for both, spectral assignment and collection of 
structural restraints. Conversely, for biomolecules with molecular weights larger than 10 kDa 
the isotopic enrichment with 
15
N and 
13
C is required to overcome the resolution problems 
related to the small chemical shift range of protons compared to the high number of protons. 
In particular, carbon and nitrogen labeling allows to increase the spectral resolution and 
spread the signals overlap on a higher number of nuclear dimensions, correlating together 
three different nuclei (
1
H, 
13
C, and 
15
N) through heteronuclear scalar couplings (triple 
resonance NMR experiments). 
In the frame of this research project, the first approach has been used to characterize 
the relatively small DNA construct (11-mer, 3.5 kDa) and to confirm the G-triplex 
conformation. Both coherence transfer experiments based on scalar coupling and dipole–
dipole experiments, acquired at 274 K, have been implemented in the assignment procedure.  
2D COSY
1,2
 (COrrelation SpectroscopY), for the correlation of geminal or vicinal 
protons, and 2D TOCSY
3
 (TOtal Correlation SpectroscopY), for the spin system assignment, 
collected at 700 MHz allowed the assignment of all protons but the imino and amino ones. 2D 
1
H-
31
P COSY experiment was acquired at 600MHz to confirm the sequential connectivities. 
2D JR-HMBC
4
 (Jump and Return Heteronuclear Multiple Bond Correlation) experiment, 
performed at 600 MHz and 950 MHz on isotopic natural-abundance, allowed the assignment 
of imino protons through bond connectivities with the aromatic protons of the same base.  
2D 
1
H-
1
H NOESY
5
 (using mixing times ranging between 50 and 300 ms) and 2D 
1
H-
1
H ROESY acquired in H2O at 900 and 800 MHz allowed the identification of spatially near 
nuclei through dipolar interactions.  
On the contrary, triple-resonance NMR experiments have been used for the 
characterization of MMP-1, S100A14 and RAGE. These experiments rely on the transfer of 
magnetization through 
1
J or 
2
J heteronuclear scalar couplings, which are relatively large and 
Methodological Aspects 
54 
 
allow to get high sensitivity and selectivity (Figure 1). In particular, the 3D experiments used 
for the complete backbone resonance assignment in the present research projects are
6
: 3D 
HNCA
7
, 3D CBCA(CO)NH, 3D HNCACB
8
, 3D HNCO
7
, 3D HN(CA)CO. For side-chain 
assignment, instead, the 3D spectra HBHA(CO)NH and (H)CCH-TOCSY
9
 have been 
performed. For the evaluation of dipolar interactions between nuclei 3D NOESY experiments, 
such as 3D 
15
N-NOESY
10
 and 
3D
13
C-NOESY, have been 
implemented. 
2D 
1
H-
1
H experiments 
(see S100A14 project) have 
been associated to the triple-
resonance experiments for the 
assignment of aromatic side-
chains and for the 
identification of further spatial 
connectivities among aliphatic 
and aromatic side-chains.  
NMR experiments 
relying on transfer of magnetization through scalar coupling have been acquired at magnetic 
fields of 500 and 700 MHz; instead the experiments relying on dipolar interactions have been 
acquired at higher magnetic fields (800-900 MHz). 
In the case of very large biomolecules (such as in the case of the full-length RAGE 
receptor), experiments based on Transverse Relaxation-Optimized SpectroscopY (TROSY)
11
, 
which makes use of interference effects between different relaxation mechanisms, have been 
exploited to reduce broadening and to achieve satisfactory linewidths. 
Proton-less experiments
12
 (2D CON, 2D CACO, 2D CBCACO) have used instead for 
a better characterization of unfolded proteins or less-structured regions. In fact C-direct 
detected experiments allow a better spreading of the frequency resonances of overlapped 
signals based on amino acids resonances specificity.  
All NMR experiments were acquired on Bruker AVANCE 900, AVANCE 800, 
AVANCE 700 AVANCE 600 and DRX 500 spectrometers equipped with triple resonance 
CRYO-probes. 
 
Figure 1 Size of the 
1
J and 
2
J coupling constants along the spin 
system that are used for magnetization transfer in 
13
C-, 
15
N-labelled 
proteins. 
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2.1.2 Assignment strategy 
 
All the acquired spectra were then processed with the Bruker TOPSPIN software 
Packages and analyzed with the program CARA
13
 (Computer Aided Resonance Assignment, 
ETH Zürich) for the resonance assignment. 
 In the assignment procedure for unlabeled biomolecules, at first instance, the spin 
system is assigned through the implementation of 2D COSY and 2D TOCSY and then the 
sequential assignment is obtained through the identification of NOEs among nearby bases.  
In the case of DNA, while with 2D COSY/TOCSY the sugar spin systems can be 
assigned, with the 2D 
1
H-
1
H NOESY experiment it is possible to establish the conformation 
of the glycosidic torsion angle, according to the relative intensity of the NOEs between the 
aromatic protons of the base and the anomeric proton of the sugar of the same nucleotide 
(higher for bases in the syn conformation with respect to those in the anti). Moreover, from 
the 2D 
1
H-
1
H NOESY the sequential assignment can be achieved from aromatic-anomeric 
backwards connectivities for bases adopting the anti conformation. The topology of DNA 
construct can be evinced from the NOEs among non-adjacent bases and also exploiting the 
effect of spin diffusion (with long NOESY mixing times) among paired base. In this way, it is 
easier to identify H-bonded coupled bases. 
The application of multidimensional NMR spectroscopy allowed the development of 
general strategies for the assignment of nuclei resonances in proteins. All procedures use the 
known protein sequence to connect nuclei of amino acid residues which are neighbors in the 
sequence.  
The assignment procedure can be divided into three main steps. The first step consists 
in the sequential assignment of the backbone and in the association of the protein residues to 
the signals of the 2D 
1
H-
15
N HSQC spectrum, for which are required the abovementioned 
experiments. Once the backbone assignment is obtained it is possible to monitor the residue-
specific behavior during a titration experiment, dynamics properties and to exploit 
paramagnetic constraints for the protein structural and dynamics characterization. 
The complete set of backbone chemical shifts for the Hα, Cα, Cβ, CO and N nuclei 
resonances can be used to predict the secondary structure of the protein and to derive the 
backbone torsion angles (φ, ψ), with the program TALOS+14, that are then implemented in the 
structure calculation procedure. 
Methodological Aspects 
56 
 
The second step of the assignment procedure, instead, regards with the side-chains 
assignment in order to determine carbons and protons belonging to the same spin system, 
starting from already assigned Cα and Cβ. Interestingly, in multidimensional NMR 
spectroscopy, the sequence-specific assignment of the backbone resonances precedes the 
identification of side-chains spin systems. 
The third step concerns with the interpretation of the NOESY spectra to find 
connections between protons close in space, that are then used as distance constraints for the 
structure calculation.  
 
2.1.3 Structure calculation, refinement and validation 
 
Protein structure calculation based on NMR data typically involves two steps: 
structure generation and structure refinement.  
In the first step, all the conformational restraints are assembled as input to suitable 
programs, whose output is a bundle of conformers that are all equally consistent with the 
restraints. 
For the structure generation, NMR measured parameters need then to be converted 
into structural restraints. This process is based on a known physical relationship between the 
NMR observable and the geometrical property they refer to, that derives from the analysis of 
the already known structures.  
Structure calculation mostly rely on the identification of a dense network of distance 
restraints from NOEs between nearby hydrogen atoms, permitting the identification of pairs 
close in space, although distant in the protein sequence. Long-range NOEs are, in fact, crucial 
for defining the overall protein folding.  
NOEs are converted into distance restraints according to the following relation, that 
correlate together the NOESY cross-peak volume (V) to the distance (r) between the two 
hydrogen atoms: 
 
V= <r
-6
> f(τc) 
 
The program CYANA 2.1
15
 implements an automated calibration routine of the 
NOESY peak volume on the basis of the expected average distance observable in the spectra, 
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that can be adjusted and NOEs are usually treated as upper interatomic distances rather than 
as precise distance restraints. 
Supplementary constraints can be derived from dihedral angles that restrict the local 
conformation of a residue to the α-helical or β-sheet region of the Ramachandran plot. 
In addition to the experimental constraints, information about the covalent structure of 
the protein, such as the amino acid sequence, bond lengths, bond angles, chiralities, planar 
groups, as well as steric repulsion between non-bonded atom pairs, should be implemented in 
the program used for the structure calculation. The program CYANA-2.1
15
 uses a torsion 
angle dynamics algorithm, where torsion angles are used as degree of freedom in the 
molecular dynamics simulation, while bond lengths, angles, and backbone peptide plane 
angles are fixed, according to the values of the library. 
At the end of the structure calculation two important parameters have to be 
considered: the agreement of the calculated structure with the experimental constraints, 
expressed by the target function, and the convergence of the calculation, evaluated by the root 
mean square deviation (RMSD) of the calculated models with the lowest target function. The 
average values of target function for a considered good bundle of structures, should be smaller 
than 1 Å
2
 and each single violation should be smaller than 0.3 Å
2
. Instead the RMSD 
evaluated for the family of structures should be close or less than 1 Å.  
The second step instead involve structure refinement. Programs using force field, such 
as AMBER
16
, are particularly suitable for this purpose. The structure refinement is carried out 
with a molecular dynamics simulation in explicit water box to further improve the quality of 
the structure
17
. 
The refined structure is then validated according to specific programs, such as iCING 
(http://nmr.cmbi.ru.nl/cing/Home.html) and PSVS
18
 servers that evaluate the geometry of the 
protein and the Ramachandran plot appearance of backbone torsion angles. The solution 
structure is considered acceptable if more than 90% residues fall into the allowed region of 
Ramachandran plot and less than 1% residues in the disallowed region.  
 
2.1.4 Evaluation and analysis of paramagnetic constraints  
 
Paramagnetic constraints can be used both for structure calculation and refinement 
because they provide long-range distance and orientational information. Since, paramagnetic 
constraints are consistent with the diamagnetic ones (NOEs and the dihedral angles), they can 
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be profitably used to improve both the precision and the accuracy of the structure of the 
investigated protein.  
The chemical shifts and 
1
J splittings are largely affected by the presence of a 
paramagnetic metal ion and therefore the comparison of these parameters in the presence and 
in the absence of the metal ion itself allow the measurement of paramagnetic constraints.  
The paramagnetism-based constraints that have been addressed to, in the present 
research project, are pseudo-contact shift (PCS) and residual dipolar coupling (RDC).  
 
a) Pseudo-conctact shifts 
 
The pseudo-contact shift arises from the dipolar interaction between the nuclear 
magnetic moment and the average induced magnetic moment of the paramagnetic metal ion 
unpaired electron
19
. In fact, when the electron magnetic moment is anisotropic, such as in 
most of lanthanides (Ce
3+
, Pr
3+
, Nd
3+
, Pm
3+
, Sm
3+
, Eu
3+
, Tb
3+
, Dy
3+
, Ho
3+
, Er
3+
, Tm
3+
, Yb
3+
), 
the dipolar interaction with the nearby nuclear spins magnetic moment is not completely 
quenched by molecular rotation. The nuclear spins thus sense the sum of the external 
magnetic field and of the field generated by the electron magnetic moment, which causes a 
difference in chemical shift of the paramagnetic molecule with respect to the diamagnetic one. 
The pseudo-contact shift depends on the distance (r) and the angular position 
(expressed by the angular coordinates θ and φ) of the nucleus with respect to the metal ion 
and on the anisotropy of the magnetic susceptibility tensor of the paramagnetic metal ion 
itself (expressed by the axial (Δχax) and rhombic (Δχrh) anisotropy parameters) (Figure 2): 
 
δpcs  
 
PCSs are calculated from the difference between the chemical shifts of the nuclei in 
the paramagnetic system and in a diamagnetic analog. The latter is obtained by substituting 
the paramagnetic metal ion with a diamagnetic metal. The acquisition and the complete 
assignment of the 2D 
1
H–15N HSQC spectra in both conditions is thus needed.  
The assignment of the spectrum of the paramagnetic system can be obtained by 
comparison with the correspondent one of the diamagnetic system, considering that in 2D 
1
H–
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15
N HSQC spectrum the shift must be the same for both dimensions (
1
H and 
15 
N), since PCSs 
do not depend on the observed nucleus. However, the re-assignment of the paramagnetic 
spectra is usually not complete because the interaction with the electron spin enhances the 
relaxation rates of the nearby nuclear spins. This increased relaxation rate causes the loss of 
resonances in the NMR spectrum due to severe line broadening.  
From a first subset of PCS (at least eight), if a structural model is available, a first 
estimate of the susceptibility anisotropy tensor can be obtained using the program 
FANTASIAN
20
, that, according to the PCS equation, provides also the calculated PCS for the 
other nuclei. A much larger number of PCS can then be found from the comparison of 
observed values in the 2D 
1
H-
15
N HSQC spectrum with the calculated ones.  
 
b) Residual dipolar couplings  
 
The same magnetic susceptibility 
anisotropy of the paramagnetic metal ion 
responsible for PCS also determines a 
perturbation on the 
1
J splittings of 
coupled nuclei. In fact, the average 
magnetic moment of the unpaired 
electron induces partial orientation of the 
molecule in high magnetic fields, as a 
result of the different values of the 
energy for the different orientations with 
respect to the magnetic field. In this way, 
the nuclei dipolar interactions are not 
averaged to zero by isotropic molecular 
tumbling in solution and the residual 
dipolar coupling can be measured. 
 The self-orientation RDC due to paramagnetism can thus be expressed as a function of 
Δχax and Δχrh : 
 
Figure 2 Structural parameters determining the H
N 
PCS 
(r,θ,φ) and PRDC values (Θ,Φ). The angles are provided in 
the frame established by the principal axes of the magnetic 
susceptibility anisotropy tensor. 
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Δνrdc  
 
where the Θ and Φ angles are defined in the principal frame of the paramagnetic susceptibility 
tensor (Figure 2). These angles define the orientation of the coupled nuclei independently of 
their position with respect to the metal ion. Therefore paramagnetic RDC depends only on the 
orientation of the nuclear pair, on the applied magnetic field and on the gyromagnetic ratio of 
the coupled nuclei (γA and γB). 
RDC can be obtained from the difference between paramagnetic system and the 
diamagnetic analog in the measured 
1
J splitting (in Hz) on the 
15
N dimension (for a given N–
H
N
 pair) in the 2D 
1
H–15N HSQC IPAP21 (in-phase/antiphase) experiments. 
RDC can be implemented in program for structural refinement, such as paramagnetic-
cyana. Solution structure determination and refinement protocols are based on cycling 
between the simulated annealing structural calculation, performed using paramagnetism-based 
restraints (PCS and RDC), with fixed Δχax and Δχrh values provided by PCS, and the new 
evaluation of the tensors based on the new refined coordinates of the protein structure, until 
convergence is reached.  
However, in these simulated annealing calculation distinct sets of PCSs and RDCs are 
necessary to reach convergence. In fact, a large number of possible positions and orientation 
can equally fulfill the PCSs and RDCs equations. Therefore, to escape false minima, reach 
convergence and remove degeneracy of solutions, different alignment provided by 
substitution of different paramagnetic ions in the metal binding site, are needed. 
 
2.2 NMR and protein dynamics  
  
2.2.1 NMR Relaxation experiments 
 
Dynamics information of proteins can be easily obtained from the measurement of 
relaxation rates. Relaxation refers to the return of a system to equilibrium after a perturbation 
and the relaxation time/rate is the time/rate constant for such a process. Relaxation is linked 
with the dynamics of a system because this effect is caused by the molecular motions that 
induce local magnetic field fluctuations. 
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The dynamics of a protein can be regarded as a superposition of global reorientational 
dynamics of the whole particle and internal dynamics at a more local level. However, the two 
classes of dynamics take place in separate time scales and can be readily separated. 
In relaxation experiments it is monitored how the orientation of a particular bond 
vector changes with time. The 
15
N relaxation experiments are the most common and have 
been extensively used to characterize backbone dynamics. The relaxation of this nucleus is 
due to the 
15
N chemical shift anisotropy (CSA) and to the dipolar interaction with the 
covalently attached hydrogen. Since the reorientation of this bond vector, that causes the 
relaxation, with respect to the static magnetic field is faster than the molecular tumbling, 
information about pico- to nanosecond motions can be obtained by this analysis.  
The return of the magnetization to the equilibrium depends on two components, 
parallel to magnetic field (longitudinal relaxation), that relaxes with the rate-constant R1, and 
perpendicular to the magnetic field (transverse relaxation) that relaxes with the rate-constant 
R2. 
The 
15
N longitudinal relaxation rates (R1) have been measured using a sequence 
modified to remove cross correlation effects between the dipolar and 
15
N CSA relaxation 
mechanisms during the relaxation delay
22
. Different inversion recovery times have been used 
for the evaluation of the decay of the signals in the experiments.  
The 
15
N transverse relaxation rates (R2) were measured using a Carr-Purcell-
Meiboom-Gill (CPMG) sequence
23
 with different delays.  
Heteronuclear NOE
24
 can be also measured as reporter of the internal dynamics of the 
system. The measurement is performed by saturating the proton signal and observing changes 
in the 
15
N signal intensities.  
The longitudinal (R1) and transverse (R2) relaxation rates were determined by fitting 
the cross-peak volumes as a function of the different used delays to a single-exponential 
decay using the program Origin. The equation used for the fitting is written below: 
 
where f(t) is the calculated volume, t is the variable time used in seconds, R is the 
relaxation constant R1 or R2 in (s-1) which has to be determined and I0 and A0 are the 
constants used for the fitting of the curve. 
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The experimental data are usually compared with predicted data considering a rigid 
bead hydrodynamic model of the protein with the program HydroNMR
25
. Deviation of the 
experimental values from calculated ones is an indication of protein motion.  
R1 and R2 experimental values contain both the information about the overall 
rotational dynamics, linked to the protein dimension and expressed by the correlation time, 
and about the local bond vectors dynamics. The correlation time is derivable from the ratio of 
longitudinal and transversal relaxation times of rigid structures of the protein, in the case of 
the isotropic approximation, using the program TENSOR2
26
. R1, R2, and NOE values can be 
then used in the anisotropic approximation to map out the spectral density functions 
describing protein motions at a number of frequencies faster than the correlation time.  
 
2.2.2 The protocol of the maximum occurrence for the evaluation of conformational 
heterogeneity of multidomain proteins 
 
Multidomain proteins exist in solution in different conformations with similar energy and 
PCSs and RDCs are quite informative restraints of this conformational heterogeneity. In fact, 
the experimentally measured values are the averages of the values corresponding to the 
different conformations assumed by the proteins. 
RDCs can be used to assess the presence of interdomain mobility in proteins. In fact, 
RDCs do not depend on the distance of the observed nuclear pairs from the metal ion and in 
case of rigid systems their distribution should be similar in both the domain bearing the 
paramagnetic metal ion and the other one. On the contrary, in case of motion, the spreading of 
the observed RDC values is reduced and it can collapse to zero for cases of overall isotropic 
reorientation of one domain with respect to the metal-bearing domain. Conformational 
heterogeneity should be thus invoked in the case of significantly reduced RDC for domain 
without the paramagnetic metal ion with respect to the domain with the coordinated 
paramagnetic ion. 
The analysis of the experimental RDCs and PCSs also provides information on the 
conformations actually experienced by the system. With the protocol of the maximum 
occurrence
27
, it is possible to score any possible conformation with a value indicating its 
maximum probability to be sampled in solution. The protocol is based on the availability of 
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the magnetic susceptibility anisotropy tensors from the PCS data measured for the domain 
hosting the paramagnetic metal.  
Random conformations with all possible relative domain positions and orientations are 
generated (with the program RANCH
28
) and PCSs and RDCs are calculated (with the 
program CALCALL) for all the generated conformations. Then a simulated annealing 
minimization is carried out for each selected conformation, that is so included with a fixed 
weight in a ensemble of 50 other conformers with variable weights, in order to provide 
weighted average of calculated PCSs and RDCs that are in agreement with the experimental 
data. During the minimization, the weight of the fixed conformation is then gradually 
increased. The MO of such a conformer is defined as the largest weight for which the TF is 
smaller than a given threshold. The minimum for the TF is calculated by generating structural 
ensembles without any fixed conformation and giving 10% of tolerance.  
These calculations were performed through the GRID infrastructure that allow big 
computational sources. 
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Nucleic acids represent the alphabet of the cellular language and through their sequence and 
their topology regulate vital cell functions. In recent years it has been found that many 
variations from the Watson-Crick duplex structure play key roles in many cellular processes. 
Examples are hairpins,
[2]
 cruciforms,
[3]
 parallel-stranded duplexes,
[4]
 triplexes,
[5]
 G-
quadruplexes
[6]
 and the i-motif.
[7]
 These structures can be formed by nucleotide sequences 
distributed throughout the whole human genome, their location is not random and often 
associated with human diseases.
[8]
 These complexes are formed from one up to four strands, 
stabilized by base stacking and hydrogen bond interactions with a variety of non-standard 
pairings. For instance, DNA triplexes can present G:G-C, A:A-T, C
+
:G-C and T:A-T pairings, 
with two strands in the standard Watson-Crick duplex structure (i.e. G-C and A-T) and the 
third one lying in the major groove of the duplex. Instead, G-quadruplexes are four stranded 
structures stabilized by stacking of two or more guanine tetrads (Figure 1). 
These examples highlight the high structural polymorphism of DNA and suggest that other 
DNA structures might exist, perhaps with specific cellular functions that are to date unknown. 
In this scenario, the discovery of novel DNA structural motifs is more than ever an important 
breakthrough. Here, by using metadynamics simulations,
[9]
 we have identified a stable folding 
intermediate of the Thrombin Binding Aptamer (TBA) quadruplex.
[10]
 This intermediate is 
characterized by a “G-triplex” structure, having G:G:G triad planes stabilized by an array of 
Hoogsteen-like hydrogen-bonds (Figure 1). This kind of structure has been already 
hypothesized in other investigations on different DNA sequences,
[11]
 but never experimentally 
proven. Here, for the first time, we have structurally and thermodynamically characterized 
this new DNA structural motif, through a combination of a number of biophysical 
experiments.  
The metadynamics calculations have been used to study the unfolding/folding of TBA, which 
is a 15-mer oligonucleotide (5’-dGGTTGGTGTGGTTGG-3’) organized in an anti-parallel 
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monomolecular G-quadruplex with a chair-like structure (Figure 2a). This structure consists 
of two G-tetrads, able to coordinate a metal ion at the center, connected by two TT loops and 
a single TGT loop.  
Metadynamics accelerates the sampling adding a bias on few degrees of freedom of the 
system, called collective variables (CVs). In such a way, long time scale events, such as 
ligand/protein docking
[12]
 or protein/DNA folding, can be sampled in an affordable 
computational time and the free energy profile of the whole process can be computed. In the 
present case, the Free Energy Surface (FES) was calculated as a function of two CVs, the 
radius of gyration CV defined by the oxygen atoms of the guanines forming the G-tetrads and 
a second CV that counts the number of hydrogen bonds between these guanines (see 
Experimental Section in Supporting Information). Looking at the FES obtained after 
approximately 80 ns of metadynamics simulation, three main energy minima can be identified 
(Figure 2b). The deepest one, basin A, corresponds to the experimental G-quadruplex 
structure of TBA
[13]
 with two G-tetrad planes and eight guanines involved in standard 
Hoogsteen hydrogen bonds. In the second minimum, basin B, TBA shows a partial opening of 
the 3’ end with G15 oriented towards the solvent. In this basin G14 moves slightly from its 
original position, with the oxygen of the base pointing towards the center of the planes formed 
by G1:G6:G10 and G2:G5:G11 (Figure 2b). In such a way, G14 conserves the hydrogen bond 
interactions with G2 and G11 and at the same time it partially fills the vacancy in the 
coordination shell of the metal present in the core. This step can be considered the very first 
event in the unfolding process of TBA. In basin C, the 3’ end opens completely with G14 and 
G15 leaving the G-tetrad planes and pointing towards the solvent (Figure 2b). This minimum 
is approximately 6.5 kcal/mol higher in energy than basin A and here TBA assumes a number 
of different conformations due to the conformational flexibility of the 3’ overhang formed by 
T13-G14-G15. In fact, these bases rearrange to form a single helix that assumes a number of 
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conformations, all of them stabilised by stacking interactions. While the 3’ overhang is 
flexible, the rest of TBA is rather stable forming two G:G:G planes, namely G-triads, 
composed by G1:G6:G10 and G2:G5:G11, that form an array of Hoogsteen-like hydrogen 
bonds (Figure 1 and 2b). In this conformation the metal ion is coordinated at the center of the 
two triads in a way similar to that of the G-quadruplex structure. This structure, named “G-
triplex”, differs from the known triplex structures not only for the base pairing but also for the 
structure (Figure 1).  
It can be observed that the 3’ end of TBA opens and closes several times, passing from basin 
A to basin B and basin C, and then folded again in the G-quadruplex structure, basin A 
(Figure 2c). Thanks to these recrossing events, the calculated FES is accurate and 
quantitatively well characterized. The stability of the TBA conformation in the three energy 
minima A, B and C, has been further assessed through molecular dynamics calculations  (see 
Supporting Information). A movie showing the metadynamics simulation on TBA is provided 
in the Supporting Information. 
To establish the intrinsic stability of the G-triplex, we removed from the 3’ end of TBA the 
last four residues that are highly mobile in basin C. The resulting structure was found stable in 
an ordinary MD simulation that lasted over 100 ns (see Supporting Information for details). 
Its coordinates are provided in the Supporting Information. 
The prediction of a stable G-triplex structure needed to be validated by experiments. To this 
effect, we performed a number of experiments on the same truncated form of TBA (5’-
GGTTGGTGTGG-3’, I). First, I was studied through 1H-NMR experiments at 25 °C showing 
the presence of a predominant well defined hydrogen bonded structure in solution. This is 
supported by the presence of four well-defined exchangeable proton signals in the 11.0-12.5 
ppm region of the 1D 
1
H-NMR spectrum (Figure 3a). These signals are typical of DNA 
structures with Hoogsteen hydrogen bonds.
[14]
 On the other hand, the region of aromatic 
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protons (6.5-8.5 ppm) is characterized by the presence of eleven intense signals that can be 
attributed to the seven guanines H8 and four thymines H6 protons, and by a number of minor 
signals (Figure 3a). The latter might be due to the presence of unstructured DNA in 
equilibrium with the structured one. This equilibrium is very sensitive to temperature with the 
structured form highly favored at low temperature, as shown by the spectrum obtained at 1 °C 
(Figure 3b). The structure adopted by I turned out to be very stable over the weeks. 
The non-exchangeable base and sugar protons of I were assigned through the analysis of 2D 
NOESY, 2D TOCSY and 2D COSY NMR spectra (see Table S2 and Supporting 
Information). Interestingly, the presence of three intense cross-peaks between the H8 proton 
bases and sugar H1’ resonances for residues G1, G5 and G10 in the NOESY spectrum (900 
MHz, T = 1 °C, mixing time 100 ms), along with the presence of weak cross-peaks between 
the same aromatic protons and the H2’ and H2” protons of their own ribose moiety, indicated 
that these three residues adopt a syn glycosidic angle conformation (Figure 3c). On the 
contrary, G2, G6, G8 and G11 turned out to have an anti glycosidic conformation, being 
inverted the intensity of the cross-peaks mentioned before (Figure 3c). The three H8 peaks of 
syn G residues are downfield shifted with respect to those of the anti ones, exactly as reported 
for TBA.
[15]
 Furthermore, the three anti-Gs (G2, G6 and G11) show H8/H2’-H2’’ sequential 
connectivities with the 5’ neighboring syn-Gs (G1, G5 and G10). This suggests the presence 
of the tracks G1–G2, G5–G6, G10–G11 (underlined residues have a syn conformation) and 
the formation of a helical structure. The presence of unusual NOE connectivities between a 
number of Gs and Ts indicates that 5’-TG-3’ and 5’-GT-3’ do not adopt a helical winding, 
and that the TT and TGT tracts realistically form loops. Finally, the alternation of syn and anti 
G residues implies that I, as TBA, folds into an antiparallel structure.  
The assignment of the exchangeable imino protons was instead obtained by JR-HMBC 
correlation experiment. The jump-return version of HMBC
[16]
 allowed us to assign for each 
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guanine the imino proton starting from its H8 proton (see Figure 4a and Supporting 
Information). Once the imino protons have been assigned, we could determine the folding 
topology of I using the jump-return version of the 2D NOESY experiment. This allows to 
identify NOEs representing the interaction between the imino proton of one base and the H8 
proton of the other. Generally, these NOEs are diagnostic of the presence of Hoogsteen base 
pairings. In our case, we observed NOEs between G11-NH (12.08 ppm)/ G5-H8 (7.44 ppm) 
and G5-NH (12.23 ppm)/G2-H8 (8.04 ppm). These two correlations indicate that, as in TBA, 
G5 is involved in the formation of Hoogsteen hydrogen-bonds with both G11 and G2 and this 
is in agreement with the calculated structure (Fig. 4b-c). We have also observed a NOE 
between G1-NH (12.00 ppm) and G6-H8 (8.26 ppm), indicating that G1 and G6 are also 
paired. All of this indicates that the structure of I could be characterized also by a second G-
triad formed by G10, G6 and G1. Due to unfavorable T1 noise, no NOE between G6-NH and 
G10-H8 could be unambiguously detected. Nevertheless, the fact that the subunit G10-G11 
adopts a helical winding strongly supports the idea that actually also G10 does take part in the 
second G-triad. The formation of the G-triplex is also supported by the presence of further 
NOEs between NH protons and other exchangeable protons identified by 
1
H-
15
N-HSQC 
experiments (see Supporting Information). In particular, we observed strong NOEs between 
G1-NH/G5-NH and G6-NH/G11-NH; medium intensity NOEs between G1-NH/G6-NH and 
G5-NH/G11-NH; and weak NOEs between G5-NH/G6-NH, that once again support the 
formation of the G-triplex, having two G-triads: G1-G6-G10 and G2-G5-G11 characterized 
by syn-anti-syn and anti-syn-anti arrangement of the residues, respectively. Finally, a number 
of other NOEs definitely confirmed the structure of the G-triplex. Particularly, T7-Me shows 
correlations with G1-NH, G6-NH and G10-NH, confirming that the loop TGT is spatially 
very close to the G-triad G1-G6-G10. Then, G11-NH shows correlations with T4-
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H2’,H2”,H4’,H5’,H6 and T3-H4’,H5’,H5”,H6. Furthermore, G5-NH is also correlated with 
T3-H3’, indicating that the TT loop is very close to the G-triad G2-G5-G11.  
All these experimental evidences are in fully agreement with the G-triplex structure found in 
our calculations (see Figure S3 and Supporting Information).  
The thermodynamic stability and the molecularity of I was investigated by Circular 
Dichroism (CD) and Differential Scanning Calorimetry (DSC) experiments. The CD 
spectrum of I shows two positive bands at 289 and 253 nm, and two negative at 235 and 265 
nm, indicative of an homopolar stacking of the nucleobases,
[17]
 in agreement with the 
proposed G-triplex structure (see Supporting Information). Such spectrum closely resembles 
that of TBA (Figure 5a). However, both positive and negative bands are slightly shifted, thus 
suggesting a similar, but not identical, stacking of the bases. The CD melting profile of I, 
recorded at the wavelength of maximum absorbance variation upon folding (λ = 289 nm), 
shows almost superimposable heating and cooling curves (Figure 5b), i.e. the melting profile 
was reversible, with no significant hysteresis, indicating a quasi-equilibrium process.  From 
these measurements, a melting temperature, Tm, of 33.5 (± 1.0) °C and a van’t Hoff enthalpy 
change, ΔH°vH, of 145 (± 15) kJ mol
-1
 are derived (see Experimental Section in the 
Supporting Information). 
DSC experiments were carried out to characterize the denaturation thermodynamics of I with 
a model-independent analysis method.
[18]
 DSC thermograms for denaturation of I (Figure 5c) 
were obtained at two different heating rates, 0.5 and 1.0 °C min
-1
. The different heating rate 
does not alter the thermodynamic parameters significantly, thereby demonstrating that the 
investigated process is not kinetically controlled.
[19] 
Furthermore, the unfolding of I is a 
highly reversible process, since the original signal is recovered by rescanning the same 
sample. The DSC curves show a symmetric shape with a maximum centered at Tm of 34.0 (± 
0.5) °C, in good agreement with that obtained by CD melting. The melting temperature was 
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almost concentration-independent, consistent with a structure resulting from unimolecular 
folding. The integration of the denaturation peak gives a ΔH°cal of 135 (± 5) kJ mol
-1
, which is 
almost identical to the van’t Hoff enthalpy calculated from DSC curves and very close to that 
calculated from CD. This indicates that the transition of I is a two-states process. Finally, the 
calculated Gibbs energy value, ΔG°, at 298 K is 4 (± 1) kJ mol-1, and results from the 
characteristic compensation of the favorable enthalpy term with an unfavorable entropy 
contribution (ΔS° = 0.44 ± 0.02 kJ mol-1K-1). The whole set of thermodynamic parameters 
show that, as expected, I is less stable than TBA.
[20]
 In particular, the enthalpy term is lower 
than the one derived for TBA, probably due to the greater contribution resulting from the 
stronger base stacking and larger number of hydrogen-bonds involved in the quadruplex 
structure. This is consistent with the lack of G-tetrads in the structure adopted by I. 
In summary, during the folding process of the G-quadruplex DNA aptamer TBA, we have 
observed the formation of the G-triplex structural motif. The existence of this structure has 
been proven in an 11-mer oligonucleotide, whose structural and thermodynamics properties 
have been characterized by advanced computations, NMR, CD and DSC experiments. At 
variance with the already known triplex structures characterized by triads having standard 
Watson-Crick base pairings, G-triplex presents G:G:G triad planes stabilized by an array of 
Hoogsteen-like hydrogen bonds (Figure 1). Although this kind of structure was already 
hypothesized as intermediate of the folding process of other quadruplex forming 
sequences,
[11]
 this is the first time that DNA has been unambiguously  isolated and 
structurally characterized  in this conformation. 
This discovery is an important breakthrough that paves the way to new horizons in biology. In 
fact, guanine-rich regions, potentially able to form G-triplex structures, are very abundant in 
the genome and our study provides the molecular bases and the tools to investigate the 
presence of these structures in the genome, their biological role and the way to interact with 
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them. Furthermore, our study raises new questions: are G-triplex structures present in the 
folding process of other DNA or RNA structures? Are there small molecules able to bind and 
interact with G-triplex? Are G-triplex structures exploitable to design new aptamers? These 
are only some of the issues that will be addressed in the near future. 
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Figures: 
 
 
 
Figure 1. DNA structural motifs. (Top panel) Schematic illustration of duplex, triplex, G-
triplex and G-quadruplex. (Bottom panel) Examples of base pairing: T-A and C-G for duplex, 
T-A:T and C-G:C
+
 for triplex (where C-G and T-A form the standard Watson-Crick duplex 
structure, whereas the colon signs indicate the pairing with the third strand, that lies in the 
major groove of the duplex), G-triad for G-triplex, and G-tetrad for G-quadruplex. G-triad and 
G-tetrad consist of a planar arrangement of three and four guanines, respectively, held 
together by Hoogsteen-like hydrogen bonds. 
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Figure 2. The 3’ end opening of TBA. a) Tridimensional Representation of the NMR 
structure of TBA (PDB ID code 1qdf).
[13]
 b) The Free Energy Surface (FES) of the 3’ end 
opening of TBA shows three main energy minima are shown: one deep and narrow, basin A, 
which represents TBA in the G-quadruplex structure; the second one, basin B, which 
represents an intermediate state; and the last one, basin C, which shows the G-triplex structure 
formed by the triads G1:G6:G10 and G2:G5:G11. Residue labels are the same of (a). c) Plots 
showing the phase space represented as the Hcore and Rcore CV, explored during the 
metadynamics simulation.  
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Figure 3. 1D 
1
H-NMR and 2D NOESY spetra of 5’-GGTTGGTGTGG-3’ (I) ( 0 mM KCl, 
10 mM KH2PO4, 0.2 mM EDTA, pH 7). Imino, amino and aromatic regions of the 1D 
1
H-
NMR spectra of I acquired at 25°C (a) and 1 °C (b). In the latter spectrum (b) the signal at 
7.63 ppm, attributed to G10-H8, is slightly broad, suggesting that its conformation can vary 
on the NMR timescale. c) Two expanded regions of the NOESY spectrum (900 MHz, T = 1 
°C, mixing time 100 ms). H8 protons of the syn residues G1, G5 and G10 show intense cross-
peaks with H1’ proton and weak connectivities with H2’ and H2” protons of their own sugar. 
On the contrary, anti residues G2, G6, G8 have opposite relative intensity. d) Distances of the 
correlated protons in the NOESY spectrum. 
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Figure 4. JR-HMBC and JR-NOESY spectra of 5’-GGTTGGTGTGG-3’ (I) (70 mM KCl, 10 
mM KH2PO4, 0.2 mM EDTA, pH 7). a) Expanded regions of the JR-HMBC (600 MHz, T = 1 
°C) showing correlations between H8 and H1 guanine protons with C5 carbons. b) Expanded 
region of the 2D JR-NOESY (900 MHz, T = 1 °C) showing diagnostic correlations between 
H8 and H1 protons of paired bases. c) Tridimensional representation of the G-triplex structure 
adopted by I (Supporting Information). d) G-triads involved in the formation of the G-triplex. 
Red arrows show NOE correlations between H8 and H1 protons of paired bases. 
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Figure 5. Biophysical characterization of 5’-GGTTGGTGTGG-3’ (I). a) CD spectra of I 
(solid line) and TBA (dashed line) at 1 °C. b) Normalized CD melting curves of I recorded at 
289 nm at a scan rate of 0.5 °C min
-1
. Heating and cooling curves are shown with solid and 
dashed line, respectively. c) DSC profiles for I at 0.5 (solid line) and 1.0 (dashed line) °C min
-
1
 heating rate. All the experiments were performed in a buffer solution containing 10 mM 
potassium phosphate, 70 mM KCl, 0.2 mM EDTA (pH 7.0). 
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SUPPORTING INFORMATION 
 
Supporting Information Available:  
- The results of the standard MD simulations carried out on the basin A, B and C 
conformation. 
- The results of the standard MD simulation carried out on the 11-mer oligonucleotide I. 
- NMR assignment of other exchangeable protons. 
- NOEs supporting the formation of the G-triplex. 
- Other investigated truncations of TBA. 
- Further consideration on CD experiments. 
- Experimental Section. 
- The atoms used to define the radius of gyration and hydrogen bond CV (Table S1). 
- 
1
H-NMR assignment of I at 1°C (900 MHz) (Table S2). 
- The movie of the folding/unfolding process of the 3’ end of TBA (tba_movie.m4v). 
- The atomic coordinates of I in the G-triplex structure (G-triplex.pdb). The reported 
structure is representative of the conformations ensemble obtained from the over 100-ns-long 
MD simulation. 
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Molecular dynamics simulations on TBA in the conformations representing the energy basins 
A, B and C. 
We assessed the stability of the conformations representing the energy basins A, B and C 
using 50 ns long molecular dynamics simulations. Different behaviors have been observed for 
the different poses considered. As expected, basin A resulted very stable throughout the whole 
simulation with the two G-tetrads planes formed by G1:G6:G10:G15 and G2:G5:G11:G14, 
constantly formed (Figure S2A). As seen in the metadynamics calculation, even in the MD 
simulation the T7-G8-T9 loop is rather stable while T12 in the T12-T13 loop, is very flexible 
and points away towards the solvent. Furthermore, T3, T4 and T13 present a good 
conformational stability favored by the engagement of stacking interactions with the 
nucleobases placed above. 
At variance with basin A, basin B is rather unstable. At this basin the partial opening of the 3’ 
end of TBA has been observed during the metadynamics simulation, with the G15 base 
pointing towards the solvent (Figure 2 in the main text). As shown in Figure S2B, after 
approximately 18 ns of MD simulation TBA leaves its starting conformation, basin B, 
transforming in that of basin A. In particular, G15 slowly moves towards the center of the G-
tetrads forming again the G-tetrads planes and the Hoogsteen hydrogen bonds first with G1 
and then with G10. This finding is not totally surprising since, looking at the FES of the 
metadynamics simulation (Figure 2 in the main text), the energy barrier that separates basin B 
from basin A, is rather small, approximately 2 kcal/mol, and thus it can be overcome in the 
standard MD time-scale. This motion can be appreciated looking at Figure S2B where the 
r.m.s.d. of the guanine bases with respect to their position in the G-quadruplex conformation 
has been calculated. 
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A different behavior has been instead observed for basin C. In fact, during the MD simulation 
the TBA conformation of this energy minimum is stable conserving all the interactions 
previously found in the metadynamics calculation. In particular, at this pose, the 3’ end of 
TBA is completely open with T13, G14 and G15 forming a single helix overhang that points 
away from the core of the TBA structure (Figure 2 in the main text). The other nucleobases 
are arranged to form a well-organized structure where G1:G6:G10 and G2:G5:G11 form two 
G-triad planes stabilized by an array of Hoogsteen-like hydrogen bonds. At variance with the 
other two minima A and B, in basin C, T12 does not point out towards the solvent, on the 
contrary it is rotated towards the core of TBA and is involved in stacking interactions with T4 
of the TT loop at the 5’ end (Figure 2b in the main text). This position favors the formation of 
hydrogen bond interactions between the imide hydrogens of T13 and G14 and the backbone 
phosphates of G11. These interactions further contribute to the energy stability of this pose.  
The G-triplex structure is very stable along the whole MD simulation with a low average 
r.m.s.d. of 0.63 Å for the guanine bases forming the G-triad planes (Figure S2C).  
 
Molecular dynamics simulation on the 11-mer oligonucleotide I. 
We have carried out an extensive MD simulation, more than 100 ns, on the oligonucleotide I 
in the G-triplex conformation at the ionic concentration of 70 mM KCl used in the 
experiments. During this simulation the G-triplex structure is very stable with a low average 
r.m.s.d. of 0.88 Å for the guanines forming the triad planes. As found in the metadynamics 
simulation, the triads formed by G1:G6:G10 and G2:G5:G11 are stabilized by Hoogsteen-like 
hydrogen bonds (Figure S3). At the center of the two triad planes the potassium ion is 
coordinated by the six oxygen atoms of the guanines. Analogously to the metadynamics 
results, T4 has a good conformational stability thanks to the stacking interactions engaged 
with G5, while T3 is more flexible. However, during the simulation this base often occupies a 
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position under G2 where favorable stacking interactions can be formed. On the other hand, 
the T7-G8-T9 loop is stable with G8 stacked above the plane formed by the G1:G6:G10 triad 
engaging favorable interactions with G6. It is interesting to note that the T7-G8-T9 loop in 
oligonucleotide I occupies a conformation different from that assumed in TBA. However, 
these two different conformations are equally stable in all the simulations suggesting a 
considerable conformational freedom for the bases forming this loop. 
All the simulations, on TBA and I, have shown a great stability of the G-triplex structure 
suggesting to investigate in the near future the presence of G-triplex structures even in other 
poliguanine sequences of DNA and RNA.  
 
NMR assignment of other exchangeable protons 
In the 1D 
1
H-NMR spectrum, along with the intense and narrow signals of the assigned imino 
protons (δH 12.00, 12.08, 12.23, 12.51) a number of other exchangeable protons could be 
observed. In order to clarify whether these signals could be attributable to other imino or 
amino protons, a 2D 
1
H-
15
N HSQC experiment was acquired at 25 °C. At this temperature, 
the already assigned signals with δH (T=1°C) of 12.00, 12.08, 12.23, 12.51 and 10.65, were 
shifted respectively at δH 11.92, 11.99, 12.14, 12.37 and 10.45. These signals turned out to be 
correlated to nitrogens resonating at δN 143.37, 144.36, 144.66, 145.74 and 144.67 
respectively. All these values are characteristic of N1 guanine bases. It is interesting to note 
that also the broad signal at δH 11.52 (25 °C) turned out to be correlated to similar frequencies 
(143.72 ppm), indicating that also this resonance is attributable to an imino proton of guanine. 
Unfortunately, no correlation could be observed in the JR-HMBC spectrum for this signal and 
it could not be unambiguously assigned to the pertinent base. Nevertheless, this signal is 
correlated with T9-H6,H1’,H2”,Me; T -Me; G10-H2” and G8-H4’. All of this can be 
interpreted assuming that the imino proton resonating at δH 11.52 is assigned to G10. 
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Probably, the signals of this NH proton is observable because involved in hydrogen bond. In 
fact, taking into account that the strand G14-G15 originally present in TBA is now missing, it 
is reasonable to assume that the strands G1-G2 and G10-G11 tend to bring themselves closer 
to each other, so that the formation of hydrogen bonds between G1 and G2 and G10 and G11, 
respectively, cannot be ruled out.  
 
 
 
NOEs supporting the formation of the G-triplex. 
The assignment of the exchangeable imino protons was obtained by JR-HMBC correlation 
experiment. The jump-return version of HMBC (ref. 16 in the main text) allowed us to assign 
for each guanine the imino proton starting from its H8 proton (Figure 4a in the main text). In 
particular, H8 signals at δH 7.40 (G1), 8.02 (G11), 7.44 (G5) and 8.26 (G6) turned out to be 
correlated to the NH protons of their own base resonating at δH 12.00, 12.08, 12.23 and 12.51, 
respectively. As discussed in the main text, only in the case of G8, H8 (δH 8.11) is correlated 
with the imino proton at δH 10.65. This low value for an imino proton suggests that G8 is not 
involved in classical Hoogsteen hydrogen bonds.  
 
Other investigated truncations of TBA. 
Three additional oligodeoxynucleotides (5’-GGTTGGTGTGGTTG-3’ (A), 5’-
GGTTGGTGTGGTT-3’ (B) and 5’-GGTTGGTGTGGT-3’ (C)) have been studied by NMR 
to investigate the formation of the G-triplex structure in other truncations of TBA. Samples A, 
B and C were analyzed by 
1
H-NMR at 1 °C in 80 mM K
+
-containing buffer (see experimental 
section). The spectra of the three samples exhibited conformational heterogeneity. This does 
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not depend on the nature of the buffer solution, be it a potassium or sodium containing buffer, 
or on its concentration and temperature. 
 
Further consideration on CD experiments. 
Circular Dichroism (CD) spectroscopy has been exploited to further investigate the structure 
adopted by I in solution. CD spectra were recorded at 1 °C, a temperature at which the folded-
unfolded equilibrium of I is strongly shifted towards the folded form, as shown by NMR, CD 
melting and DSC experiments. For DNA, a CD spectrum is generated by a chiral orientation 
of the chromophores, i.e. the nucleobases, and it is strictly related to the base-stacking pattern. 
Since the two faces of a base are heterotopic, when two bases are stacked together, they can 
interact through the same (head-to-head or tail-to-tail) or the opposite (head-to-tail) faces, 
leading to a heteropolar or homopolar stacking, respectively. When the glycosyl bonds of the 
guanines alternate in syn and anti conformations along the strand, head-to-head and/or tail-to-
tail interactions are realized, leading to a CD signal characterized by two positive bands at 
approx. 295 and 245 nm and two negative bands at approx. 230 and 265 nm (Ref. 17 in the 
main text). The experimental CD spectrum of I is characterized by two positive CD bands at 
289 and 253 nm, and two negative bands at 235 and 265 nm (Figure 5a in the main text), 
values that are consistent with the structure proposed by metadynamics calculations and 
NMR.  
 
Experimental Section. 
Metadynamics simulations. The starting conformation coordinates for TBA were obtained in 
its G-quadruplex conformation (PDB ID code 1qdf).
[1]
 The system was solvated using the 
TIP3P water model
[2]
 and neutralized adding Na
+
 ions with one of these ions placed at the 
center of the G-tetrad planes. All the simulations were carried out using periodic boundary 
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conditions and Particle Mesh Ewald to treat long range electrostatic. Before doing 
metadynamics simulations the system was equilibrated through 25 ns MD under NPT 
conditions at 1 atm and 300 K using the parmbsc0 parameters, which is a modified version of 
the Amber force field adapted for nucleic acids.
[3-5] 
The Amber charges were applied to the 
DNA and waters atoms. The PLUMED plugin
[6]
 was used to carry out metadynamics 
calculations with the NAMD code.
[7]
 
The estimation F(s,t) at time t of the free-energy surfaces F(s) as a function of the CVs was 
determined by metadynamics in its new well-tempered variant, using the following formula: 
 
where V(s,t) is the bias potential added to the system and T is the temperature of the 
simulation. ΔT is the difference between the fictitious temperature of the CV and the 
temperature of the simulation. The bias potential is made up by the sum of the Gaussians 
deposited along the trajectories of the CVs. Thanks to this new formalism, one can increase 
barrier crossing and facilitate the exploration in the CVs space by tuning ΔT. A Gaussians 
deposition rate of 0.2 kcal/mol per picosecond was initially used and gradually decreased on 
the basis of the adaptive bias with a ΔT of 2,700 K. 
We used two CVs. The first one is the radius of gyration (Rcore) calculated on the oxygen 
atoms of the guanines forming the G-tetrad planes (Table S1). This collective variable is 
calculated using the following formula: 
 
where the sums are over the n atoms and the center of mass is defined by 
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The gyration radius is a common descriptor in protein folding studies because it is able to 
discriminate between completely unfolded and globule states. A Gaussian width of 0.02 Å 
was used for this CV. In order to distinguish between globule and folded states, we used as 
second CV the number of intramolecular hydrogen bonds engaged by the guanine bases 
forming the G-tetrad planes (Hcore). The number of hydrogen bonds is evaluated using the 
switching function 
 
where r0 is set to 2.0 Å, n and m are set to 6 and 12, respectively, i and j are the donor and 
acceptor hydrogen bond atoms of the guanines used to calculate the number of hydrogen 
bonds (Table S1). 
The Hcore CV has been used to compute the two-dimensional FES by means of a reweighting 
algorithm.
[8]
 In fact, this algorithm is able to reconstruct the Boltzmann distribution of CVs 
different from those used originally in the metadynamics run. Once the free energy of the 
metadynamics simulation is converged, using the newly computed probability distribution, 
the reweighting method allows to build the FES on these CVs. 
 
NMR spectroscopy. All the experiments were collected on samples of the TBA and of its 
truncated construct I at concentrations ranging from 0.7 mM up to 1.5 mM in potassium 
phosphate buffer (70 mM KCl, 10 mM KH2PO4, 0.2 mM EDTA, pH 7). NMR spectra were 
performed at 1 °C and 25 °C on Bruker spectrometers operating at 900, 700 and 600 MHz, 
equipped with triple resonance cryo-probes. Different pulse sequence schemes (presaturation, 
excitation sculpting
[9,10]
 and watergate
[11]
) were used to suppress the water signal. 2D 
1
H-
1
H 
TOCSY and 2D 
1
H-
1
H COSY experiments were performed at 1 °C operating at 700 MHz for 
the assignment of the spin systems. Proton–proton distance restraints were derived from the 
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analysis of 2D 
1
H-
1
H NOESY and 2D 
1
H-
1
H ROESY acquired in H2O at 900 and 800 MHz. 
2D 
1
H-
1
H NOESY was acquired using several mixing times ranging between 50 and 300 ms. 
2D 
1
H-
15
N HSQC spectrum was acquired at 800 MHz to identify imino protons. 
Intranucleotide connectivities between imino and aromatic protons were obtained by a jump-
and-return HMBC spectrum acquired at 600 MHz and 950 MHz on an isotopically natural-
abundance sample using 5120 transients. All spectra were processed with the Bruker 
TOPSPIN software packages and analyzed by the program CARA (Computer Aided 
Resonance Assignment, ETH Zurich).
[12]
 
 
CD and DSC experiments. Oligonucleotide samples were prepared by using the same buffer 
solution used for NMR experiments. CD spectra and CD melting curves of oligonucleotide 
samples were recorded by using a Jasco J-715 spectropolarimeter equipped with a Jasco JPT-
423-S temperature controller using 1 mm path-length cuvettes. CD spectral scans were 
accumulated over the wavelength range 200−360 nm at 1 °C. The spectra were recorded at a 
scan rate of 100 nm/min with a response of 1 s, at 2.0 nm bandwidth and were averaged over 
5 scans. Buffer baseline was subtracted from each spectrum. CD melting and annealing curves 
were recorded as a function of temperature in the range 0-90 °C at 289 nm with a scan rate of 
0.5 °C/min. The CD melting curve of I was analyzed with a two-state model, using a 
theoretical equation for an intramolecular association, according to the van’t Hoff analysis.[13] 
The Tm and ΔH°vH values provide the best fit of the experimental melting data. 
Differential scanning calorimetry (DSC) measurements were carried out using a Nano DSC 
III (TA Instruments, New Castle, DE). The experiments were performed at oligonucleotide 
concentration of 0.2 mM. Scans were carried out at 0.5 and 1.0 °C/min scan rate in the 
temperature range 0-90 °C. Reversibility and repeatability were proven by multiple scans. A 
buffer-buffer scan was subtracted from the sample-buffer scans and linear-polynomial 
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baselines were drawn for each scan. Baseline corrected thermograms were then normalized 
with respect to the oligonucleotide concentration to obtain the corresponding molar heat 
capacity curves. We note that the initial and final states of the transition have similar heat 
capacity values, indicating that the unfolding of I is accompanied by a negligible heat capacity 
change. The model-independent transition enthalpies were obtained by integrating the area 
under the heat capacity versus temperature curves.
[13]
 The melting temperatures were 
estimated as the temperatures corresponding to the maximum of each thermogram peak. 
Entropy values were obtained by integrating the ΔCp/T versus T curves (where ΔCp is the 
molar heat capacity and T is the temperature in kelvin) and the Gibbs energy values were 
computed by the equation ΔG° = ΔH° - TΔS°. The thermodynamic parameters reported are 
the averages of at least three different heating experiments. The reported errors are the 
standard deviations of the mean from the multiple determinations.  
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Supporting Information Figures 
 
 
 
Figure S1. Schematic representation of the main results of the study. Through metadynamics 
calculations we have found that the DNA aptamer, TBA, is able to assume the G-quadruplex 
conformation (left) and a totally new structure named G-triplex (middle). This new DNA 
structural motif has been also found in an 11-mer oligonucleotide, called I in the main text, 
combining advanced computations and experiments. 
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Figure S2. Plots regarding the MD simulations on basin A, B and C conformation. (Top 
graph) Plot of the rmsd of the heavy atoms of guanines foming the G-tetrad planes, 
G1:G6:G10:G15 and G2:G5:G11:G14, during over 50 ns of MD simulation. The very low 
rmsd values reflect the good stability of this pose. (Middle graph) Plot of the rmsd of the 
heavy atoms of guanines forming the G-tetrad planes, G1:G6:G10:G15 and G2:G5:G11:G14, 
during over 50 ns of MD simulation using the basin B conformation as starting pose. The 
rmsd are calculated relatively to the basin B (black lines) and basin A (red lines) 
conformation. The red plots clearly show that the basin B conformation transforms in the 
basin A one after approximately 17 ns. As discussed in the Supporting Information, this 
change is possible thanks to the relatively low energy barrier that separates basin B from basin 
A. (Lower graph) Plot of the rmsd of the heavy atoms of guanines forming the G-triad planes, 
G1:G6:G10 and G2:G5:G11, during over 50 ns of MD. The very low average rmsd value of 
0.63 Å reflects the high stability of the G-triplex structure. 
 97 
 
 
 
Figure S3. Plots regarding the MD simulation of the oligonucleotide I. (Left graph) Plot of the 
rmsd of the heavy atoms of the guanines forming the G-triad planes, namely G1:G6:G10 and 
G2:G5:G11, in I. The very low average rmsd value of 0.88 Å reflects the high stability of the 
G-triplex structure that is represented in the inset picture. (Right graph) Representation as 
histograms of the mean values of the distances between the hydrogen bond acceptor and 
hydrogen bond donor groups of the guanines forming G-triplex. The error bars show the SEM 
(standard error of the mean). Data for both the graphs are obtained from the over 100-ns-long 
MD simulation at the ionic concentration of 70 mM KCl. 
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Table S1. List of the atoms used to define the Rcore and Hcore CV. 
CV type Atoms 
Rcore O6 (G1); O6 (G2); O6 (G5); O6 (G6); O6 (10); O6 (G11); O6 (G14); O6 (G15) 
Hcore 
H-bond acceptor H-bond donor 
O6 (G1) H1 (G15) 
N7 (G1) H21 (G15) 
O6 (G2) H1 (G5) 
N7 (G2) H21 (G5) 
O6 (G5) H1 (G11) 
N7 (G5) H21 (G11) 
O6 (G6) H1 (G1) 
N7 (G6) H21 (G1) 
O6 (G10) H1 (G6) 
N7 (G10) H21 (G6) 
O6 (G11) H1 (G14) 
N7 (G11) H21 (G14) 
O6 (G14) H1 (G2) 
N7 (G14) H21 (G2) 
O6 (G15) H1 (G10) 
N7 (G15) H21 (G10) 
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Table S2. 
1
H-NMR assignment of I at 1°C (900 MHz). 
 H8/H6 CH3 H1' H2' H2'' H3' H4' H5'/H5'' H1/H3 H2 
(H-bonded) 
H2 
(non H-bonded) 
G1 7.40 -- 5.62 2.68 1.81 4.67 3.60 3.40, 2.86 12.00 9.72 6.15 
G2 8.04 -- 6.16 2.44 2.75 4.92 4.41 4.80, 4.02 12.42 6.90 6.90 
T3 7.09 1.65 5.04 1.30 2.04 4.41 4.29 4.23, 3.83 -- -- -- 
T4 7.41 1.61 6.05 2.23 2.29 4.45 3.01 2.81, 2.59 10.34 -- -- 
G5 7.44 6.12 6.12 3.64 2.84 4.87 4.51 4.37, 3.96 12.23 7.17 7.17 
G6 8.26 -- 6.13 2.66 3.00 5.02 4.57 4.25 12.51 6.91 6.91 
T7 6.86 1.92 5.50 0.50 1.79 4.65 4.17 4.00, 3.99 11.76 -- -- 
G8 8.11 -- 6.03 2.54 2.98 5.01 4.18 4.06, 4.00 10.65 -- 5.90 
T9 7.25 1.54 5.91 1.72 2.22 4.52 3.62 3.44, 2.54 12.42 -- -- 
G10 7.63 -- 5.98 2.84 2.53 4.72 4.31 3.95 11.55 6.48 6.48 
G11 8.02 -- 5.74 2.38 2.65 4.78 4.15 4.10, 3.60 12.08 10.12 6.91 
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3.2 The catalytic domain of MMP-1 studied through tagged 
lanthanides 
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Abstract 
A significant number of proteases and kinases are multidomain enzymes. In matrix 
metalloproteinase 1 (MMP-1), interdomain flexibility is crucial for collagen degradation. A 
rigorous assessment of the most readily accessed conformations in solution is required to explain 
the onset of substrate recognition and collagenolysis. Recovering such information from 
experimental data that are averages over a conformational ensemble is a so-called “ill-posed 
inverse problem” that admits an infinite number of solutions. We address this issue by calculating 
the maximum occurrence (MO) of conformations, through paramagnetic NMR and small angle 
X-ray scattering (SAXS). Analysis of the highest MO conformations suggests that MMP-1 in 
solution is poised to interact with the substrate and then can easily proceed along the steps of 
collagenolysis. The MO approach described herein can evaluate the predominant domain 
conformations for numerous multidomain enzymes, providing insight into mechanistic action and 
novel inhibitor design. 
 
                                                          
‡
Ivano Bertini passed away on July 7
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Proteases and kinases represent ~6% of the human genome (1, 2). Within these enzyme 
superfamilies, a significant number are multidomain (2, 3). Unfortunately, there is often little 
knowledge as to how enzyme domains are oriented for substrate recognition or how they 
cooperate to enhance catalytic activity. Many proteases and kinases are important therapeutic 
targets, as their activities have been correlated or validated to disease progression. Documenting 
the predominant conformational states of multidomain enzymes represents an opportunity to 
better define mechanisms and to develop novel, selective inhibitors. 
Matrix metalloproteinases (MMPs) are a family of proteases with the striking feature of 
hydrolyzing structurally unrelated substrates (4, 5). This broad proteolytic specificity, together 
with tight regulation of enzyme activation and localization, has been achieved by an evolutionary 
process where specialization of protein domains and protein flexibility interplay to facilitate 
recognition and hydrolysis of a variety of substrates (6). In particular, several active MMPs, 
including MMP-1, are two-domain [catalytic (CAT) and hemopexin-like (HPX)] enzymes 
capable of catalyzing the hydrolysis of highly structured substrates such as triple-helical, 
interstitial (types I-III) collagen. Interdomain flexibility appears particularly important for 
allowing movement of the MMP along collagen fibrils and for unwinding of the collagen and 
accommodation of a single, otherwise inaccessible, peptide chain into the active site (6-12). 
Assessment of the most easily accessed conformations within the ensemble of all sterically 
possible conformations in solution can be critical to understanding substrate recognition. 
When a system rapidly samples multiple conformations, the experimental data are a weighted 
average of the data relative to each conformation. Recovering a conformational ensemble from 
averaged data is known as an “ill-defined inverse problem” (13) that has an infinite number of 
solutions. Various methods (14-23) have been proposed to reconstruct ensembles consistent with 
the experimental data. To advance from simply obtaining many “plausible” ensembles to 
identifying specific conformations within these ensembles that are more likely sampled by the 
system, we proposed the idea of maximum allowed probability (24), later extended to the concept 
of maximum occurrence (MO) (25). The MO of a given conformation is defined, and numerically 
calculated, as the maximum weight that this conformation can have in any suitable ensemble 
while still maintaining the ensemble’s ability to reproduce the experimental data. Paramagnetic 
NMR spectroscopy and small angle X-ray scattering (SAXS) average data can be efficiently used 
as experimental restraints to calculate the MO of conformations of two-domain proteins, as 
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previously demonstrated for calmodulin (CaM) (25, 26) as well as for its complexes with target 
peptides (24, 27). 
MMP-1 was analyzed herein using the MO approach. Many of the MMP-1 conformations 
with the highest MO value were found to have interdomain orientations and positions that can be 
clearly grouped into a cluster. Remarkably, in the conformations belonging to this cluster, (i) the 
collagen binding residues of the HPX domain are solvent exposed and (ii) the CAT domain is 
already correctly positioned for its subsequent interaction with the collagen. A modest structural 
rearrangement, that can be easily performed by a ~50° rotation around a single axis of the CAT 
domain with respect to the HPX domain, is sufficient to position the CAT domain right in front 
of the preferred cleavage site in triple-helical collagen. The conformations belonging to this 
cluster can thus be seen as the antecedent step of collagenolysis. 
 
Results 
Pseudocontact shifts (PCS) and self-orientation residual dipolar couplings (RDC) (13) from at 
least three metals ions with large paramagnetic susceptibility anisotropy are needed as 
paramagnetic NMR restraints to provide sufficient average data and minimize degeneracy (28). 
The introduction of covalently bound lanthanide chelators has been widely exploited to introduce 
paramagnetic centers in diamagnetic proteins (29-31); the rigid lanthanide chelator CLaNP-5 (32) 
does so by covalently binding two neighboring Cys residues in a rigid fashion
§
. 
 
Paramagnetism-Based NMR Data  
The correspondence of the chemical shifts in the diamagnetic (Lu
3+
) tagged and untagged 
protein indicates that the presence of (Ln
3+
)CLaNP-5 does not affect the CAT structure (35). The 
magnetic susceptibility anisotropy tensors were determined from the best fit of the PCSs of the 
CAT domain to the previously refined protein structure (Table 1). The averaged anisotropy 
tensors obtained from the best fit of the RDCs of the amide protons of the HPX domain to the 
available X-ray structure of full-length proMMP-1 (pdb entry: 1SU3) (36) were also evaluated 
                                                          
§
It has been shown that the paramagnetic metal ion cobalt(II) can be introduced in the place of the catalytically 
active zinc(II) ion
(33, 34)
, and this could complement paramagnetic NMR data. However, the magnetic susceptibility 
anisotropy of cobalt(II) in the CAT domain is not large enough to provide measurable effects as far away as needed 
to reach the HPX domain nuclei. 
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(Table 1). The two sets of tensors for the CAT and HPX domains should be similar to one 
another in the case of a rigid system. The much smaller values obtained for the HPX domain with 
respect to those of the CAT domain (to which (Ln
3+
)CLaNP-5 is attached) reveal the presence of 
sizable interdomain mobility, and the relative tensor magnitudes and orientations reflect the 
conformational heterogeneity experienced by the system in solution (see later). Because the 
RDCs induced by one paramagnetic center can always be described by a single averaged 
anisotropy tensor in the case of rigid domains, independently of the fact that they originate from a 
weighted average of a number of conformations, the good quality of the fits (Supplementary 
Figure 1) reflects good agreement of the data with the X-ray structure of the HPX domain. Thus, 
the HPX domain moves essentially as a rigid body with respect to the CAT domain. 
To quantify the extent of the interdomain mobility we compare the RDCs back-calculated for 
the HPX domain from the susceptibility anisotropy tensors obtained for the CAT domain and the 
1SU3 structure (which would correspond to the case of absence of internal motion) (Figure 1A 
left panel) with the RDCs back-calculated from the averaged anisotropy tensors, which report 
their real distribution in solution (Figure 1B left panel). For comparison purposes, the distribution 
of RDCs calculated from uniformly sampled sterically allowed conformations was determined 
(Figure 1C left panel). The spreading in the actual distribution (Figure 1B left panel) is sizably 
smaller (by a factor of 3-4) than expected for a rigid system (Figure 1A left panel), thus 
indicating considerable mobility, but also much larger than the uniform sampling case (Figure 1C 
left panel), thus indicating the occurrence of preferred conformations in solution. The ratio of the 
spreading between the real RDC distribution and the RDC distribution calculated in the 
assumption of no motion, which can be taken as a generalized order parameter reflecting the 
interdomain mobility (19), is sizably larger in MMP-1 with respect to what was observed for 
CaM (Figure 1 right panels). This generalized order parameter for MMP-1 is 0.28, 0.27, and 0.29 
for Tb
3+
, Dy
3+
, and Tm
3+
, respectively. Different generalized order parameters as well as different 
scaling factors of the components of the anisotropy tensor indicate that the HPX domain motion 
causes different motional averaging for the different metals, because of the different rhombicity 
and directions of the principal axes of the anisotropy tensors. SAXS data, previously measured 
for MMP-1 solutions under the same experimental conditions as utilized here (10, 37), also 
indicated that the structure of the protein cannot be described by the crystallographic 
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conformation alone, but that ensembles with closed and more extended conformations must be 
considered, further indicating that the protein experiences noticeable flexibility. 
 
Maximum Occurrence (MO) Analysis 
A MO analysis was performed using as restraints the motionally averaged PCSs and RDCs 
collected for the HPX domain, the metal anisotropy tensors determined from the PCSs of the 
CAT domain, and the SAXS data. The latter data provide restraints complementary to those of 
the NMR data, and were recently demonstrated to be very useful to make the overall dataset more 
stringent in characterizing the different conformations through their MO values (25).  
If one examines the discrepancy of the calculated average data from the experimental dataset 
(expressed as Target Function values, TF) for each analyzed conformation as a function of their 
arbitrarily given weight in any suitable ensemble (see Supplementary Figure 2), the substantial 
differences in the weight at which the TF value starts increasing result in markedly different MO. 
Only 6% of the 1000 analyzed conformations were found to have a MO smaller than 5%, while 
most of the conformations (80%) have a MO smaller than 20%. Only 3% of the conformations 
have a MO larger than 30%, and only 0.3% have a MO larger than 40%. To visualize the results, 
the CAT domains of all the structures were superimposed and the position of the HPX domain 
was schematized by a triad of vectors pointing along the axes of a Cartesian coordinate system. 
Initial orientation is defined arbitrarily, pointing along the axes of the pdb file used for 
calculations and centered in the center of mass of the domain. The Cartesian axes system was 
color-coded with respect to the MO of the corresponding conformation, from blue (MO lower 
than 5%) to red (highest MO, 48%) (Figure 2A). Different orientations and positions of the 
Cartesian axes system thus reflect different orientations and positions of the HPX domain with 
respect to the CAT domain.  
The conformations having the HPX domain in the region proximal to (Ln
3+
)CLaNP-5 (and 
distal to the catalytic site cleft) were found to have a negligible weight in solution, with MO 
values below 5% (blue tensors in Figure 2A). Thus, these conformations are not sampled 
significantly by the protein. A striking finding is that most of the conformations with the highest 
MO (orange-red tensors in Figure 2A-B) are clustered in a well-defined region of the distribution, 
corresponding to relatively elongated structures. A second region comprising high MO 
conformations with lower density of structures, and more spread in the conformational space, is 
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present. To increase the resolution of the regions populated by the structures with the highest 
MO, additional conformations near these high MO structures were selected from the pool of 
50,000 generated by RanCh. In this way, the MO values of 281 additional conformations have 
been evaluated. All conformations with MO larger than 35% have been examined. It was 
confirmed that the largest share of high MO conformations was grouped into a well-defined 
cluster. 
MO values can be represented as a function of the translational and rotational parameters of 
the corresponding structures with respect to the structure with highest MO (Figure 3). The 
translations are reported with respect to the center of mass of the reference structure. To simplify 
distance calculations, rotations are represented through the corresponding 4-components complex 
number (quaternion) and distances are calculated as the projection of one quaternion to the 
reference one (38).
**
 There is continuity in the MO values as a function of these structural 
parameters, thus indicating a correlation between position/orientation and MO. The main regions 
with conformations possessing the highest MO values are clearly visible (Figure 3). A reasonably 
well-defined peak encompassing the conformations with the largest MO value was observed as 
well as another region with somewhat smaller MO values (up to 40%). From the shape of the 3D 
plot in Figure 3, it appears that the highest MO conformations can be clearly identified 
independently from the generation probability of RanCh.  
All available X-ray structures of human full-length MMP-1 (pdb entries: 1SU3 (36) and 
2CLT (39, 40)) display relatively closed conformations. It is crucial to understand how much 
these structures are represented in the ensemble sampled by the protein in solution. In order to 
calculate their MO values, these two structures were included in the pool of structures to be 
analyzed. The MO values obtained for the X-ray structures 1SU3 (proMMP-1) and 2CLT (active 
MMP-1) were 20% and 19%, respectively. 2CLT (active MMP-1) was highly similar to the X-
ray crystallographic structure of porcine full-length MMP-1 (41), while the recently reported X-
ray crystallographic structure of an MMP-1/triple-helical peptide (THP) complex (pdb entry: 
4AUO) has a more closed structure than 2CLT (40) and has a MO of 18%.  
                                                          
**
A quaternion is a complex number with 3 imaginary components. As 2D rotations can be represented by a complex 
number with norm 1 according to the Euler’s rule, a 3D rotation can be represented with a quaternion with norm 1. 
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The radii of gyration (Rg) of the two crystallographic structures are 25.5 and 25.7 Å, 
respectively, whereas the structures with highest MO (>35%) have Rg of 28.9 ± 1.3 Å. This range 
of Rg is in better agreement with the experimentally determined values from the SAXS data 
alone, indicating that the X-ray structures are more compact than the average solution 
conformation. Furthermore, the relative orientations of the HPX and CAT domains in the 
structures with the highest MO are different from those in the X-ray crystallographic structures. 
 
Discussion 
Conformational selection or induced fit are often invoked to explain the mechanism used by 
proteins constituted of multiple domains and connected by flexible linkers to recognize partners 
or substrates. While a detailed structural characterization of the bound-state conformation is often 
possible, much more difficult is the analysis of the conformations sampled by multidomain 
proteins before the interaction. However, analysis of the conformational space experienced by the 
free protein is useful not only to investigate the mechanism of binding, but also to determine the 
role of the different domains in the identification of substrates or partners, to predict new possible 
substrates or partners, and to investigate natural and new mechanisms of inhibition (6, 16, 18, 23, 
27, 42-44). 
The full-length form of MMP-1 was observed by NMR and SAXS to experience a sizable 
interdomain flexibility and an open-closed equilibrium (10, 37). The compact arrangement of the 
two domains of MMP-1 observed in the crystal structure, in fact, was shown not to be fully 
representative of the conformations sampled by the protein in solution. It was demonstrated in 
previous work that for at least one third of the time, the enzyme exists with the CAT and HPX 
domains in a more extended arrangement (10). Moreover, it has been hypothesized that the 
interface of the CAT and HPX domains may conceal secondary binding sites (exosites) involved 
in the recognition of the substrate (37). While X-ray crystallographic analysis of an MMP-1/THP 
complex has revealed binding of the THP to a closed form of MMP-1, it has been noted that the 
mode of binding in the MMP-1/THP structure was unproductive (40). Interdomain mobility in 
solution appears essential for the protein to be poised to catalyze collagen hydrolysis.  
More recently, the interaction of MMP-1 with a THP has been investigated utilizing NMR 
spectroscopy, leading to a plausible multistep mechanism for collagenolysis (11). In this model, 
the initial binding of the HPX domain to the THP is followed by the interaction of the CAT 
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domain with the THP in front of the cleavage site, and by a subsequent back rotation of the CAT 
and HPX domains toward the closed conformation that drives the unwinding of the triple-helix 
and causes the displacement of one peptide chain into the active site. 
While there is experimental evidence for the formation of the initial MMP-1/THP complex, 
the mechanism that leads to the observed two-domain interaction is still unclear. The MO 
analysis performed for MMP-1 can shed light on this elusive step preceding catalysis. The MMP-
1 conformations with large MO values (up to 48%) are restricted into a relatively small 
conformational region, much smaller than what observed for the previously investigated protein 
CaM, where all MO values were below 35% (24, 25). All conformations with high MO values 
largely differ from the closed MMP-1 structures obtained by X-ray crystallography. The MO of 
the latter is around 20%, which represents the upper limit for the presence of this conformation in 
the ensemble sampled by the protein in solution. In all the high MO conformations, the CAT and 
HPX domains are not in tight contact, and the residues of the HPX domain reported to be 
responsible for the binding to the THP are solvent exposed. The MMP-1 conformations that may 
be more relevant in solution can be examined by comparing the structures with the highest MO 
values (40-48%) among themselves, after having superimposed their HPX domains (Figure 4). 
The reciprocal orientation of the CAT domain has been evaluated by considering the differences 
in the orientation of the hA and hC helices of the CAT domain (defined by residues 130-141 and 
250-258, respectively), which are almost perpendicular to one another (Figure 4B). The angles 
among these highest MO structures for the first and second helix change up to a maximum of 28° 
with respect to the mean orientation, with the exception of one structure with the longest helix 
pointing at about 180° with respect to the others. This indicates that all highest MO structures are 
characterized by an interdomain orientation and position that can be defined relatively well. The 
single structure differently oriented with respect to the others is most likely a “ghost” solution, 
arising from the quadratic form of the RDC equation (28), which in this case neither PCSs nor 
SAXS have been able to remove. A second, much less populated region with high MO values (up 
to 38%) is also present in the pool of conformations, but its importance for collagenolysis appears 
negligible, as the reciprocal orientation of CAT and HPX domain is distant from the MMP-1 
structure in the first step of the collagenolytic mechanism and also from any MMP-1 
crystallographic structure. 
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In the highest MO structures, the residues of the HPX domain essential for the binding to 
collagen are not buried between the CAT and HPX domains, and the open space between the two 
domains is wider than in the crystallographic structures. Furthermore, and more importantly, the 
secondary binding sites (exosites) of the HPX domain responsible for collagen interaction, and 
the active site of the CAT domain, face the same side. If triple helical collagen is modeled in its 
experimentally determined bound position to the HPX domain (11), the CAT domain faces 
closely the collagen cleavage site, and in about half of the highest MO structures even penetrates 
the triple helical substrate (Figure 5). Actually all the high MO conformations (MO >35%) of 
free MMP-1 fall along the boundary between the penetrating and non penetrating conformations. 
Therefore, the largest MO conformations sampled by MMP-1 when free in solution, i.e. in the 
absence of collagen, appear to be much more poised for interaction with collagen than the 
compact X-ray crystallographic structures. Comparison of the non penetrating structures with 
high MO values with the structural models corresponding to the different steps of the catalytic 
mechanism (11) suggests that the protein in solution has a marked tendency to assume 
“catalytically prone” conformations: once the HPX domain is bound to triple helical collagen, the 
CAT domain can effectively search within a restricted and productive subset of binding modes 
that face the collagen hydrolysis site, and can start collagen unwinding and cleavage. Therefore, 
the high MO conformations that are not colliding can be seen as a possible antecedent step for the 
recently proposed mechanism of collagenolysis (11). 
In order to confirm whether the protein can easily rearrange from the highest MO 
conformations to the conformation assumed when interacting with the substrate, a morphing 
between these two conformations has been performed with the programs Climber (45) and 
FATCAT (46). Rearrangement from one conformation to the other involves only one twist in the 
hinge region, and the angle that the CAT domain has to cover to reorient itself on the cleavage 
site of collagen, once the HPX domain is attached, is about 50° along one single axis (Figure 6). 
The transition seems to be feasible at physiological temperature as the difference in free energy 
between these steps in the pathway is favorable (-0.133 kcal/mol). Therefore, the conformational 
rearrangement reasonably occurs through a small energetic barrier, and the entropy loss is 
compensated by the enthalpy gain associated to the new interaction between the CAT domain and 
the triple-helix.  
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It has been previously reported that G271 is critical for the collagenolytic activity of MMP-1. 
In particular, it has been observed that the replacement of this Gly with bulkier amino acids such 
as Asp drastically reduce the catalytic efficiency of the enzyme (47). This effect has been 
explained as being due to an alteration of the linker mobility. Analysis performed with Climber 
on the G271D MMP-1 mutant showed that the conformational space sampled by the linker 
passing from the highest MO structures to the conformation in step 1 of the collagenolysis 
mechanism differs from that observed in the wild type protein, supporting previous results that 
G271 is largely involved in the hinge bending motion. 
The flexibility of MMP-1 domains, and particularly the highly favored extended 
conformation, also has a critical role in enzyme movement on collagen fibrils that occurs during 
the proteolytic process. MMPs are known to bind to numerous regions within the collagen triple-
helix (48). MMPs then progressively move on collagen fibrils (49). Elongated MMP structures 
have been observed upon binding to collagen (6), from which an “inchworm” mechanism for 
MMP movement has been proposed(50). The application of mechanical stress facilitates collagen 
hydrolysis in the fibril (51). Both the MMP movement and the mechanical stress could be derived 
from the closing of an open MMP-1 conformation. 
The overall conclusion from the present study is that conformational selection followed by 
induced fit should be invoked to describe the MMP-1/collagen binding process. In fact, among 
the many conformations sampled by MMP-1 where the residues of the HPX domain essential for 
collagen binding are not buried between the protein domains, the largest MO conformations have 
the CAT domain in an orientation that can easy access the collagen once the latter binds to the 
HPX domain. The present study represents a striking example of the pathway followed by a 
multidomain protein with flexible linker(s) to perform its catalytic activity. In a broader context, 
the MO approach described here can evaluate the predominant domain conformations for 
numerous multidomain enzymes, including members of the protease and kinase superfamilies. 
 
Methods 
 
The MMP-1 mutations H132C and K136C were engineered to attach (Ln
3+
)CLaNP-5 to the 
protein through disulfide bonds. The residues mutated were on the rigid amphipathic helix (hA), 
far enough from the active site cleft and the HPX domain to avoid steric clashes that could affect 
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the conformational heterogeneity of the protein. The paramagnetic ions Tb
3+
, Dy
3+
, and Tm
3+
 
were ligated to CLaNP-5(32), as previously described for the isolated CAT domain (35). 
Contrary to the procedure for the single MMP-1 CAT domain (35), no DTT or reductant of any 
kind was added to the protein at any stage of the (Ln
3+
)CLaNP-5-protein ligation (see 
Supplementary Text 1) to avoid reduction of the structurally important and solvent exposed 
disulfide bridge present in the HPX domain between C278 and C466.  
Calculations of the MO values were performed for the first 1000 MMP-1 conformations 
obtained from a pool of 50,000 conformations that were randomly generated by RanCh (15, 25, 
52), as representative of all possible conformations in solution. A flexible linker of 13 residues 
(from R262 to T274) was used to connect the rigid structures of the previously refined CAT(35) 
and HPX (1SU3) domains. Calculations were performed as described in the Supplementary Text 
2, largely through the web server
††
 at py-enmr.cerm.unifi.it/access/index/maxocc (53). 
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Table 1. Tensors obtained by FANTASIAN Software package implemented in the WeNMR 
Portal. 
 Tb
3+
 Dy
3+
 Tm
3+
 
 Δχax 
(10
-32
 m
3
) 
Δχrh 
(10
-32
 m
3
) 
Δχax 
(10
-32
 m
3
) 
Δχrh 
(10
-32
 m
3
) 
Δχax 
(10
-32
 m
3
) 
Δχrh 
(10
-32
 m
3
) 
PCS Tensor of CAT -45.4 16.5 -40.4 -13.2 51.9 -9.9 
RDC Tensor of HPX -12.7 7.7 -10.9 -2.3 15.0 -2.3 
The PCS measured on the CAT domain and the RDC measured on the HPX domain for 
1
H-
15
N 
couplings were used. 
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Figure Legends 
 
Figure 1. (Left) Distribution of the RDC values of the (Tm
3+
)CLaNP-5 MMP-1 HPX domain 
based on the magnetic susceptibility tensors obtained from (A) experimental PCS of the CAT 
domain, (B) experimental RDC of the HPX domain, and (C) average RDC of the HPX domain 
obtained from sterically allowed uniformly sampled conformations. (Right) Distribution of the 
RDC values of the Tm
3+
CaM C-terminal Bax structure based on the magnetic susceptibility 
anisotropy values obtained from (A) experimental PCS of the N-terminal domain, (B) 
experimental RDC of the C-terminal domain, and (C) average RDC of the C-terminal domain 
obtained from sterically allowed uniformly sampled conformations(19). 
 
Figure 2. Results of MO calculations for 1000 MMP-1 conformations. Two stereo views of 
MMP-1 are presented, one (A) with all conformations superimposed on the CAT domain, the 
other (B) with all conformations superimposed on the HPX domain. Within the CAT domain, the 
residues in pink color are those mutated to Cys to incorporate (Ln
3+
)CLaNP-5 and the gray 
spheres are the metals in the protein. The colored axes are positioned in the center of mass and 
indicate the orientation of 1000 different structures of the HPX and CAT domain, respectively, 
randomly generated in space. Colors from blue (<5%) to red (48%) represent the MO values of 
the various structures. 
 
Figure 3. Representation of MO values as a function of translational and rotational parameters. 
Both plots are centered at the conformation with the highest MO value. (Left) 3D plot 
representation of the MO value as a function of the distance between the centers of mass of the 
different HPX domain conformations and the angle between their quaternion representations. 
(Right) The probability distribution in space of the conformations generated by RanCh. Plots 
were generated using Gnuplot, interpolating the data 30 times along each direction. 
 
Figure 4. Results of MO calculations for 1281 MMP-1 conformations. In the stereo view 
representation, only conformations with MO higher than 40% are reported. One main cluster is 
distinguishable containing conformations with the highest MO (A). CAT domain -helices hA 
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and hC are in blue and red, respectively (B). The complete structure of one of the CAT domains 
is also displayed in gray along with the colored helices for reference. 
 
Figure 5. Stereo view representation of MO results for 1281 conformations superimposed on the 
HPX domain. The conformations where the CAT domain collides with collagen, when the HPX 
binds collagen as in step 1 of the proposed collagenolytic mechanism(11), are removed (A) and 
separately shown in panel B. 
 
Figure 6. Climber calculations of MMP-1 conformations. From left to right: structure with the 
highest MO, two morphing intermediate steps, and the previously proposed first step of 
collagenolysis.(11) Structures in the bottom row are rotated 180° about the vertical axis with 
respect to the top row. The highest MO structure and morphing results were aligned to the HPX 
domain of the MMP-1/THP complex structure obtained previously.(11) In yellow is the surface 
representation of MMP-1, in blue is the MMP consensus sequence HEXXHXXGXXH, in orange 
is the catalytic Zn
2+
 ion, and in green is the surface of the THP. The blue and red arrows indicate 
the directions of the helices hA and hC, respectively, to facilitate visualizing the movement of the 
CAT domain with respect to the HPX domain and the THP.  
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Supplementary Text 1: Protein Expression and Functionalization 
 
Protein Preparation 
MMP-1 E219A construct (residues N106 to N469) was prepared as described previously. The double 
mutation H132C/K136C, engineered for the attachment of the (Ln
3+
)CLaNP-5 tag, was obtained during a 
single PCR step using QuickChange Site Directed Mutagenesis Kit (Stratagene): 5' - GCC AAG AGC 
AGA TGT GGA CTG TGC CAT TGA GTG TGC CTT CCA ACT CTG GAG - 3'; 5' - CTC CAG AGT 
TGG AAG GCA CAC TCA ATG GCA CAG TCC ACA TCT GCT CTT GGC - 3'. The mutations were 
confirmed by nucleotide sequencing. The expression vector was inserted into the competent E. coli 
BL21(DE3) CodonPlus RIPL strain, and the colonies were selected for ampicillin and chloramphenicol 
resistance. Monolabeled 
15
N protein was expressed using minimal medium containing 
15
N-enriched 
(NH4)2SO4. Cell growth occurred at 37 °C with induction at 0.6 O.D. with 500 M of IPTG and 
harvesting after 5 h expression. Triple mutant MMP-1 (H132C/K136C/E219A) precipitated into inclusion 
bodies, and these were solubilized, after lysis of the cells, in a solution of 8 M urea, 20 mM dithiothreitol, 
and 20 mM Sigma-Aldrich Trizma-base (pH 8), stored at -20 °C. The refolding of triple mutant MMP-1 
consisted of decreasing the urea concentration according to the following steps, performed at 4 °C. The 
desired amount of protein was diluted in a 500 mL solution containing 6 M urea, 50 mM Trizma-base, 10 
mM CaCl2, 0.1 mM ZnCl2, and 20 mM cysteamine, at pH 8.0. The solution was then dialyzed against (a) 
4 L of 4 M urea, 50 mM Trizma-base, pH 8.0, 10 mM CaCl2, 0.1 mM ZnCl2, 5 mM 2-mercaptoethanol, 
and 1 mM hydroxyethyl disulphide (overnight dialysis); (b) 4 L of 2 M urea, 50 mM Trizma-base, pH 7.2, 
10 mM CaCl2, 0.1 mM ZnCl2, and 0.3 M NaCl; and (c) three steps of 20 mM Trizma-base, pH 7.2, 10 mM 
CaCl2, 0.1 mM ZnCl2, and 0.3 M NaCl. The resulting 500 mL protein sample was concentrated down to 
100 mL using MiniKros Modules (Spectrumlabs). H132C/K136C/E219A MMP-1 was purified using 
HiLoad 26/60 Superdex 75 pg (Amersham Biosciences) in 20 mM Trizma-base, pH 7.2, 10 mM CaCl2, 
0.1 mM ZnCl2, and 0.3 M NaCl buffer. Protein pure stocks were stored at 4 °C. 
 
(Ln
3+
)CLaNP-5-Protein Ligation. CLaNP-5 was synthesized and functionalized with the different 
lanthanides as previously described
1
. 
2 mg of purified H132C/K136C/E219A MMP-1 was concentrated down to 1 mL in 2 M Trizma-base, 
pH 7.2, 10 mM CaCl2, 0.1 mM ZnCl2, and 0.3 M NaCl buffer. 6-10 equivalents of (Ln
3+
)CLaNP-5 (where 
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the lanthanide ions were Lu
3+
, Tb
3+
,
 
Dy
3+
, and Tm
3+
) from DMF stock (ca. 3-6 µL) were added to the 
protein solution. The triple mutant MMP-1/(Ln
3+
)CLaNP-5 mixture was left on mild stirring overnight. 
Some protein precipitation was observed after reaction. Contrary to the procedure for the MMP-1 CAT 
domain, here no DTT or reductant of any kind was added to the protein at any stage of the tag-protein 
ligation, so to avoid reduction of the structurally important and solvent exposed disulphide bridge present 
in the HPX domain between C278 and C466. After reaction with (Ln
3+
)CLaNP-5, approximately 10-20% 
of diamagnetic MMP-1 remained, as estimated from the 2D 
1
H-
15
N HSQC spectra acquired on these 
samples. The overall yield of obtained paramagnetic (Ln
3+
)CLaNP-5-MMP-1, considering precipitation 
occurring during CLaNP-5 reaction and efficiency of MMP-1 functionalization, was estimated to be ~60-
70%. 
 
NMR Measurements 
All experiments were performed on samples of triple mutant (H132C/K136C/E219A), full-length 
MMP-1 functionalized with the (Ln
3+
)CLaNP-5 (Ln = Lu
3+
, Tb
3+, 
Dy
3+
, Tm
3+
), at concentrations ranging 
between 0.10 and 0.20 mM in water buffer solution (20 mM Tris, pH 7.2, 0.15 M NaCl, 0.1 mM ZnCl2, 10 
mM CaCl2, and 200 mM AHA). All NMR experiments were performed at 310 K and acquired on a 
Bruker AVANCE 700 spectrometer equipped with triple resonance cryo-probe. All spectra were 
processed with the Bruker TOPSPIN software packages and analyzed by the program CARA (Computer 
Aided Resonance Assignment, ETH Zurich). The 2D 
1
H-
15
N HSQC spectrum of (Ln
3+
)CLaNP-5-MMP-1 
was recorded as the diamagnetic reference to evaluate the PCSs. The assignment of the protein 
functionalized with (Lu
3+
)CLaNP-5 was based on the assignment previously reported for MMP-1
2
; the 
spectrum was easily reassigned because no meaningful shifts with respect to the non-functionalized 
protein were observed, indicating that the presence of the CLaNP-5 does not alter the structure of the 
protein. The assignment of MMP-1 in the presence of the paramagnetic lanthanides was performed by 
comparison with the assigned spectra obtained for the isolated CAT domain in presence of the same metal 
ions. 
1
H-
15
N RDCs were measured for the MMP-1 functionalized with (Tb
3+
)CLaNP-5, (Dy
3+
)CLaNP-5, 
and (Tm
3+
)CLaNP-5, by using the IPAP-HSQC method. 
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Supplementary Text 2: Computational Details  
MO Calculations 
The MO value of each of the 1000 conformations was obtained from the largest weight that the 
conformation can have when included in any best-fit ensemble together with 50 other conformations with 
different weights freely chosen from a pool of 50,000 conformations generated with the program RanCh. 
These best-fit ensembles were found as families of structures in best agreement with the experimental data 
by minimizing the target function (TF), defined as a measure of the disagreement from the experimental 
data of the weighted average PCS and RDC calculated according to the ensemble itself. During the 
minimization, the weight of the fixed conformation (one of the 1000 randomly generated conformations) 
was set to different values ranging from 0% to 50% in steps of 5%. The MO of such a conformation was 
defined as the largest weight for which the TF is smaller than a given threshold. A minimum for the TF 
was calculated by generating structural ensembles without any fixed conformation, and it was equal to 
~0.253. The threshold was defined 10% larger than this lowest value (0.278). Most calculations were 
performed through the web portal MaxOcc (http://py-enmr.cerm.unifi.it/access/index/maxocc)
3
. The final 
weights of the restraints used in the calculations were 1.0 for RDC and PCS and 0.1 for SAXS. 
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Supplementary Figure 1: Quality of fit of calculated versus observed RDC values of the HPX domain. 
 
 
 
 
 142 
 
Supplementary Figure 2: Progression of the target functions (TFs) as a function of the weight given to 
the selected structure within the minimized ensemble of 50 structures. The dashed line represents the 
threshold at which the MO value is assigned when intercepted by the TF. Only the TF for the first 500 
calculated structures is represented here. 
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Table S1. 
13
C Resonance Assignments for S100A14 (pH 6.5, T=310K) 
Chemical shifts (ppm) 
Residue C Cα Cβ Cγ Cδ Cε 
MET 1             
GLY 2             
GLN 3             
CYS 4             
ARG 5 176.35 56.02 30.68 26.89 43.22   
SER 6 174.12 57.99 63.69       
ALA 7 177.24 52.60 19.02       
ASN 8 174.94 52.86 38.80 177.04     
ALA 9 177.84 52.72 18.92       
GLU 10 176.43 56.88 29.63 36.16 183.83   
ASP 11 176.09 54.28 40.75 179.89     
ALA 12 177.78 52.51 18.78       
GLN 13 175.68 55.91 29.11 33.64 180.35   
GLU 14 175.78 55.80 29.95 36.11 183.65   
PHE 15 176.90 55.33 39.25       
SER 16 174.80 56.97 65.60       
ASP 17 179.69 57.97 39.45       
VAL 18 176.86 66.48 31.94 CG1 24.34, CG2 21.04     
GLU 19 178.62 59.99 28.66 39.29     
ARG 20 178.71 59.10 29.71 28.45 43.10   
ALA 21 179.34 55.22 17.93       
ILE 22 177.49 66.03 37.44 CG1 29.29, CG2 16.94 CD1 14.76   
GLU 23 178.02 60.30 29.51 36.47     
THR 24 177.03 67.09 68.22 CG2 21.31     
LEU 25 178.15 59.33 41.74 26.39 CD1 26.28, CD2 24.47   
ILE 26 177.95 64.09 37.26 CG1 28.33, CG2 17.50 CD1 12.89   
LYS 27 179.64 60.06 32.05 25.69 29.68 41.81 
ASN 28 175.96 57.70 40.34       
PHE 29 176.16 61.21 38.61       
HIS 30 177.40 58.54 29.61       
GLN 31 176.58 57.76 28.37 33.52     
TYR 32 174.84 59.73 38.70       
SER 33 175.03 57.24 63.24       
VAL 34 177.79 64.36 32.11 CG1 21.39, CG2 21.39     
GLU 35 177.76 57.49 29.78 36.44     
GLY 36 175.05 45.26         
GLY 37 174.09 45.79         
LYS 38 176.02 56.14 32.72 24.57 28.86 41.97 
GLU 39 175.61 56.81 30.21 36.39     
THR 40 173.38 59.32 72.14 CG2 21.79     
LEU 41 177.02 53.34 45.30 26.66 CD1 26.46, CD2 23.12   
THR 42 174.13 59.84 68.06 CG2 21.70     
PRO 43 178.59 66.21 31.71 28.21 50.01   
SER 44 176.17 61.51 62.17       
GLU 45 178.97 59.05 29.67 36.06     
LEU 46 177.64 57.27 40.85 26.61 CD1 26.41, CD2 23.81   
ARG 47 178.85 59.98 29.04 27.09 43.09   
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ASP 48 176.71 57.54 39.43 179.09     
LEU 49 179.11 59.04 41.26 27.60 CD1 25.63, CD2 24.56   
VAL 50 178.76 66.35 31.46 CG1 22.44, QG2 22.17     
THR 51 175.99 65.76 68.86 CG2 21.31     
GLN 52 178.29 57.82 28.54 34.07 181.05   
GLN 53 176.94 54.96 28.43 32.07     
LEU 54 176.88 53.94 42.13 26.78 CD1 24.73, CD2 23.33   
PRO 55 178.29 65.33 30.75 27.01 49.79   
HIS 56 176.35 57.76 28.25       
LEU 57 176.39 55.44 42.55 26.61 CD1 25.10, CD2 22.36   
MET 58 171.61 53.51 32.66 28.86   17.11 
PRO 59 177.44 63.11 31.89 27.25 49.91   
SER 60 174.71 59.13 63.23       
ASN 61 175.52 52.99 37.90 177.33     
CYS 62 175.34 59.23 27.36       
GLY 63 175.61 46.25         
LEU 64 177.85 57.57 41.98 26.66 CD1 24.43, CD2 23.66   
GLU 65 179.07 60.05 28.39 36.18 183.28   
GLU 66 178.18 59.06 29.14 36.31 182.06   
LYS 67 179.39 58.86 32.11 24.99 28.92 41.87 
ILE 68 177.81 64.54 37.34 CG1 29.11, CG2 17.24 CD1 12.90   
ALA 69 179.62 54.44 17.94       
ASN 70 176.48 54.30 38.66       
LEU 71 178.33 56.30 42.34 26.03 CD1 25.03, CD2 22.86   
GLY 72 174.44 45.73         
SER 73 175.03 58.88 63.57       
CYS 74 174.51 58.66 27.72       
ASN 75 174.75 53.80 38.90       
ASP 76 175.53 54.42 40.55 180.59     
SER 77 173.31 59.04 63.14       
LYS 78 175.26 55.58 33.35 24.29 28.94 42.00 
LEU 79 176.07 54.25 41.96 27.07 CD1 25.40, CD2 24.22   
GLU 80 177.08 55.16 31.64 36.65     
PHE 81 177.01 62.33 38.50       
ARG 82 178.03 59.19 29.18 26.54 43.21   
SER 83 175.81 61.69 62.71       
PHE 84 175.05 60.01 39.22       
TRP 85 179.08 59.75 29.16       
GLU 86 179.06 59.29 29.49 36.20     
LEU 87 178.90 57.95 41.35 26.62 CD1 26.59, CD2 24.63   
ILE 88 177.35 62.97 35.55 CG1 26.29, CG2 18.20 CD1 11.46   
GLY 89 175.69 45.38         
GLU 90 179.13 58.18 28.81 35.75     
ALA 91 178.70 54.02 17.97       
ALA 92 177.93 53.91 17.89       
LYS 93 177.04 57.45 31.83 24.58 28.92 41.82 
SER 94 174.54 58.81 63.93       
VAL 95 175.42 63.16 31.49 CG1 21.03, CG2 21.03     
LYS 96 175.99 55.48 32.46 24.38 28.66 42.05 
LEU 97 176.72 54.44 42.25 26.53 CD1 25.30, CD2 23.25   
GLU 98 175.87 56.21 30.10 36.04     
ARG 99 173.86 53.60 29.92 26.76 43.14   
PRO 100 176.70 62.80 31.73 27.10 50.38   
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VAL 101 176.00 62.13 32.24 CG1 20.81, CG2 20.81     
ARG 102 176.40 55.88 30.74 26.71 43.09   
GLY 103 172.87 45.04         
HIS 104 179.02 56.88 30.29       
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Table S2. All proton assigned resonances of S100A14 (pH 6.5, T=310K) 
 
Chemical shift (ppm) 
 
 
Residue N HN Hα Hβ Hγ Hδ Hε Others 
MET 1                 
GLY 2                 
GLN 3                 
CYS 4                 
ARG 5 124.10 8.57 4.05 (1.90) (1.71) (3.29)     
SER 6 117.46 8.37 4.51 3.96, 3.92         
ALA 7 125.90 8.41 4.40 (1.46)         
ASN 8 117.45 8.36 4.77 2.91, 2.81       HD21 7.57, HD22 6.87 
ALA 9 124.38 8.27 4.35 (1.47)         
GLU 10 119.31 8.47 4.31 2.04, 1.91 2.32       
ASP 11 120.61 8.20 4.61 (2.70)         
ALA 12 123.80 8.07 4.09 (1.37)         
GLN 13 118.55 8.23 4.27 2.02, 1.95 2.37, 2.46       
GLU 14 120.60 8.10 4.30 2.05, 1.91 2.37, 2.22       
PHE 15 121.08 8.03 4.88 3.46, 3.09   (6.92) (7.14) HZ 7.35 
SER 16 119.43 9.53 4.85 (4.28)         
ASP 17 121.31 9.27 4.55 2.92, 2.80         
VAL 18 120.64 8.23 3.68 2.28 (1.15)     QG2 (0.93) 
GLU 19 121.01 8.18 3.74 1.98, 1.52 3.20       
ARG 20 118.07 8.92 4.30 (2.12) 2.06, 1.90 3.47, 3.34     
ALA 21 123.83 8.06 4.42 (1.88)         
ILE 22 118.18 8.01 3.72 1.96 (0.98) (0.74)   QG2 (0.78) 
GLU 23 120.11 8.45 3.96 2.55 2.39, 2.20       
THR 24 117.32 8.72 4.01 4.01       QG2 (1.25) 
LEU 25 123.44 8.15 4.28 (2.67) 2.23 (1.09)   QD2 (1.16) 
ILE 26 119.53 8.51 4.00 2.01 1.60, 1.20 (0.68)   QG2 (0.98) 
LYS 27 120.51 9.00 4.15 (2.05) 1.75, 1.55 (1.77) (3.04)   
ASN 28 117.26 7.99 4.56 2.96, 2.48       HD21 7.62, HD22 7.25 
PHE 29 119.13 7.99 3.91 3.33, 2.67   (6.49) (7.10) HZ 7.27 
HIS 30 114.68 8.18 4.32 3.27       HD2 7.21, HE1 7.09 
GLN 31 118.53 8.28 4.08 2.15 2.29     HE21 7.45, HE22 6.80 
TYR 32 115.68 7.41 4.21 3.11, 2.70   (7.52) (6.84)   
SER 33 113.97 7.26 4.53 (3.76)         
VAL 34 126.63 8.49 4.01 2.18 (1.04)     QG2 (0.99) 
GLU 35 122.08 8.98 4.25 2.11, 2.05 2.38       
GLY 36 108.46 8.49 4.01           
GLY 37 108.71 8.14 4.00           
LYS 38 118.05 8.05 4.47 (1.96) 1.52, 1.45 1.74, 1.68 (3.05)   
GLU 39 118.14 8.63 4.56 2.38, 2.19 2.42, 2.33       
THR 40 108.10 7.49 5.16 4.15       QG2 (1.21) 
LEU 41 120.75 8.66 5.04 1.73, 1.50 1.24 (0.58)   QD2 (0.68) 
THR 42 113.47 9.13 5.00 4.85       QG2 (1.40) 
PRO 43     4.15 2.41, 2.08 2.37, 2.24 4.04, 3.96     
SER 44 111.60 8.09 4.17 (3.95)         
GLU 45 123.94 7.70 4.26 2.16 2.48       
LEU 46 118.92 8.40 4.08 2.00, 1.47 1.60 (0.97)   QD2 (1.08) 
ARG 47 119.26 8.26 3.77 2.16, 1.95 (1.58) 3.26, 3.07     
ASP 48 122.30 8.16 4.43 3.08, 2.81         
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LEU 49 122.57 7.98 3.17 1.75, 1.09 1.24 (0.68)   QD2 (0.65) 
VAL 50 118.23 8.39 3.55 2.18 (1.05)     QG2 (1.01) 
THR 51 114.98 8.48 3.99 4.35       QG2 (1.32) 
GLN 52 116.42 8.18 4.25 2.32, 2.22 2.84, 2.60       
GLN 53 112.15 8.49 4.85 2.28, 2.03 2.68, 2.59     HE21 7.20, HE22 6.77 
LEU 54 119.81 7.92 5.26 1.96, 1.74 1.57 (0.86)   QD2 (0.82) 
PRO 55     4.47 2.20, 1.58 1.93, 1.21 3.50, 3.38     
HIS 56 116.48 9.77 4.59 3.46, 3.01       HD2 7.47, HE1 7.13 
LEU 57 116.64 7.83 4.33 1.99, 1.55 1.74 (0.77)   QD2 (0.75) 
MET 58 117.98 7.97 4.54 2.42, 1.86     (1.96)   
PRO 59     4.45 2.37, 2.04 (2.00) 3.52, 3.44     
SER 60 114.90 8.36 4.34 4.06, 3.99         
ASN 61 120.75 7.99 4.81 (3.00)         
CYS 62 117.83 8.26 4.57 3.09, 3.03         
GLY 63 111.28 8.52 4.09           
LEU 64 122.42 7.91 4.05 1.77, 1.63 1.62 (0.92)   QD2 (0.83) 
GLU 65 117.90 8.66 3.91 2.08, 1.97 2.36       
GLU 66 120.04 8.22 4.12 2.14, 2.08 2.34       
LYS 67 119.32 7.78 4.14 2.00, 1.87 1.50, 1.61 1.69, 1.62 (2.97)   
ILE 68 118.41 8.23 3.72 1.97 1.80, 1.63 (0.82)   QG2 (0.97) 
ALA 69 122.85 8.07 4.22 (1.55)         
ASN 70 115.44 7.88 4.87 2.96, 2.90       HD21 7.62, HD22 6.97 
LEU 71 120.60 7.82 4.33 1.98, 1.62 2.04 (0.96)   QD2 (0.95) 
GLY 72 106.78 8.24 4.05           
SER 73 115.63 8.22 4.57 4.06, 4.02         
CYS 74 119.30 8.26 4.65 3.11         
ASN 75 120.02 8.43 4.84 3.04, 2.83       HD21 7.75, HD22 7.09 
ASP 76 119.19 8.30 4.67 2.88, 2.73         
SER 77 112.82 8.22 4.26 4.04, 4.00         
LYS 78 120.52 7.93 4.56 (1.90) 1.52, 1.43 (1.78) (3.08)   
LEU 79 123.72 9.02 4.78 2.05, 1.77 1.55 (0.95)   QD2 (0.92) 
GLU 80 121.18 8.63 4.90 2.58, 2.25 2.49       
PHE 81 123.46 9.36 3.53 2.92, 2.89   (6.56) (6.86) HZ 6.70 
ARG 82 116.45 8.94 4.04 2.08, 1.92 (1.77) 3.21, 3.28     
SER 83 115.73 7.61 4.51 4.14, 4.04         
PHE 84 122.19 7.49 4.22 (3.10)   (6.88) (7.20) HZ 7.33 
TRP 85 120.70 8.77 3.76 3.12, 2.59       HD1 6.92, HE1 10.04, HE3 7.15, HH2 6.41, HZ2 5.87, HZ3 6.83 
GLU 86 119.09 8.15 4.08 2.33, 2.17 2.53       
LEU 87 120.84 7.60 4.05 (1.78) 1.72 (0.82)   QD2 (0.85) 
ILE 88 115.18 7.96 3.59 1.66 0.92, 0.82 (0.32)   QG2 (0.58) 
GLY 89 108.14 7.62 2.85,2.16           
GLU 90 120.00 7.41 3.96 2.14, 2.05 2.28       
ALA 91 122.45 7.61 4.01 (1.37)         
ALA 92 117.96 7.74 3.67 (0.90)         
LYS 93 114.64 7.20 3.77 1.83, 1.74 1.40, 1.29 (1.61) (2.92)   
SER 94 113.04 7.53 4.45 4.15, 4.00         
VAL 95 122.14 7.44 3.94 2.17 (0.99)     QG2 (0.96) 
LYS 96 126.31 8.47 4.40 (1.90) 1.52, 1.44 (1.76) (3.05)   
LEU 97 123.36 8.14 4.41 1.60, 1.51 1.57 (0.82)   QD2 (0.80) 
GLU 98 121.36 8.32 4.34 2.07 2.33       
ARG 99 122.83 8.28   1.86, 1.75 (1.67) 3.26, 3.21     
PRO 100     4.52 2.33, 1.91 (2.03) 3.80, 3.65     
VAL 101 120.49 8.23 4.13 2.06 (0.96)       
ARG 102 124.58 8.39 4.42 (1.83) (1.69) (3.25)     
GLY 103 110.43 8.40 3.96           
HIS 104 123.38 7.89 4.50 3.25, 3.11       HD2 7.10, HE1 6.81 
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Table S3. 
15
N R1, R2, NOE evaluated on the S100A14 at 298 K and 700 MHz. 
 
 
                             R1 (s-1)                 R2 (s-1)           NOE 
 
 
Res N° Exp Calc Exp Calc Exp 
              
  1           
G 2 2.50   20.97   -1.12 
Q 3 2.53   14.34   -0.85 
C 4 2.12   20.61   -0.85 
R 5 2.36   18.44   -0.23 
S 6 2.36   9.56   -0.09 
A 7 2.39   12.92   -0.07 
N 8 2.29   17.33   -0.01 
A 9 2.21   9.69   0.26 
E 10 1.89   8.03   0.20 
D 11 1.80   7.52   0.23 
A 12 1.63   10.04   0.25 
Q 13 1.70   12.67   0.40 
E 14 1.72 0.91 13.02 18.76 0.35 
F 15 1.30 0.86 17.51 19.84 0.43 
S 16   0.92   18.48 0.75 
D 17 1.69 0.86 24.98 19.72 0.88 
V 18 1.51 0.82   20.58 0.45 
E 19 1.27 0.89 22.60 19.12 0.90 
R 20 0.96 0.90 25.35 18.94 0.69 
A 21 0.92 0.81 26.35 20.83 0.75 
I 22 0.89 0.82 16.34 20.58 0.99 
E 23 0.66 0.83 18.82 20.37 0.72 
T 24 0.45 0.82 17.73 20.79 0.67 
L 25 0.80 0.82 25.54 20.66   
I 26 1.17 0.83 25.00 20.49 0.81 
K 27 0.92 0.83 29.45 20.37 0.72 
N 28 0.60 0.84   20.24 0.77 
F 29 0.94 0.81   20.92   
H 30 1.05 0.81 21.76 20.88 0.73 
Q 31 0.81 0.84 26.42 20.24 0.80 
Y 32 0.57 0.85   19.96 0.83 
S 33   0.87   19.57 0.80 
V 34   0.96   17.86   
E 35 1.75 0.94 21.43 18.12 0.56 
G 36   0.93 19.26 18.28 0.64 
G 37 1.76 0.84 14.89 20.24 0.60 
K 38 1.63 0.96 31.57 17.79 0.65 
E 39   0.81   20.88 0.56 
T 40   0.92   18.42 0.37 
L 41   0.97   17.57   
T 42   0.97   17.64 0.72 
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P 43           
S 44 1.17 0.94 22.05 18.18 0.87 
E 45 0.82 0.96 24.75 17.70 0.97 
L 46 0.69 0.93   18.35 0.79 
R 47 0.94 0.90 19.78 18.83 0.79 
D 48 0.99 0.95 22.72 17.92 0.97 
L 49 0.71 0.96   17.67 0.92 
V 50 0.62 0.91   18.69 0.77 
T 51 0.96 0.90 23.77 18.98 0.84 
Q 52 0.74 0.96 21.98 17.83 0.81 
Q 53 1.08 0.94 27.53 18.08 0.78 
L 54   0.84 31.88 20.16 0.59 
P 55           
H 56   0.95   18.02 0.71 
L 57   0.96   17.79 0.75 
M 58 1.14 0.96 35.78 17.73 0.76 
P 59           
S 60 1.82 0.96 19.94 17.76 0.60 
N 61   0.92 12.69 18.52 0.13 
C 62   0.95   17.89 0.44 
G 63   0.95 19.58 17.86 0.44 
L 64 1.34 0.96 23.13 17.79 0.77 
E 65 1.22 0.96 22.17 17.86 0.70 
E 66 1.08 0.93 18.63 18.25 0.80 
K 67 0.91 0.96 21.05 17.70 0.61 
I 68 0.66 0.96   17.83 0.59 
A 69 1.10 0.95 26.06 17.95 0.83 
N 70 1.04 0.96 25.06 17.67 0.80 
L 71 0.89 0.92 18.94 18.55 0.58 
G 72 1.29 0.92 16.42 18.48 0.48 
S 73 1.55 0.94 19.02 18.05 0.62 
C 74 2.01 0.87 18.87 19.49 0.54 
N 75   0.86 23.73 19.80 0.66 
D 76 1.63 0.96 20.11 17.79 0.47 
S 77   0.93   18.28 0.49 
K 78 1.30 0.87 18.54 19.61 0.58 
L 79   0.87   19.42   
E 80   0.95   17.89   
F 81   0.96   17.86   
R 82 0.92 0.95   17.95 0.70 
S 83 0.76 0.93   18.25 0.64 
F 84   0.96   17.83   
W 85   0.95   17.99   
E 86 1.31 0.91   18.69 0.89 
L 87 1.13 0.94 35.53 18.08 0.50 
I 88   0.96   17.86   
G 89   0.94   18.12   
E 90 1.26 0.92 31.21 18.48 0.69 
A 91   0.95   18.05 0.73 
A 92   0.95   17.99   
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K 93 1.73 0.86 28.23 19.69   
S 94 1.36 0.94 22.31 18.08 0.55 
  95   0.94   18.08   
  96   0.96   17.86   
L 97   0.95   18.02 0.36 
E 98 1.54   16.54   0.44 
R 99 1.68       0.43 
P 100           
V 101     10.77   0.33 
R 102 2.12   11.47   0.16 
G 103 2.13   14.72   -0.19 
H 104 1.58   10.34   -0.34 
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Figure S1. 2D 
1
H-
15
N-HSQC spectra of S100A14 in the absence (blue cross-
peaks) and in the presence (red cross-peaks) of 80 mM calcium(II) ions. 
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Figure S2. Relaxation data of S100A14 measured at 298K and pH 6.5. The 
experimental data are reported as black dots, instead the grey bars represent the 
predicted values by HydroNMR considering the homodimeric NMR solution 
structure of S100A14. 
 
Results 
169 
 
 
 
3.5 NMR characterization of the C-terminal tail of full-
length RAGE in a membrane mimicking environment 
 
Valentina Borsi 
1
, Linda Cerofolini 
1
, Marco Fragai 
1,2
, Claudio Luchinat 
1,2 
 
1
 Magnetic Resonance Center (CERM) – University of Florence, Via L. Sacconi 6, 50019 
Sesto Fiorentino, Italy. 
2
 Department of Chemistry – University of Florence, Via della Lastruccia 3, 50019 Sesto 
Fiorentino, Italy 
 
 
J Biomol NMR. (2012), 54, 285-290 
 
 
 
 
 
 
 	

	
 !"#$%&$
'$&%
()(*+(,-./012(34.35 ))(67(,-38(67(9:(;34.35<1:=*>?(,@2=*2(-338(67(9:(;34.3A86;*2B(;8)*(2)(CD1>*2(>>E(,*FDGHG34.3#
 F;B(7*2B7?(;()(67@;I@;7?(F,+F2)(,B=J)FK7*@2(2,6;@,1)7>L MN>*B2F=*2B?F>F6@7(27*F=I@;7?(6;(+(27*@2F2,7;(F79(27@I>(+(;F=6F7?@=@B*(>GO7;F)(=K=1=F;F)7*+F7*@2@I M7;*BB(;>7?(*27(;F)7*@2>@I7?( M)J7@6=F>9*)7F*=P*7?*27;F)(=1=F;6;@7(*26F;72(;>GQ(;(7?()J7@6=F>9*)7F*=@I M?F>:((2*2+(>7*BF7(,:JREF>6F;7@I7?(I1=K=(2B7?6;@7(*2S*27?(6;(>(2)(@IF9(9:;F2(K9*9*)T*2B(2+*;@29(27G?(*>@=F7(,)J7@6=F>9*)7F*=?F>F=>@:((2>71,*(,I@;)@96F;*>@2G?(RE>6()7;F@I7?(P?@=(;()(67@;>?@P7?F7>@9(:172@7F=;(>*,1(>:(=@2B*2B7@7?(K7(;9*2F=;(B*@2@I7?()J7@6=F>9*)7F*=?F+(F=F;B(U(O*:*=*7JSP?*=(7?(9(9K:;F2(6;@O*9F=;(B*@2>((9>7@:(;*B*,=J)@22()7(,7@7?(7;F2>K9(9:;F2(,@9F*2F2,()7@,@9F*2>G?(F2F=J>*>*2,*)F7(>7?F77?(:(?F+*@;@I7?()J7@6=F>9*)7F*=*>>7;@2B=JFI()7(,:J*7>:(*2B6F;7@I7?(P?@=(;()(67@;G?(>(;(>1=7>6;@+*,(2(P *2>*B?77@PF;,>7?(12,(;K>7F2,*2B@I>*B2F=7;F2>,1)7*@2:J MGVWX&#  MY8*B2F=7;F2>,1)7*@2YE(9:;F2(6;@7(*2>YRE>6()7;@>)@6J Z&
?(;()(67@;I@;F,+F2)(,B=J)F7*@2(2,6;@,1)7>L MN*>F91=7*=*BF2,;()(67@;@I7?(*9912@B=@:1=*2>16(;IF9*=J6;(>(27@27?()(=>1;IF)(F2,*2+@=+(,*2*2UF99F7*@2F2,*9912(;(>6@2>(>L8)?9*,7(7F=G3444[R((6(;(7F=G.\\3[86F;+(;@(7F=G344\[?F+FT*>(7F=G344]NG M)@2>*>7>@IF2RK7(;9*2F=(O7;F)(=1=F;6@;7*@2S)@96;*>*2B,@9F*2>HS.F2,3L3/^/._NS@IF7;F2>9(9:;F2(?(=*OL/]/^/`/NSF2,@IF>?@;7)J7@6=F>9*)7F*=L/`]^]4]NG?(=F7(;6=FJ>F);1)*F=;@=(*27?(7;F2>,1)7*@2@I7?( MK=*BF2,*27(;F)K7*@2>LQ1,>@2(7F=G344a[F*(7F=G34.3[8FTFB1)?*(7F=G34..NS:177?(,(7F*=>@I7?(9@=()1=F;9()?F2*>9F2,7?(9@,1=F7*@2@I MF)7*+F7*@2F;(>7*==F;B(=J12;(+(F=(,G8(b1(2)(F=*B29(27>?@P>7?F77?(;(*>F?*B?=(+(=@I)@2K>(;+F7*@2:(7P((27?()J7@6=F>9*)7F*=>@I7?(+F;*@1>>6(K)*(>SF2,(O)=1,(>F2J(2cJ9F7*)F)7*+*7JI@;7?(K7(;9*2F=,@9F*2@I MG ))@;,*2B7@7?(F9*2@F)*,)@96@>*7*@2F2,7@7?(,(>);*:(,I12)7*@2F=;@=(>S7?*>>?@;7>(b1(2)(?F>:((2,*+*,(,*27@7?;((,*>7*2)7;(B*@2>S@2(6;@O*9F=7@7?()(=9(9:;F2(S;*)?@I:F>*)F9*2@F)*,>SF)(27;F=I;FB9(27;*)?@IF)*,*)F9*2@F)*,>SF2,F=@PK)@2>(;+(,K7(;9*2F=;(B*@2L>?*?F;F(7F=G344/NGQ(;(S7?()J7@6=F>9*)7F*=@I M?F>:((2*2+(>7*BF7(,F>6F;7@I7?(I1=K=(2B7?;()(67@;*27?(6;(>(2)(@IF9(9:;F2(K9*9*)T*2B(2+*K;@29(27SF2,)@96F;(,P*7?7?(*>@=F7(,6(67*,(G?(F2F=KJ>*>*2,*)F7(>7?F77?(:(?F+*@;@I7?()J7@6=F>9*)7F*=*>>7;@2B=JFI()7(,:J*7>:(*2B7(7?(;(,7@7?(P?@=(;()(67@;G#&&#<;(6F;F7*@2@I7?(6;@7(*2>F96=(>?()J7@6=F>9*),@9F*2@I MS*2)=1,*2B7?;((;(>*,1(>:(=@2B*2B7@7?(7;F2>K9(9:;F2(,@9F*2L/`.K<]4]S

#ddW?(@2=*2(+(;>*@2@I7?*>F;7*)=(L,@*-.4G.44_5>.4aeaK4.3K\`_.K4N)@27F*2>>166=(9(27F;J9F7(;*F=SP?*)?*>F+F*=F:=(7@F17?@;*c(,1>(;>GHGD@;>*YG(;@I@=*2*YEGf;FBF*YG1)?*2F7LgNEFB2(7*)(>@2F2)((27(;LENSh2*+(;>*7J@If=@;(2)(S+*FG8F))@2*`Se44.\8(>7@f*@;(27*2@S7F=J(K9F*=-=1)?*2F7i)(;9G12*jG*7HGD@;>*YEGf;FBF*YG1)?*2F7k(6F;79(27@I?(9*>7;JSh2*+(;>*7J@If=@;(2)(S+*F,(=FF>7;1))*F/Se44.\8(>7@f*@;(27*2@S7F=J ln0D*@9@=REL34.3Ne]-3ae^3\4ko.4G.44_5>.4aeaK4.3K\`_.K4
 	
	

	 !
"#$%%&&'(		 
)*!
+,
'*-,		 ./
 -0/&1 			2		
3	
	
 3/
	 
1
./1 	
	
	456789!:;& '	
 1

 		:!

'<=
>(%%? %.<
	
 ./2		 
	
 
&# ,/
	

	)
'<=.	
	1 	

@%%%A
 
 /	)%#+B#3C&#
%.%;D.
	

 	

0%%%%A
		  
 
	E	
	

&% 1
		
/	)%#+B
&#./3/

	1	 
1
 &	&	 

		
		)
	
1	3	2&(.(%<) 
 
	+3&%#+<.;
&)%#.2	
		
	1	33&<F
 	


	
;)%

	
	"	.3
&)
&)&'	   
  	 		  
 	
12 	#@

 
&) +0;3>0
&' 
	
 
		 	 1.C !
"#$%%&&'(
 /&)1 			2		


	 
1
./1 	
	
	456789!:;& '0'	

 		:!

;)=
>(%%? %.<
	
 ./2		 
	
 
&#,/
	

1	
;)=.	
	1 	

@%%%A
 
 /	;%# 
'%%##3C&#
%.%;D
+B./		 

 
G
	 
/	;%#
'%%#H	
B##3C&#33%.;F
+B./G	
		G2  	
	
+:
;(D(%3	2<) 
 
	E	


/		./	
	+



3
	CC 
	
	
	
	 
/	;%#
'%%#%.;F
+B

G)%%#./		
			
  
 
	E	

	 
/	;%#
0%#%.;)
+B

&% 1
		
/	;%#
)%%# %.;F
+B./	
	
 
	 
/	;%#
'%%#).<F
+B.3
&'
&)	 		 
 	
12 	#@

 
&) +0;3>0
&' 
	
 
		 	 1.#
	
	
/2		E   
 
 
 %.;I%.'#
		&%#+3+<.;&)%#
			
	
	;@BJ!	"	K 			

@%%
<%%#+G
E		
  		./
+*L
M	
 




&+  ;&+I&)+3N'+'+>'! >+'+!
&' OP7QR7S8TUU ;>;>;!>#2	 !	
.;%%(./

  
&+
&'	
 	
	

' ++/>3V 	
<%%#+G.


			/
3&
/
3;./2	 %.&#
		;%#/	+B'%%#
;%#
;

 
 
	  	
 E	
;@BJ
!	"	K 			

@%%#+G
E
 		.&;
>
	/2		
	&)	
2
	

&+&)>	
 E	
;@BJ
<%%#+G!	"	1
  		&)	 
 
 


  	
%.;
%.&#	 1./&)
	
2
	
 &	
	  
	; &+I&) +3N 	

E 	1 	 	
 		
2


 	1
	
1		 1	
	
;%
&)%%	
 
 

;%
;%%%		 1 J

.&@B@W!
	

.&@@;./	  

0.%

 EB&	
	
2

	./&) 	
1		
2
	
 ;	
	
#E  J

.&@B@W
X
	&@@0
#	 
Y#0)%Z
1
	

	
	&(.@(<)%	
 
 

	B.0B;0).@;		 		 1.+	 
	&+[&)>	
	
;B( \!# ;%&;)0];B)I;@%
 	
	
					


					 
					
	 ! ""#!		
	
	"$ 	

 "%&'&()*+
	 


	
			,		- 

		
- 	&"$./012304566708100795			:;<=

>
	>
		 ?@>"-:;<=! 	
	
,	)*>	)*(>

&()*+
	 	

		-	


 A	!*$:		
 	

		>	>
				 <>)B-
>@"-<>@C-;
>@D-;
>@B	<>D"!*
	 A&	!	 		 E
	

	  
	



 		
 

	;>F'G 	&""B!*-*-H-I-I	J					
	
	>
	
 E 	

A

	
	
		:;<= 


				?	
	
-	
	
K	>	
>		 	


		

	)*
:-:&-	*'=
 A	--!:	>	L

	
	
	
K		 *'=	 ")
	?

:;<=-		
		
	
	
	 
		-
	
*'=
				
K

		>
	
 A!*'=					:;<=L		I>



:		> 
M
	
	>
	
		 :		&"&!
	

		#

		
		

>
			

		


:;<=	
		
?
			:;<=	

	
				K  


	
	M		

E	
	


		
	
K		
*$:	>K	

	

	>
	

->:;<= 	-
		
	
K*$:?&()*:'N>+
	-

)*>
	>


- 

		M	

		 A!	

	>

 			 	 

>	M:;<=$
	-
>	M
	>


		:;<=- 		
		
		
			
	

 O--&	
	
		!

	
		

 	
 >>:;<=O

	-
			M	 

 
	A 	 A
-	P!>	>
 !-		
	 A
&!		

	'>
K			

	




	:;<=	
		

	# 	Q
M	Q	&"!
>	M
	>:;<=	
	 ,
;C)-=CC-=D-=D&-=D-=D-;D@-=DC-FDD-=B-=B)-;B@-<BC-=BD-<"&	<"-
> A!- 


	 :C-+CB-:D)-*DB-+B"-=B&!	
	A 

	M-

	

-	;	-
	M?@-F@&-R@-:@)-:@@-<C"-*CD-B-BB-""-"-
-	


	

; 		,	
:;<=>

		
				
	
>	M

	- A&?			


	
	E	
	
	
>:;<=	



>		?	
	
-		M		 
	:;<=
-		



	I>


	 :		&"&!	
	()*>*'=	-	
:		:&	 A-	--!		 
		 	

SP*$: &"&!)T&D)(&B" &DCUW
 	
	 !"#"$%&'#!#(()#*#+,#!"-).!(*'/	
012+	)"#+#())3,#$%& )-(#!#(()).! (* ))()4*'5-**#,*6789:;<=8:9*">.(,)!!*'?	
	)#*)3,#$%& @A")-*(6>'0)4 ,*6#
*?>*.,)),!#.(B )#))(""*"6C#
D"
0>!#(),,!*,'C*B)*"(*)	
	 ))#**#.* !"#"$%&E/;:96789:;<=8:9)>B)*")"#+#()).!#*(* ))()4*)	
	EF=8G6**!HIJ;H>B).!#*" )))(,#E(6**!KJIH>B)*" )L.!#))"#* )"L)#-,E M<JNGB)*")(*.)#*B) ))).(,B#".,)*!.**'C)"#+#())B!#(()),!#.(B#*!.#E?NOJ8=IJ<=NHB)*")#*"*((),#).) 	
 	 "**3,#EP#,)*6QRST6QR	>U6QRV>WX'>6YL#'$$Z>-*!)*")#,#)"#+#() ))#*6M<JNG#",>*!6[;JO#",>3,#%% \],#^ 6X>_`%
$Xac
  	
 	  	  		
	 	 	 	 
  
  

		 
	  		  	

	
  	     	 

  	 !	
 
  	"      
# $%&$' 		 			 #()*&+)*$,)*)-)*.)*/)**)0%)0&)0$1)0.!)023)4&3)443.%%.%&'	   	   56
  
   	 		(	 	 	&78&/!!9		 )42.%$	 	 
  			  	#: $'
   		  	 	
 	 
    

	
 
 ; 
 (
   		 	
 	 
   

	    


	
 
 ;  	
		 <=>?@A;&/!	 
	0%%B7$421&$		!9	 			 CDE	 &$		!9	
   					 FGH	 IA 
!B#$%&$'/.J$2/8$4% $24KM
 	
 	
	 ! 		"##!	#$   ##"!	%# 	$%&! # '	 	(		

		)*+,	 ##!"##-'	#	!! '!		! $./0$1/0$2/0/"# 	)*+, 		!'		 ) 
3
	"' $!	 ! # '		!'	 "# 				! # 
	$		(# 		 	 )*+,	!'  " 	$  #'! '	(# 		 "# 		
	 ' $	##!"##-#		 	 	 #	!'#	 		 # 		 		 ##!
456789:;6<=>?@=AB@6:C;585<;7@8;?D8;7@E;56B* 	 #	    	  	 #$-	'		)*+, '	 '			 #	#   
)*+,		!   	 #") 
3$,)F"G. 
33/		 	!(FH$.)*(IJJ-  
3
.  $!		    #"!K" ##"!	%# 		)*+,$ 		" 	/LM%!  		! 			.)*(IJJ	
.	! 	 #		    #			 #   " 	 	 	!	!"! 	#   
N7A65O8>:<?>6EB 	-! 	!I.P)".)Q	)Q1*3/RIS$)Q)3SQI)Q.(301$!,)#	&$!, 		##	$	Q	"I)
0J0/$,"I)
JT0$),(I,
30T3$(.,"UI(1,V,3/3$2"I)0S
 W>X>=>67>BQ!	+$.- I$F1,$(	)2$Q%*LLQ-!	#	 #	   ! %	 '	"#	 I)		Y  %M%! 
Q	#/Y0LSJQ# 2$Q.$ .$1Z"I$1 $( )330(		 I) %#	[ "\#	!-!	   	 	
]*##	JY/LJ/LL'-$Q *$	((33T)*+,		' 		 Y  M##		
I	!.0YL+&-$Q%*$ 	+I$+	!	*I$ ]$F #]$( #.$ ]$2\ (LL0	  	  	.^"'  %	 # 		! 	/	#	-		-
 Q	 /Y/T3/T 	Q.$F *R$*	I$_,$Q	  ,$`*^$#*I 33J.		)*+,	 #	#	 "[ 	 "#     #		 '		)T
]Q	 #J/Y/TTS/TT0J.F$  #F$F$-_#I$F	-33/		' 	"	 )*+, !	,)F!"	#" -	-
,Q13Y3S/F1,$	*$Q%*LJLQ-!	#		  !  ' 	  I)		Y 		abcdefbghghhcijkhilcml
Q	#"JYJLSJLSLI$#*I$Q]$Z$2$(Z$, 	F$$*LL 	%		  		' 	 		 		
]Q	 #0SYTLLJ33T(]2$2+LLT.'			#		' %	# #
I	,&#	 /LY0/L0) $^I 		*Z$Q &$)'	$#*I$-#* 3  			' 		 )*+,
	  	  	"# )*+,!	#
]Q	 #JSY//TT- I$I $Z##		F$U	$- Z$I		#*$!	$F	-F$ 3.)*($			1)GT$  	#)*+,		  	 !
(1	U,0JY//n-nR$.-	($"" '$'I]$' $#*I3	  	  		  ! 		' 		 )*+,
]Q	 #J0Y/S/S/T#*I$Z$Z$I333!	 				' 		  
Q	#Q	*I	  )TLJYLLZ$  	$	  +$Q%*33L*1UoY!#			!-!			 	#I)# 
]Q	#	 I)TTY//'	1]$* "*_$F)$1$*#$.#]$)  )$1Q$*#		**$R]$1	&I33L)*+,		' 		 $)*+, $	 M##	
]ISYSL3 ]Q	#	 I)3TYJL3pr
 176 
 
NMR CHARACTERIZATION OF THE C-TERMINAL TAIL OF FULL-LENGTH RAGE IN 
A MEMBRANE MIMICKING ENVIRONMENT 
Valentina Borsi
1,2
, Linda Cerofolini
1
, Marco Fragai
1,2
, Claudio Luchinat
1,2
* 
1 
Magnetic Resonance Center (CERM) – University of Florence, Via L. Sacconi 6, 50019 Sesto 
Fiorentino, Italy. 
2 
Department of Chemistry – University of Florence, Via della Lastruccia 3, 50019 Sesto Fiorentino, 
Italy. 
Address correspondence to: Claudio Luchinat, via L. Sacconi 6, 50019 Sesto Fiorentino, Italy, Tel.: 
+390554574263. Fax: +390554574253. E-mail: luchinat@cerm.unifi.it 
 
 
 
 
 
 
Supplementary Material 
 177 
 
INDEX 
 
 
Table S1. 
13C Resonance Assignments for cytRAGE polypeptide in water buffer solution……….. 3 
Table S2. 
1
H and 
15
N Chemical Shifts for cytRAGE polypeptide in water buffer solution…….… 5 
Table S3. 
15N relaxation values cytRAGE in water buffer ……..…………………........………… 6 
Table S4. Experimental 15N relaxation values for RAGE full-length receptor in the presence of DPC 
micelles………………………...……………………………..……………………………………… 8 
Figure S1. 2D 1H-15N TROSY-HSQC spectra of the full-length RAGE………………................. 9 
Figure S2.  Reducing denaturing and non-reducing native polyacrylamide gels of full -length 
RAGE.……………………………………………………….......................................................... 10 
 178 
 
Table S1. 13C Resonance Assignments for cytRAGE polypeptide in water buffer solution 
(pH 7.2, 298K). 
 
Chemical Shifts (ppm) 
 
 
Residue C Cα Cβ Cγ Cδ Cε 
        
        
GLY 359       
SER 360       
ILE 361 176.14 61.35 38.21 CG1 26.91, CG2 17.11 CD1 13.54  
LEU 362 177.09 55.39 41.74 30.04 CD1 26.42, CD2 25.32  
TRP 363 176.26 57.51 28.97    
GLN 364 175.74 56.07 29.23 33.60   
ARG 365 176.27 56.47 30.24    
ARG 366 176.72 56.20 30.47    
GLN 367       
ARG 368       
ARG 369       
GLY 370 174.08 45.24     
GLU 371 176.33 56.26 30.07 36.09   
GLU 372 176.16 56.55 29.96 36.12   
ARG 373 175.75 55.81 30.61 26.89 43.07 41.87 
LYS 374 175.64 55.72 32.87 24.48 28.79 41.89 
ALA 375 175.37 50.35 17.85    
PRO 376 176.93 63.14 31.87 27.16 50.29  
GLU 377 176.12 56.81 29.80 36.16   
ASN 378 174.78 53.01 38.72 176.90   
GLN 379 175.76 56.10 29.16 33.53   
GLU        
GLU 381 176.49 56.75 29.99 36.03   
GLU 382 176.44 56.56 30.13 35.99   
GLU 383 176.41 56.64 30.26 36.13   
GLU 384 176.33 56.58 30.00 35.95   
ARG 385 175.89 55.81 30.52 26.83 43.10  
ALA 386 177.67 52.54 19.00    
GLU 387 176.32 56.37 29.87 36.08   
LEU 388 176.91 54.99 42.17 26.70 CD1 24.73, CD2 23.16  
ASN 389 174.91 53.05 38.66 176.86   
GLN 390 175.71 55.73 29.15 33.63   
SER 391 174.10 58.26 63.68    
GLU 392 175.93 56.02 30.27 35.99   
GLU 393 174.31 54.05 29.46 35.74   
PRO 394 176.82 62.86 31.90 27.14 50.38  
GLU 395 176.23 56.36 29.85 36.04   
ALA 396 178.03 52.46 19.08    
GLY 397 174.01 44.94     
GLU 398 176.57 56.34 30.07 36.00   
SER 399 174.58 58.15 63.61    
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SER 400 174.80 58.21 63.59    
THR 401 174.97 61.72 69.50 CG2 21.24   
GLY 402 174.01 45.05     
GLY 403 179.67 44.21     
PRO 404       
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Table S2. 1H and 15N Chemical Shifts for cytRAGE polypeptide in water buffer solution 
(pH 7.2, 298K). 
 
Chemical Shifts (ppm) 
 
Residue N H
N
 Hα Hβ Hγ Hδ Qε Other 
                  
GLY 359                
SER 360                
ILE 361 122.93 8.29 4.11 1.88 1.36, 1.16 (0.84)    QG2 0.91 
LEU 362 125.35 8.15 3.69 (2.96)  1.86 (1.67)     QD2 1.73 
TRP 363 121.45 7.94 4.08 (3.19)        
GLN 364 121.11 8.05 4.44 (2.05) (2.29)      
ARG 365 121.10 8.07   (1.95)        
ARG 366 121.46 8.17            
GLN 367                
ARG 368                
ARG 369                
GLY 370                
GLU 371 120.37 8.22 4.19 1.99, 1.82 (2.19)      
GLU 372 121.83 8.46 4.18 1.98, 1.83 (2.16)      
ARG 373 122.13 8.27 4.25 1.76, 1.67 (1.55) (3.12)  (2.91)  
LYS 374 123.05 8.28   1.72, 1.64 (1.34) (1.59) (2.91)  
ALA 375 126.77 8.30 4.49 (1.29)        
PRO 376     4.32  2.20, 1.89 (1.93) 3.71, 3.59    
GLU 377 120.12 8.60 4.14 2.01, 1.82 (2.21)      
ASN 378 118.24 8.28 4.59 2.78, 2.66        
GLN 379 120.51 8.28 4.25 (1.89) (2.27)      
GLU 380                
GLU 381 121.60 8.42 4.21 1.94, 1.84 (2.19)      
GLU 382 121.26 8.31 4.17 1.96, 1.84 (2.17)      
GLU 383 121.97 8.34 4.17 1.99, 1.86 (2.20)      
GLU 384 122.34 8.38 4.15 1.96, 1.85 (2.18)      
ARG 385 122.53 8.26 4.15 1.75, 1.66 (1.52) (3.11)    
ALA 386 125.50 8.27 4.23 (1.31)        
GLU 387 119.78 8.36 4.19 1.97, 1.84 (2.19)      
LEU 388 122.70 8.12 4.18 (1.54) 1.53 (0.83)    QD2 0.78 
ASN 389 119.50 8.38 4.24 2.77, 2.68        
GLN 390 120.94 8.31 4.28 2.03, 1.90 (2.27)      
SER 391 116.99 8.31 4.37 (3.79)        
GLU 392 122.60 8.36 4.36 (2.03) (2.25)      
GLU 393 123.20 8.32 4.25 1.94, 1.78 (2.20)      
PRO 394     4.32 2.20, 1.82 (1.93) 3.71, 3.62    
GLU 395 121.24 8.48 4.33  1.95, 1.84 (2.20)      
ALA 396 125.46 8.33 4.14 (1.33)        
GLY 397 108.13 8.29 4.23, 3.90          
GLU 398 120.64 8.26 3.89 1.96, 1.85 (2.18)      
SER 399 116.87 8.40 4.42 (3.85)        
SER 400 118.08 8.41 4.48 (3.80)        
THR 401 114.99 8.17 4.33 4.23       QG2 1.13 
GLY 402 111.02 8.30            
GLY 403 109.50 8.05            
PRO 404                
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Table S3. 15N relaxation values for cytRAGE in water buffer solution measured at 700 
MHz 
1
H frequency, and 298 K. 
 
      R1 (s-1)      R2(s-1)  NOE  
Residue Exp. Calc. Exp. Calc. Exp. 
            
GLY 359          
SER 360   1.79   9.12  
ILE 361 2.30 1.79 4.91 9.14 0.15 
LEU 362 1.75 1.78 6.27 9.14 0.08 
TRP 363 1.97 1.73 6.05 9.49 0.21 
GLN 364 2.18 1.73 6.09 9.45 0.17 
ARG 365 2.26 1.84 5.12 8.84 0.20 
ARG 366 2.28 1.75 6.10 9.35 0.18 
GLN 367  1.82  8.95  
ARG 368  1.83  8.90  
ARG 369  1.81  9.01  
GLY 370 2.27 1.68 6.81 9.75 0.34 
GLU 371 2.29 1.83 5.20 8.87 0.33 
GLU 372   1.83   8.88  
ARG 373 2.32 1.64 4.85 10.04 0.27 
LYS 374 2.31 1.82 5.15 8.98 0.19 
ALA 375 2.03 1.74 5.49 9.38 0.16 
PRO 376          
GLU 377 2.05 1.77 4.56 9.23 0.18 
ASN 378 2.33 1.69 5.04 9.72 0.26 
GLN 379 2.18 1.83 4.94 8.90 0.23 
GLU 380   1.79   9.10  
GLU 381 2.02 1.67 4.41 9.82 0.29 
GLU 382 1.82 1.65 4.00 9.98 0.18 
GLU 383 1.83 1.78 3.99 9.14 0.12 
GLU 384 1.86 1.74 4.58 9.39 0.22 
ARG 385 1.78 1.76 4.84 9.31 0.22 
ALA 386 1.92 1.83 5.43 8.90 0.20 
GLU 387 1.82 1.63 4.47 10.07 0.13 
LEU 388 1.77 1.79 4.40 9.12 0.15 
ASN 389 2.29 1.72 4.63 9.53 0.08 
GLN 390 1.99 1.81 6.35 8.98 -0.08 
SER 391 2.43 1.84 4.43 8.85 -0.02 
GLU 392 2.16 1.67 4.18 9.81 0.02 
GLU 393 1.76 1.83 3.76 8.87 -0.10 
PRO 394          
GLU 395 1.86 1.69 3.31 9.68 -0.06 
ALA 396 1.93 1.84 4.19 8.85 -0.26 
GLY 397 1.94 1.78 4.51 9.15 -0.33 
GLU 398 1.98 1.69 3.82 9.70 -0.30 
SER 399 2.63 1.76 3.18 9.29 -0.57 
SER 400   1.78   9.18  
THR 401 2.34 1.72 2.95 9.55 -0.78 
GLY 402 2.19 1.73 2.73 9.45 -1.09 
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GLY 403 1.53 1.82 3.94 8.94 -1.65 
PRO 404          
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Table S4. Experimental 15N relaxation values for RAGE full-length receptor in the presence 
of DPC micelles measured at 700 MHz 
1
H frequency, and 298 K. 
 
Residue R1 (s-1) R2(s-1) NOE  
 
        
GLY 359       
SER 360       
ILE 361       
LEU 362       
TRP 363       
GLN 364       
ARG 365       
ARG 366       
GLN 367       
ARG 368       
ARG 369       
GLY 370       
GLU 371       
GLU 372       
ARG 373       
LYS 374       
ALA 375 3.05 9.04 0.27 
PRO 376      
GLU 377 2.29 6.62 -0.07 
ASN 378      
GLN 379      
GLU 380      
GLU 381 1.93 9.20 0.05 
GLU 382 2.25 8.18   
GLU 383 2.01 6.03 0.00 
GLU 384 2.01 11.41 -0.01 
ARG 385 2.30 5.08 0.02 
ALA 386 3.41 10.11 -0.27 
GLU 387 2.13 9.26 0.06 
LEU 388 2.26 5.38 -0.05 
ASN 389      
GLN 390      
SER 391      
GLU 392      
GLU 393 1.96 6.00 -0.17 
PRO 394      
GLU 395 1.81 6.71 -0.17 
ALA 396 2.86 9.03 -0.33 
GLY 397      
GLU 398    0.43 
SER 399      
SER 400      
THR 401      
GLY 402 3.53 8.70 -0.24 
GLY 403 3.85 5.57 -1.61 
PRO 404       
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Figure S1. 2D 1H-15N TROSY-HSQC spectra of the full-length RAGE represented with two 
different intensity thresholds in order to highlight, besides the intense signals of the cytoplasmic tail 
(panel A), the additional broad signals present in the spectra (panel B). 
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Figure S2. Reducing denaturing (A) and non-reducing denaturing (B) 4-12% Bis-Tris 
polyacrylamide gels. The spot corresponding to the monomeric full-length RAGE are marked with 
open black circles. Non-reducing native 10-20% Tris-Tricine polyacrylamide gel (C). Only two spots 
corresponding to species with very high molecular weight can be observed in the gel. 
  
 
 
 
 
 
 
 
4. Conclusions and perspectives 
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A complete description of the activity of biological systems often requires the rigorous 
investigation of their conformational heterogeneity and the analysis of the energy landscape 
related to the transitions between the different conformations. 
In the present research project, structural and dynamics information provided by NMR 
studies have been fruitfully used for the analysis of four different biomolecules, with the aim 
to answer specific questions about their biological function and the molecular mechanisms in 
which they are involved. 
Starting from the analysis of the truncated G-quadruplex construct, the NMR analysis 
has demonstrated, for the first time, the existence of the computational predicted G-triplex 
structure. The existence of this new folding is significant because it can open new 
opportunities for the comprehension of the mechanisms that control the maintenance of 
genome stability.  
In fact, this innovating finding supplies a step forwards for the understanding of the 
prologue of the process of chromosomal elongation due to the telomerase activity that is 
associated with aging and cancer. In particular, since this new conformation can be considered 
the possible intermediate of the folding/unfolding pathway of more complex G-quadruplex 
structures, it may also create new chance to block the telomerase activity, thus providing new 
tools for anticancer therapy. 
Relevant are also the results obtained in the analysis of matrix metalloprotease-1 in 
solution. Actually, the maximum occurrence (MO) analysis performed on NMR and SAXS 
data has provided the disclosure of the conformations of matrix metalloprotease-1, that can 
exist for the maximum per cent of time in solution. This is a fundamental clue for the 
inspection of the still not clarified mechanism of collagenolysis.  
In fact, this innovating strategy, scoring any wished conformation with a weight, 
allows to estimate also the probability of existence of the crystal structures. The latter, 
surprisingly, appear not to be the most probable ones, but to have only a maximum occurrence 
in solution of 20%. Therefore, the conformations possessing the lowest energy in 
crystallization conditions are not necessarily the most significantly represented in solution. 
This also explains the necessity of the refinement of crystal structures with NMR-based 
experimental constraints prior to use them as representative models of the protein in the 
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physiological conditions. Furthermore, the results we got, demonstrate that multidomain 
proteins should be analysed in terms of ensembles of conformations and not as single 
structures.  
Collectively, our results suggest that collagenolysis by MMP-1 can be described 
considering the conformations with the highest MO values as the starting point of a multistep 
mechanism where interdomain flexibility, conformational selection and induced fit cooperate 
in the degradation of triple helical collagen.  
Obviously, for the description of this very complex process both conformational 
selection and induced fit should be considered. A sequence of events, where the most 
probable (highest MO) conformations are the most easily selected and accessible, followed by 
the induced fit-related reorientation of the multidomain enzyme to proceed along the steps of 
collagenolysis, is plausible and possible.  
In conclusion, our results provide a contribution to elucidate the not trivial mechanism 
of collagenolysis that is crucial not only to clarify the molecular basis of the pathologies 
where the uncontrolled collagen degradation play a critical role, but also to design selective 
inhibitor of MMP-1.  
In the last few weeks new paramagnetic constraints have been acquired on MMP-1 in 
the presence of a collagen model. This new data will provide more details about the 
mechanism of collagenolysis.  
Furthermore, the analysis of the conformational space sampled by other members of 
the MMPs’ family in the absence and in the presence of collagen models, hopefully, will 
allow us to answer the questions concerning the different role of each MMP in vertebrates. 
One major advantage of NMR over x-ray crystallography is the possibility to solve the 
three-dimensional structure of biomolecules in experimental conditions closer to what they 
experience in vivo. Moreover, many proteins do not crystallize at all, and NMR remain the 
unique possible experimental approach to get structural information. In the present research 
project, the NMR analysis performed at physiological temperature, has revealed the unusual 
‘semi-open’ structure for the human EF-hand protein S100A14. This particular structural 
organization of the EF-hand domain together with the inability to bind calcium(II) are strictly 
related to the biological function of this protein, that seems to be constitutively activated and 
not to be modulated by the concentration of calcium(II) ion. 
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The analysis of the interaction of this peculiar member of the S100 family with the 
RAGE receptor could shed light on the function and localization of S100A14, providing also 
hints to target this biologically relevant interaction. 
 
The major challenge in the modern biomolecular NMR is the characterization of 
membrane proteins and the analysis of intracellular signal transduction mediated by 
membrane receptors after their activation by extracellular ligands.  
Cell signalling is, actually, an important mechanism to govern basic cellular activities 
and coordinates cell actions. Therefore, the elucidation of the cascade of events involved in 
signal transduction is important to design strategies to identify potential pharmacological 
targets.  
In particular, RAGE is an important pharmacological target that is involved in many 
inflammation-related pathological states. The cytosolic domain of RAGE receptor plays a 
pivotal role in signal transduction but its function, structural features and dynamical properties 
are still largely unknown.  
In the present research project, it has been highlighted that the C-terminal part of the 
cytosolic domain maintains its flexibility and structural heterogeneity also when tethered to 
the full-length receptor. In this way, the heterogeneous structural and dynamic properties of 
the cytoplasmic tail in the full-length receptor explain its broad binding capability toward 
multiple partners.  
The structural and dynamical analysis of the cytosolic domain reported in this thesis is 
only the first step in the characterization of RAGE pathway. The use of more physiological 
membrane-like environments and the analysis of the interaction with its “adaptor proteins”, 
will allow us to move deep inside in the mechanism of signal transduction mediated by the 
RAGE receptor. 
Collectively, the results obtained in the present research projects stress about the role 
of conformational heterogeneity as driving force for many biological processes, remarking the 
role of biomolecular NMR as a key tool in the study of systems biology.  
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